Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3008401	s-pujoe	— (—)	4144	4298	100.00%	Distribution not available
3008401	s-pujoe	u/ml (u/ml)	3536	3813	0.03%
3008401	pujo	— (—)	627	652	100.00%	Distribution not available
3008401	pujo	u/ml (u/ml)	118	121	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Asthma (mode)

2292

2666

4.89

307.65

1.1

1.0

1.18

1.20

u/ml

0.04

1266

886

Allergic conjunctivitis

1493

4969

3.06

307.65

1.1

1.44

1.03

u/ml

1.44

895

1932

Asthma-related infections

1416

3772

3.82

307.65

1.1

1.22

1.20

u/ml

0.04

850

1493

Asthma, including avohilmo

3324

4815

4.15

307.65

1.1

1.08

1.18

u/ml

0.27

1706

1843

Allergic asthma (mode)

1213

1624

7.94

307.65

1.1

1.0

1.22

1.30

u/ml

0.12

832

562

Asthma and allergy, excluding more controls

883

1015

9.67

307.65

1.2

1.0

1.45

1.63

u/ml

0.19

633

364

Chronic lower respiratory diseases

3032

5078

3.32

307.65

1.1

1.14

1.11

u/ml

0.08

1591

1953

Pollen allergy

1390

2046

7.74

307.65

1.1

1.41

1.11

u/ml

0.74

938

851

Asthma (only as main-diagnosis)

2168

2655

5.12

307.65

1.1

1.0

1.20

u/ml

0.00

1222

883

Asthma (only as main-diagnosis), excluding more controls

2162

2620

5.11

307.65

1.1

1.0

1.20

1.22

u/ml

0.03

1218

867

Allergic asthma (mode), excluding more controls

1213

1622

7.95

307.65

1.1

1.0

1.22

1.31

u/ml

0.12

832

560

Asthma

2294

2655

4.80

307.65

1.1

1.0

1.18

1.20

u/ml

0.05

1263

883

Asthma, hospital admissions , main diagnosis only

2312

5608

3.82

307.65

1.1

1.0

1.17

1.11

u/ml

0.17

1338

2154

Asthma and allergy

882

1002

9.78

307.65

1.2

1.0

1.45

1.64

u/ml

0.21

632

358

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1443

4704

3.12

307.65

1.1

1.47

0.99

u/ml

1.73

866

1808

Asthma, excluding more controls

2283

2620

4.82

307.65

1.1

1.0

1.18

1.22

u/ml

0.08

1261

867

Atopic dermatitis

1625

4773

3.01

307.65

1.1

2.13

0.82

u/ml

6.49

935

1918

1241

3186

4.02

307.65

1.2

1.1

1.17

1.22

u/ml

0.08

742

1291

Asthma (diagnoses ohter than nonallergic)

2388

5491

3.85

307.65

1.1

1.0

1.14

1.12

u/ml

0.06

1403

2084

Asthma, hospital admission 2, infections

1416

3772

3.82

307.65

1.1

1.22

1.20

u/ml

0.04

850

1493

Allergic rhinitis

1772

2876

6.73

307.65

1.1

1.46

1.17

u/ml

0.70

1152

1093

Asthma/COPD (KELA code 203)

2394

5026

3.45

307.65

1.1

1.19

1.12

u/ml

0.18

1259

1934

Vasomotor and allergic rhinitis

1853

2944

6.71

307.65

1.1

1.0

1.49

1.09

u/ml

1.22

1179

1102

Other diseases of upper respiratory tract

2030

4035

2.67

299.84

1.1

1.0

1.12

1.06

u/ml

0.15

1062

1469

Dermatitis and eczema

2167

5838

2.48

295.63

1.1

1.79

0.78

u/ml

5.81

1155

2298

Conjunctivitis

1745

5898

2.64

289.00

1.1

1.46

1.01

u/ml

1.77

1018

2384

Desensitization to allergens

420

633

7.87

274.43

1.1

1.67

1.24

u/ml

0.50

306

285

Asthma, unspecified (mode)

984

2207

3.62

272.74

1.1

1.0

1.18

1.27

u/ml

0.11

468

725

Asthma, unspecified (mode), excluding more controls

983

2185

3.62

271.56

1.1

1.0

1.18

1.29

u/ml

0.13

467

714

Disorders of conjunctiva

1784

6042

2.53

268.11

1.1

1.44

1.00

u/ml

1.77

1037

2440

Atopic dermatitis, strict definition with reimbursement

1037

3182

3.31

258.13

1.1

2.61

0.92

u/ml

5.91

685

1338

Chronic sinusitis

861

2433

3.64

255.80

1.1

1.0

1.12

1.09

u/ml

0.04

428

829

Chronic rhinitis, nasopharyngitis and pharyngitis

720

1828

4.08

250.69

1.1

1.0

0.92

1.06

u/ml

0.25

361

666

Nasal polyp

418

707

6.16

236.44

1.2

1.0

0.66

1.58

u/ml

1.29

245

247

Suggestive for eosinophilic asthma

279

311

9.63

230.12

1.2

1.0

0.63

1.51

u/ml

0.98

189

114

Other pulmonary diagnosis

1421

2696

2.68

209.64

1.1

1.0

1.20

1.19

u/ml

0.02

676

897

Obesity related asthma

628

1661

3.90

206.24

1.1

1.0

0.64

0.99

u/ml

1.14

299

569

Atopic dermatitis, strict definition

1009

3511

2.94

206.20

1.1

2.61

0.90

u/ml

6.01

676

1550

ILD differential diagnosis

1398

2666

2.67

204.23

1.1

1.0

1.17

1.20

u/ml

0.04

669

886

COPD differential diagnosis

1398

2667

2.67

204.11

1.1

1.0

1.17

1.20

u/ml

0.04

670

886

Excluding asthma or asthma-COPD overlap

1401

2696

2.64

201.27

1.1

1.0

1.21

1.19

u/ml

0.02

670

897

Cough

810

2554

3.12

187.00

1.1

0.92

1.28

u/ml

0.83

409

1072

Childhood asthma (age<16)

552

1097

4.21

184.06

1.1

1.0

2.06

1.44

u/ml

0.69

338

423

Childhood asthma (age<16), excluding more controls

552

1097

4.21

183.93

1.1

1.0

2.06

1.44

u/ml

0.69

338

422

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

822

2847

2.88

166.67

1.1

1.0

0.78

1.11

u/ml

1.15

364

984

Diseases of the respiratory system

1049

2007

2.66

152.56

1.1

1.0

1.36

1.14

u/ml

0.33

481

680

ILD medications: prednisolone, methylprednisolone, prednisone

1889

5454

1.98

146.07

1.1

1.42

0.97

u/ml

1.52

940

2223

Oral corticosteroids

1750

5297

2.03

145.97

1.1

1.37

1.01

u/ml

1.04

877

2094

Childhood allergy (age < 16)

691

1959

3.08

144.82

1.2

1.1

1.72

1.35

u/ml

0.52

489

900

Asthma-related pneumonia

520

1640

3.23

129.59

1.1

1.28

1.10

u/ml

0.24

315

632

Asthma, hospital admissions 3, pneumonia

521

1647

3.22

129.32

1.1

1.28

1.09

u/ml

0.25

315

637

Asthma-related pneumonia or sepsis

521

1647

3.22

129.32

1.1

1.28

1.09

u/ml

0.25

315

637

Abnormalities of breathing

1637

4969

1.98

128.49

1.1

0.90

1.22

u/ml

1.38

770

2080

Undetermined asthma, excluding more controls

254

495

5.31

123.30

1.1

1.0

1.39

1.61

u/ml

0.12

134

169

Undetermined asthma

254

496

5.30

123.02

1.1

1.0

1.39

1.57

u/ml

0.10

134

172

Symptoms and signs involving the circulatory and respiratory systems

1845

5012

1.87

116.49

1.1

0.98

1.22

u/ml

0.86

879

2101

ILD medications

1895

5801

1.81

111.78

1.1

1.38

1.01

u/ml

1.15

941

2420

Deviated nasal septum

450

1437

3.19

110.01

1.1

1.0

0.99

1.36

u/ml

0.53

196

495

Inflammatory bowel disease treatment related agents

1862

5924

1.81

109.22

1.1

1.33

1.01

u/ml

0.97

906

2457

Chronic diseases of tonsils and adenoids

1234

3915

2.02

103.75

1.1

1.0

1.00

1.07

u/ml

0.12

564

1433

First line medication for Crohn's disease

1837

5695

1.78

101.66

1.1

1.36

1.04

u/ml

0.91

904

2373

Dermatitis due to ingested food

251

564

4.91

100.76

1.3

1.1

2.14

1.02

u/ml

1.35

203

316

Adverse effects, not elsewhere classified

488

1737

2.91

99.72

1.1

1.46

1.12

u/ml

0.52

333

769

FESS (DNB20)

285

766

3.88

92.32

1.2

1.1

0.78

1.09

u/ml

0.35

153

308

Personal history of allergy to analgesic agent

32.64

91.89

1.5

1.1

0.35

0.90

u/ml

0.48

Ethmoidectomy

288

799

3.75

89.04

1.2

1.1

0.77

1.07

u/ml

0.34

155

317

Urticaria

631

2756

2.35

83.85

1.1

1.61

1.13

u/ml

0.66

364

1220

Acute upper respiratory infections

1525

5571

1.73

79.80

1.1

1.22

1.10

u/ml

0.23

692

2353

Diseases of the skin and subcutaneous tissue

1574

4580

1.74

79.56

1.1

1.52

0.76

u/ml

3.37

808

1745

Urticaria and erythema

691

3233

2.18

77.44

1.1

1.57

1.13

u/ml

0.64

399

1412

Dyspnoea

1173

5019

1.81

74.14

1.1

0.82

1.11

u/ml

1.26

557

2104

Other and unspecified effects of external causes

583

2603

2.30

73.67

1.1

1.36

1.21

u/ml

0.23

375

1162

Other medical care

498

2033

2.43

72.27

1.1

1.70

1.06

u/ml

1.34

337

825

Biological medicines for asthma

12.17

70.08

1.3

1.1

2.04

0.78

u/ml

0.55

Personal history of allergy to drugs, medicaments and biological substances

12.89

69.90

1.5

1.1

0.33

0.74

u/ml

0.76

Non-allergic asthma (mode)

265

840

3.18

64.80

1.1

1.0

0.36

1.69

u/ml

2.97

110

294

Non-allergic asthma (mode), excluding more controls

265

842

3.17

64.54

1.1

1.0

0.36

1.70

u/ml

2.99

110

293

Polypectomy (DHB20)

134

280

4.99

60.49

1.3

1.1

0.52

1.88

u/ml

1.22

109

1568

5191

1.61

60.06

1.1

1.19

1.07

u/ml

0.26

712

2129

Acute sinusitis

857

4387

1.85

59.76

1.1

1.00

1.13

u/ml

0.20

384

1838

Diseases of the eye and adnexa

1506

4690

1.62

59.12

1.1

1.41

1.04

u/ml

1.02

773

1900

Acute upper respiratory infections of multiple and unspecified sites

1160

5198

1.69

57.67

1.1

1.24

1.13

u/ml

0.18

538

2223

Dermatitis

724

3858

1.90

56.00

1.1

1.09

0.76

u/ml

0.99

355

1498

Allergic contact dermatitis

259

930

2.86

52.18

1.1

2.08

0.76

u/ml

0.97

130

348

Any reimbursement code in KELA

1223

3739

1.66

51.96

1.1

1.38

1.02

u/ml

0.79

625

1495

Bronchitis

1476

6278

1.55

51.29

1.1

1.21

1.10

u/ml

0.21

689

2632

D07AA Corticosteroids, weak (group I)

373

1644

2.33

48.94

1.2

1.1

3.11

1.16

u/ml

2.54

264

784

Sleep apnoea, including avohilmo

1153

4668

1.62

47.25

1.1

0.71

1.13

u/ml

2.70

453

1923

Other and unspecified dermatitis

602

3201

1.90

47.06

1.1

1.00

0.75

u/ml

0.71

299

1248

Medical observation and evaluation for suspected diseases and conditions

1014

3137

1.67

44.93

1.1

0.75

1.22

u/ml

2.29

510

1248

Other and unspecified urticaria

374

1736

2.20

43.24

1.1

1.54

1.16

u/ml

0.36

205

772

Asthma mixed form (mode), excluding more controls

203

4.83

41.72

1.1

1.0

0.33

2.59

u/ml

1.48

Asthma mixed form (mode)

205

4.78

41.24

1.1

1.0

0.33

2.53

u/ml

1.47

Early onset COPD, excluding more controls

167

540

3.13

40.27

1.0

0.93

1.56

u/ml

0.57

165

Headache

998

5362

1.57

37.95

1.1

0.95

1.19

u/ml

0.43

427

2317

Recurrent or chronic depression

668

2798

1.74

37.32

1.1

0.98

1.18

u/ml

0.36

290

1201

Special screening examination for infectious and parasitic diseases

523

2150

1.85

35.35

1.1

1.0

1.43

1.39

u/ml

0.04

271

803

Pain in joint

837

3447

1.62

35.15

1.1

1.10

1.12

u/ml

0.02

390

1496

Sleep apnoea

1004

4422

1.55

35.14

1.1

0.77

1.07

u/ml

1.44

392

1804

COPD/asthma related infections

1429

4942

1.46

34.94

1.1

1.26

1.08

u/ml

0.37

640

2041

COPD/asthma/ILD related infections

1429

4942

1.46

34.94

1.1

1.26

1.08

u/ml

0.37

640

2041

Idiopathic urticaria

140

5.48

34.82

1.1

0.72

0.77

u/ml

0.04

Voice disturbances

323

1539

2.13

34.81

1.1

0.73

1.06

u/ml

0.75

145

624

Examination and observation for other reasons

825

3117

1.62

34.19

1.1

0.87

1.23

u/ml

1.08

403

1240

Other special examinations and investigations of persons without complaint or reported diagnosis

965

3137

1.57

33.42

1.1

1.23

1.22

u/ml

0.00

442

1248

Migraine, single triptan purchase ok & required. ICD-code if available is included

1195

5537

1.47

32.70

1.1

1.01

1.20

u/ml

0.42

486

2389

Triptan medication for migraine, single purchase ok

1195

5537

1.47

32.70

1.1

1.01

1.20

u/ml

0.42

486

2389

Chronic laryngitis and laryngotracheitis

147

508

2.94

31.81

1.1

1.0

0.64

1.49

u/ml

0.99

175

Migraine

835

4604

1.56

30.94

1.1

0.71

1.28

u/ml

2.79

361

2010

Depression or dysthymia

908

3297

1.55

30.82

1.1

1.10

1.18

u/ml

0.13

391

1433

Other acute lower respiratory infections

682

4045

1.62

30.68

1.2

1.1

1.12

1.19

u/ml

0.14

363

1854

Gastro-oesophageal reflux disease

743

4173

1.59

30.33

1.1

0.87

1.10

u/ml

0.51

292

1746

Episodal and paroxysmal disorders

1591

5907

1.39

30.03

1.1

0.96

1.22

u/ml

0.80

691

2643

Symptoms and signs involving speech and voice

350

1826

1.94

29.31

1.1

0.78

0.98

u/ml

0.45

155

752

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

658

2007

1.66

28.59

1.1

1.64

1.31

u/ml

0.36

286

851

Neurotic, stress-related and somatoform disorders

1260

6363

1.42

28.48

1.1

1.31

1.13

u/ml

0.30

574

2692

Anxiety disorders

1264

6378

1.41

28.19

1.1

1.31

1.13

u/ml

0.31

578

2695

Dermatographic urticaria

140

511

2.83

27.76

1.1

1.39

1.07

u/ml

0.12

207

Asthma and opportunity respiratory infection

5.55

27.52

1.1

0.57

2.10

u/ml

0.60

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

513

4985

0.60

26.93

1.1

1.01

1.08

u/ml

0.09

205

2068

Malignant neoplasm, wide definition for exclusion

513

4984

0.60

26.90

1.1

1.01

1.08

u/ml

0.09

205

2068

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

514

4988

0.61

26.83

1.1

1.01

1.09

u/ml

0.10

205

2071

Sleep disorders (combined)

1168

5415

1.42

26.65

1.1

0.84

1.17

u/ml

1.69

470

2283

Malignant neoplasm

483

4746

0.60

26.19

1.0

1.1

1.01

1.08

u/ml

0.10

198

1957

COPD

228

870

2.17

25.50

1.0

0.82

1.05

u/ml

0.30

306

Bronchiectasis

137

4.52

25.24

1.0

1.1

0.42

2.09

u/ml

0.95

Speech therapy

278

1415

1.99

25.14

1.1

0.44

1.05

u/ml

2.02

110

602

Irritable bowel syndrome

373

2096

1.80

24.83

1.1

0.98

1.15

u/ml

0.15

168

858

Anxiety disorders, excluding more controls

1145

5431

1.41

24.65

1.1

1.34

1.08

u/ml

0.43

522

2296

Pain (limb, back, neck, head abdominally)

1047

3660

1.44

24.50

1.1

1.28

1.08

u/ml

0.31

487

1657

Temporomandibular joint disorders, including avohilmo

666

4358

1.54

24.24

1.1

0.65

1.25

u/ml

3.72

300

1819

Pain in throat and chest

1023

4397

1.43

23.88

1.1

0.87

1.27

u/ml

1.74

463

1792

Low back pain

921

4930

1.45

23.88

1.1

0.98

1.14

u/ml

0.25

390

2066

Other chronic obstructive pulmonary disease

211

819

2.15

23.16

1.0

0.80

1.09

u/ml

0.37

283

Any event in cancer register

590

5362

0.65

22.71

1.1

1.22

1.02

u/ml

0.27

232

2232

All anxiety disorders

970

5558

1.42

22.33

1.1

1.30

1.17

u/ml

0.18

464

2394

Tonsillectomy and adenotomy

1060

5331

1.40

22.04

1.1

0.92

1.22

u/ml

0.94

493

2427

Provisional assignment of new diseases of uncertain etiology

610

4012

1.53

21.82

1.1

0.77

1.14

u/ml

0.76

260

1795

Codes for special purposes

610

4015

1.53

21.75

1.1

0.77

1.14

u/ml

0.76

260

1796

Covid-19 suspected case

364

2127

1.74

21.35

1.1

0.84

1.35

u/ml

0.61

155

937

Dorsalgia

1316

5321

1.35

21.01

1.1

1.05

1.15

u/ml

0.18

581

2275

Anxiety (asthma-related co-morbidities)

942

5320

1.41

20.90

1.1

1.30

1.23

u/ml

0.10

446

2269

Other headache syndromes

529

3410

1.56

20.76

1.1

1.00

1.21

u/ml

0.21

238

1396

Other dorsopathies, not elsewhere classified

1365

5414

1.34

20.69

1.1

1.04

1.18

u/ml

0.29

600

2336

Acetic acid derivatives and related substances

347

1010

1.80

20.69

1.1

1.09

1.34

u/ml

0.29

137

484

Persons encountering health services for examination and investigation

890

3137

1.43

20.12

1.1

1.05

1.22

u/ml

0.31

406

1248

Coxibs

345

1041

1.78

19.76

1.1

1.55

1.36

u/ml

0.11

137

494

Conjunctivitis (acute, non atopic)

374

2241

1.68

19.67

1.1

1.91

0.97

u/ml

1.72

203

991

Depression

1234

6397

1.33

19.48

1.1

0.93

1.16

u/ml

0.71

563

2672

Parasetamol

1198

4556

1.35

19.24

1.1

1.14

u/ml

0.00

523

1975

Abnormalities of heart beat

352

2074

1.70

19.21

1.1

1.28

1.27

u/ml

0.00

138

834

Propionic acid derivatives

440

1350

1.65

19.10

1.1

1.65

1.29

u/ml

0.32

197

716

Atopic conjunctivitis

342

2.85

18.94

1.1

1.34

1.58

u/ml

0.12

159

Selective serotonin reuptake inhibitors

1268

5040

1.33

18.72

1.1

1.10

1.09

u/ml

0.02

555

2154

Diseases of the musculoskeletal system and connective tissue

981

3579

1.38

18.40

1.1

1.36

1.20

u/ml

0.24

468

1684

Mood [affective] disorders

1281

6434

1.32

18.21

1.1

0.92

1.18

u/ml

0.88

579

2695

Triptan medication for migraine, min. 3 purchases

871

4980

1.39

18.18

1.1

0.76

1.18

u/ml

0.96

348

2060

Acute bronchitis

435

2717

1.58

17.94

1.1

1.05

1.27

u/ml

0.42

208

1223

Mood disorders

1280

6437

1.31

17.86

1.1

0.92

1.18

u/ml

0.86

578

2698

Soft tissue disorders

1435

5770

1.30

17.69

1.1

1.10

1.15

u/ml

0.10

631

2589

Eosinophilic disease (BM)

7.43

17.08

1.2

1.1

0.41

5.72

u/ml

—

Other disorders of lacrimal gland

333

2020

1.66

16.96

1.1

0.78

1.15

u/ml

0.82

144

819

Temporomandibular joint disorders

229

1256

1.85

16.76

1.1

0.40

1.01

u/ml

2.86

501

Disorders of lacrimal system

400

2547

1.58

16.68

1.1

0.75

1.09

u/ml

0.88

171

1014

Gastrointestinal diseases

1047

3919

1.35

16.61

1.1

1.48

1.19

u/ml

0.52

490

1778

Dorsopathies

1402

5570

1.29

16.54

1.1

1.12

1.16

u/ml

0.05

617

2452

Functional dyspepsia

279

1630

1.73

16.40

1.1

0.89

1.10

u/ml

0.35

116

657

Exposure to unspecified factor

1184

7070

1.31

16.37

1.1

1.45

1.05

u/ml

0.87

605

3028

Lower back pain or/and sciatica

1181

6288

1.31

16.36

1.1

1.02

1.13

u/ml

0.19

495

2599

Abnormal findings on diagnostic imaging of lung

291

1675

1.70

16.22

1.1

1.70

1.04

u/ml

0.42

113

670

Myalgia

288

1713

1.70

15.91

1.1

0.54

1.26

u/ml

2.95

129

716

Diabetes, insulin treatment (Kela reimbursement)

630

5420

0.71

15.57

1.1

0.79

1.08

u/ml

0.87

248

2337

Dental caries 2, only avohilmo

1058

6378

1.32

15.52

1.1

0.92

1.12

u/ml

0.56

494

2768

Neurological diseases

1316

5167

1.29

15.34

1.1

0.89

1.27

u/ml

1.95

589

2360

Other specific joint derangements/joint disorders

1042

5320

1.32

15.32

1.1

1.03

1.23

u/ml

0.36

460

2306

Diseases of middle ear and mastoid

860

5246

1.35

15.25

1.1

1.29

1.17

u/ml

0.16

426

2368

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

616

5285

0.71

15.14

1.1

0.80

1.04

u/ml

0.70

244

2286

Fenamates

175

602

1.98

14.83

1.1

0.68

1.27

u/ml

0.97

282

Bronchitis, not specified as acute or chronic

350

2.55

14.78

1.1

1.0

1.12

1.52

u/ml

0.23

122

Lichen simplex chronicus and prurigo

248

2.88

14.78

1.1

0.52

1.16

u/ml

0.62

Codeine

1200

5121

1.29

14.71

1.1

1.03

1.12

u/ml

0.17

498

2090

Other anxiety disorders

709

4592

1.38

14.47

1.1

1.43

1.13

u/ml

0.39

352

1974

Opioids

1292

5328

1.28

14.37

1.1

1.10

1.13

u/ml

0.05

563

2195

Anti-inflammatory and antirheumatic products, non-steroids

416

1353

1.56

14.37

1.1

1.71

1.28

u/ml

0.36

181

719

Early onset COPD

167

875

1.92

14.11

1.0

1.1

0.93

1.17

u/ml

0.27

358

Dental caries 2

1056

6431

1.30

14.01

1.1

0.76

1.12

u/ml

2.11

492

2790

Depression medications

670

2415

1.41

13.99

1.1

1.56

1.10

u/ml

0.58

291

1102

Other diseases of hard tissues of teeth

783

4342

1.35

13.82

1.1

1.09

1.21

u/ml

0.20

363

1879

Dental caries 2 and operation codes

1038

6391

1.30

13.81

1.1

0.69

1.13

u/ml

3.22

484

2770

Soft tissue disorders related to use, overuse and pressure

236

1383

1.72

13.80

1.0

1.1

1.10

1.14

u/ml

0.03

540

Other antidepressants

1204

4918

1.28

13.74

1.1

1.25

1.08

u/ml

0.27

505

2054

Other soft tissue disorders, not elsewhere classified

1146

5535

1.28

13.66

1.1

1.24

1.15

u/ml

0.14

509

2453

Codeine or tramadol medication

1317

5787

1.26

13.64

1.1

1.01

1.11

u/ml

0.19

535

2366

Oxicams

216

683

1.81

13.58

1.1

1.26

1.16

u/ml

0.06

319

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

1616

0.43

13.37

1.1

0.65

1.00

u/ml

0.52

628

Renal tubulo-interstitial diseases

510

5523

0.70

13.32

1.1

0.89

1.17

u/ml

0.63

228

2370

Neurological diseases, wide definition

628

2263

1.40

12.96

1.1

0.94

1.40

u/ml

1.30

288

1125

Abdominal and pelvic pain

1287

5158

1.26

12.62

1.1

1.05

1.20

u/ml

0.30

566

2311

Other joint disorders

1293

5502

1.26

12.61

1.1

1.01

1.23

u/ml

0.48

578

2423

Allergic urticaria

139

716

1.98

12.58

1.1

2.86

1.19

u/ml

0.78

336

General symptoms and signs

1433

5797

1.24

12.57

1.1

1.00

1.19

u/ml

0.44

636

2505

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1348

6181

1.25

12.53

1.1

1.04

1.14

u/ml

0.21

661

2641

Exposure to other specified factors

901

6540

1.30

12.42

1.1

1.39

1.10

u/ml

0.46

461

2813

Schizophrenia or delusion

156

2798

0.55

12.32

1.0

1.1

0.99

1.25

u/ml

0.35

1200

Mood disorders, excluding more controls

1124

5405

1.27

12.31

1.1

0.89

1.10

u/ml

0.62

512

2255

Acute pharyngitis

258

1589

1.63

12.31

1.1

2.50

1.29

u/ml

0.85

133

791

Diseases of the ear and mastoid process

1507

6210

1.23

12.23

1.1

1.15

1.13

u/ml

0.03

680

2654

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

464

3009

1.43

12.22

1.1

1.18

1.03

u/ml

0.12

181

1244

Diseases of oesophagus, stomach and duodenum

1184

5724

1.26

12.21

1.1

0.92

1.11

u/ml

0.55

507

2423

Pruritus

119

585

2.06

12.21

1.1

0.57

0.89

u/ml

0.51

223

Migraine without aura

346

2299

1.52

12.19

1.1

0.85

1.28

u/ml

0.87

163

1019

Diabetes mellitus

779

6094

0.76

12.16

1.1

1.13

1.10

u/ml

0.03

321

2633

Diabetes medication

755

6037

0.76

12.12

1.1

0.81

1.12

u/ml

1.10

303

2602

Diabetes, varying definitions

772

6051

0.76

12.11

1.1

1.14

1.11

u/ml

0.04

318

2620

Schizophrenia, schizotypal and delusional disorders

158

2803

0.56

12.01

1.0

1.1

0.99

1.25

u/ml

0.35

1203

Paracetamol of NSAID medication

310

987

1.59

11.97

1.1

1.47

1.39

u/ml

0.05

143

561

Persons encountering health services for specific procedures and health care

1306

6531

1.24

11.92

1.1

1.23

1.10

u/ml

0.31

703

2745

Pain and other conditions associated with female genital organs and menstrual cycle

335

2128

1.53

11.91

1.1

0.91

1.28

u/ml

0.56

133

913

TMD related operations

219

1317

1.68

11.80

1.1

0.52

1.23

u/ml

2.29

527

COPD (mode)

127

506

2.00

11.70

1.0

0.86

1.76

u/ml

0.74

165

Chronic conjunctivitis

175

3.00

11.58

1.1

2.74

2.41

u/ml

0.06

Acute bronchiolitis

187

977

1.77

11.54

1.3

1.1

1.38

1.50

u/ml

0.10

134

586

Other bacterial diseases

571

5353

0.73

11.52

1.0

1.1

1.81

1.02

u/ml

1.21

268

2319

Migraine with aura

359

2436

1.49

11.41

1.1

0.63

1.31

u/ml

2.31

160

1041

Follow-up examination after treatment for conditions other than malignant neoplasms

515

2418

1.40

11.31

1.1

1.34

1.20

u/ml

0.16

220

915

Schizophrenia

1369

0.40

11.21

1.0

1.1

0.86

1.25

u/ml

0.30

606

Cystitis

986

4747

1.27

11.19

1.1

1.18

1.04

u/ml

0.24

419

2000

Symptoms and signs involving the skin and subcutaneous tissue

706

5356

1.32

11.05

1.1

1.26

1.08

u/ml

0.25

342

2241

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

197

2109

0.61

10.73

1.1

1.50

0.77

u/ml

0.47

785

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

197

2109

0.61

10.73

1.1

1.50

0.77

u/ml

0.47

785

Dentofacial anomalies [including malocclusion]

398

2763

1.44

10.60

1.1

0.52

1.29

u/ml

3.79

172

1247

Allergic contact dermatitis due to drugs in contact with skin

3.65

10.57

1.0

1.1

0.54

0.73

u/ml

0.20

Preparation and fitting of bite rail to mouth

182

1078

1.71

10.46

1.1

0.46

1.28

u/ml

2.47

434

Haemorrhage from respiratory passages

221

1272

1.62

10.38

1.1

1.01

1.31

u/ml

0.33

524

Suppurative and unspecified otitis media

608

4070

1.33

10.18

1.1

1.21

1.22

u/ml

0.01

304

1898

Kela-code for severe mental illness

198

3170

0.62

10.11

1.1

0.91

1.21

u/ml

0.53

1362

Intestinal infectious diseases

1100

6942

1.24

10.09

1.1

0.91

1.15

u/ml

0.84

502

3041

Migraine with aura and triptan purchases

248

1603

1.57

10.05

1.1

0.72

1.29

u/ml

1.28

113

699

Mouth breathing

409

2918

1.41

9.89

1.1

0.99

1.11

u/ml

0.16

183

1362

Symptoms and signs involving the digestive system and abdomen

1258

5160

1.23

9.82

1.1

1.06

1.19

u/ml

0.28

558

2313

Other and unspecified nonorganic psychotic disorders

109

2019

0.53

9.80

1.0

1.1

1.10

1.32

u/ml

0.20

892

Other and unspecified tonsillitis

548

3475

1.35

9.79

1.1

1.33

1.21

u/ml

0.14

232

1597

Emphysema

3.59

9.65

1.1

2.22

1.02

u/ml

0.53

Schizophrenia or delusion, excluding more controls

156

2591

0.59

9.63

1.0

1.1

0.99

1.14

u/ml

0.19

1102

Other chronic obstructive pulmonary disease, including avohilmo

282

1563

1.51

9.52

1.0

1.1

0.62

1.27

u/ml

1.59

121

619

Malignant neoplasm of breast

194

2230

0.62

9.49

1.1

1.44

0.77

u/ml

0.42

816

Somatoform disorder

193

1195

1.63

9.37

1.1

0.61

1.22

u/ml

1.28

487

Eosinophilia

4.17

9.33

1.2

1.1

0.41

0.48

u/ml

0.09

Migraine without aura and triptan purchases

260

1730

1.52

9.25

1.1

0.80

1.26

u/ml

0.67

110

756

Unspecified threat to breathing

3.92

9.07

1.2

1.18

0.72

u/ml

0.30

ILD, hospital admissions 1, main diag only

335

2.20

9.03

1.1

0.45

1.53

u/ml

1.34

144

Other diseases of urinary system

1162

5377

1.22

8.91

1.1

1.34

1.08

u/ml

0.44

500

2304

Inflammatory diseases of female pelvic organs

748

4442

1.28

8.90

1.1

1.01

u/ml

0.00

324

1764

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

240

1584

1.53

8.89

1.1

1.19

1.08

u/ml

0.12

100

656

Other enthesopathies

284

1937

1.48

8.87

1.2

1.1

0.89

1.01

u/ml

0.10

120

751

Benign neoplasm: Colon

276

1833

1.48

8.81

1.0

1.1

0.77

1.12

u/ml

0.75

109

706

Other nutritional deficiencies

734

5681

1.27

8.66

1.1

1.08

1.12

u/ml

0.04

324

2383

Rotator cuff syndrome

480

2654

1.35

8.63

1.1

0.94

1.05

u/ml

0.15

189

1008

Disturbances of skin sensation

318

2230

1.44

8.63

1.1

1.67

1.04

u/ml

0.51

155

902

Type 2 diabetes

670

5074

0.78

8.60

1.1

0.94

1.04

u/ml

0.22

260

2066

Injury, poisoning and certain other consequences of external causes

794

3146

1.27

8.58

1.1

1.41

1.08

u/ml

0.52

358

1327

Mental and behavioural disorders due to alcohol, excluding acute intoxication

199

3052

0.65

8.47

1.1

1.00

1.19

u/ml

0.23

1275

Alcohol use disorder, Swedish definition

273

3653

0.69

8.37

1.1

0.84

1.23

u/ml

0.78

120

1523

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

1349

0.54

8.35

1.0

1.1

1.71

1.15

u/ml

0.41

527

COPD, hospital admissions

210

1148

1.55

8.29

1.0

1.1

0.80

1.03

u/ml

0.32

458

Pain in thoracic spine

162

992

1.65

8.28

1.1

0.90

1.62

u/ml

1.05

401

COPD, early/later onset

211

1154

1.55

8.22

1.0

1.1

0.80

1.03

u/ml

0.31

459

ILD, hospital admissions

375

2.07

8.21

1.1

0.45

1.44

u/ml

1.35

162

Other and unspecified rosacea

458

1.97

8.21

1.1

1.41

1.22

u/ml

0.11

171

Allergic colitis

450

2.03

8.17

1.2

2.18

1.19

u/ml

0.62

280

Persons encountering health services in other circumstances, wide

1415

6196

1.19

8.16

1.1

1.10

1.14

u/ml

0.09

668

2648

Other interstitial pulmonary diseases

376

2.06

8.16

1.1

0.45

1.44

u/ml

1.35

162

Dental caries 2 and operation codes, only avohilmo

886

4451

1.24

8.15

1.1

0.74

1.15

u/ml

2.21

408

1984

Interstitial lung disease endpoints

377

2.06

8.10

1.1

0.45

1.44

u/ml

1.35

162

Interstitial lung disease

377

2.06

8.10

1.1

0.45

1.44

u/ml

1.35

162

Vocal cord dysfunction

159

904

1.65

8.06

1.1

0.58

0.94

u/ml

0.66

381

Acute suppurative otitis media

484

3430

1.33

8.04

1.1

1.01

1.25

u/ml

0.66

248

1644

Other menopausal disorders

262

1017

1.49

8.03

1.1

1.0

0.67

0.91

u/ml

0.21

387

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

760

0.33

7.96

1.1

0.14

0.83

u/ml

—

301

Malignant neoplasm of breast, HER2-negative

189

2135

0.65

7.96

1.1

1.51

0.76

u/ml

0.46

782

Accidents

1081

4466

1.22

7.96

1.1

1.34

1.04

u/ml

0.53

506

1833

External causes of morbidity and mortality

932

3794

1.24

7.96

1.1

1.40

1.05

u/ml

0.60

424

1575

Organic, including symptomatic, mental disorders

1030

0.50

7.91

1.0

1.1

0.83

0.94

u/ml

0.08

417

Nummular dermatitis

309

2.16

7.85

1.1

1.52

1.11

u/ml

0.14

117

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

100

546

1.86

7.74

1.1

0.76

1.01

u/ml

0.20

238

Disorders of skin appendages

568

4428

1.29

7.71

1.1

1.07

1.21

u/ml

0.28

258

1950

Alcohol use disorder, ICD-based

186

2830

0.65

7.64

1.1

0.97

1.21

u/ml

0.30

1181

Other (not insulin) diabetes medications

606

4643

0.78

7.63

1.0

1.1

0.88

1.04

u/ml

0.36

227

1869

Non-allergic asthma

414

1.98

7.62

1.0

1.1

0.28

1.01

u/ml

1.20

143

Injuries to the wrist and hand

1144

6946

1.20

7.60

1.1

0.86

1.17

u/ml

1.11

530

2992

Trochanteric bursitis

106

592

1.81

7.58

1.1

1.0

0.26

1.15

u/ml

2.53

222

Alcohol dependence

1578

0.54

7.56

1.1

0.91

1.07

u/ml

0.22

668

Sciatica+with lumbago

470

3401

1.32

7.52

1.1

0.88

1.09

u/ml

0.31

193

1365

Cervicocranial syndrome

105

587

1.81

7.51

1.1

1.59

1.60

u/ml

0.01

240

Disorders of eyelid, lacrimal system and orbit

777

4926

1.24

7.51

1.1

1.16

1.11

u/ml

0.06

339

2055

Prurigo nodularis

3.60

7.46

1.0

0.19

2.81

u/ml

0.70

345

4196

0.73

7.42

1.1

0.87

1.17

u/ml

0.63

155

1777

Oter anti-inflammatory and antirheumatic agents, non-steroids

143

471

1.69

7.38

1.1

0.19

1.28

u/ml

3.04

210

Enthesopathies of lower limb, excluding foot

218

1468

1.50

7.37

1.1

1.87

1.31

u/ml

0.28

586

Later onset COPD, excluding more controls

135

2.55

7.31

1.0

0.16

1.65

u/ml

0.83

Other intervertebral disc disorders

822

4095

1.23

7.20

1.1

1.00

1.12

u/ml

0.15

336

1666

Polyarthropathies

462

4009

0.77

7.19

1.1

0.64

1.15

u/ml

2.26

192

1683

Oedema, not elsewhere classified

237

1622

1.46

7.17

1.1

0.76

0.99

u/ml

0.43

116

682

Chronic gastritis

148

920

1.62

7.14

1.1

1.0

0.33

0.87

u/ml

1.82

360

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

306

1.96

7.13

1.1

0.48

2.30

u/ml

1.65

141

Simple and mucopurulent chronic bronchitis

106

2.96

7.13

1.0

1.1

0.37

2.51

u/ml

0.86

Type 2 diabetes, strict (exclude DM1)

608

4570

0.79

7.10

1.1

0.93

1.04

u/ml

0.23

232

1835

Arthropathies

1294

5587

1.18

7.09

1.1

1.00

1.21

u/ml

0.47

582

2490

Other respiratory diseases principally affecting the interstitium

474

1.87

7.08

1.1

0.46

1.21

u/ml

1.28

211

Lumbar disc prolapse

596

3743

1.27

7.07

1.1

0.87

1.13

u/ml

0.80

256

1508

Other disorders of patella

212

1434

1.49

7.06

1.1

0.53

1.17

u/ml

2.08

563

319

3989

0.73

7.04

1.1

0.90

1.21

u/ml

0.62

144

1682

Unspecified mental disorder

262

3676

0.71

7.04

1.1

0.92

1.18

u/ml

0.54

108

1571

Benign neoplasm: Colon, unspecified

120

710

1.70

7.03

1.0

1.1

0.94

0.93

u/ml

0.00

297

Transport accidents

552

3846

1.28

6.99

1.1

1.00

1.12

u/ml

0.27

248

1563

Substance abuse

343

4407

0.74

6.97

1.1

0.95

1.19

u/ml

0.46

163

1848

Dermatitis due to substances taken internally

319

2.07

6.92

1.1

2.91

1.01

u/ml

0.88

128

Genitourinary diseases

866

3557

1.23

6.92

1.1

1.33

1.17

u/ml

0.23

409

1707

Type 2 diabetes, definitions combined

609

4560

0.79

6.92

1.1

0.93

1.00

u/ml

0.13

233

1831

Cervicobrachial syndrome

207

1401

1.49

6.86

1.1

0.45

1.34

u/ml

3.20

537

Obesity and other hyperalimentation

683

5469

1.24

6.82

1.1

0.74

1.18

u/ml

1.36

300

2283

Other noninfective gastroenteritis and colitis

270

1922

1.41

6.82

1.2

1.1

1.37

u/ml

0.00

148

923

Obesity

680

5453

1.24

6.75

1.1

0.75

1.18

u/ml

1.29

297

2280

Lichen simplex chronicus

144

2.62

6.74

1.1

0.31

1.77

u/ml

0.90

Pain in limb

855

5104

1.22

6.73

1.1

1.23

1.14

u/ml

0.13

378

2231

Mental and behavioural disorders due to psychoactive substance use

361

4521

0.75

6.72

1.1

0.94

1.17

u/ml

0.44

168

1898

Hypertrophy of breast in women and men

212

1450

1.47

6.70

1.1

1.08

1.01

u/ml

0.08

560

Heartburn

105

609

1.74

6.68

1.1

0.68

1.29

u/ml

0.76

255

Female infertility, cervigal, vaginal, other or unspecified origin

386

1940

1.34

6.66

1.0

1.1

1.14

1.19

u/ml

0.05

142

799

Other diseases of oesophagus

317

2.04

6.62

1.1

0.63

1.27

u/ml

0.73

134

Type 2 diabetes, definitions combined, including avohilmo

629

4631

0.80

6.61

1.1

0.90

1.04

u/ml

0.32

248

1861

Insulin medication

323

3717

0.74

6.59

1.0

1.1

0.67

1.17

u/ml

1.81

135

1685

Other and unspecified vaccines and biological substances

4.15

6.57

1.2

1.1

0.41

0.50

u/ml

—

Other specified disorders of external ear

106

2.87

6.55

1.0

1.1

2.67

1.03

u/ml

0.60

Disorders of the thyroid gland

1011

5548

1.19

6.54

1.1

0.75

1.16

u/ml

1.76

393

2346

Biguanides

583

4493

0.80

6.49

1.0

1.1

0.95

1.04

u/ml

0.17

213

1799

Factors influencing health status and contact with health services

376

1405

1.35

6.45

1.1

1.43

1.17

u/ml

0.23

176

534

Dislocation, sprain and strain of joints and ligaments of knee

714

5421

1.23

6.45

1.1

1.19

1.09

u/ml

0.12

298

2265

Other external causes of accidental injury

1060

4466

1.19

6.44

1.1

1.41

1.04

u/ml

0.72

511

1833

Heart failure, not strict

309

2883

0.74

6.42

1.0

1.1

0.79

1.07

u/ml

0.63

114

1216

Diarrhoea and gastroenteritis of presumed infectious origin

811

6109

1.21

6.33

1.1

0.80

1.16

u/ml

1.68

392

2714

Cerebrovascular diseases

259

2571

0.72

6.29

1.1

0.79

1.02

u/ml

0.42

100

1041

Parodontitis or/and operation codes

457

3480

0.78

6.27

1.1

1.30

1.07

u/ml

0.19

205

1460

Shoulder lesions

671

3329

1.24

6.21

1.1

0.79

1.03

u/ml

0.48

256

1303

Benign neoplasm: Colon, unspecified

120

733

1.64

6.16

1.0

1.1

0.94

0.86

u/ml

0.08

282

Hyperkinetic disorders, excluding more controls

226

1554

1.43

6.11

1.1

1.57

1.24

u/ml

0.22

131

831

Disorders of synovium and tendon

527

3776

1.26

6.10

1.0

1.1

0.47

1.08

u/ml

6.13

188

1561

Acute and transient psychotic disorders

924

0.47

6.03

1.0

1.1

1.12

1.46

u/ml

0.23

384

Rosacea

113

689

1.66

6.02

1.1

1.25

1.26

u/ml

0.01

271

Any gastric operation

1204

5170

1.17

6.01

1.1

1.10

1.17

u/ml

0.15

555

2293

GASTRO-related operations

1204

5170

1.17

6.01

1.1

1.10

1.17

u/ml

0.15

555

2293

Mental and behavioural disorders due to alcohol

283

3718

0.74

6.00

1.1

0.97

1.21

u/ml

0.40

133

1570

Disorders of breast

507

3732

1.26

6.00

1.1

1.08

0.98

u/ml

0.14

210

1461

Diaphragmatic hernia

214

1501

1.43

5.93

1.1

0.95

0.97

u/ml

0.03

579

Herpesviral [herpes simplex] infections

125

785

1.61

5.93

1.1

2.81

1.26

u/ml

0.63

335

ILD, hospital admission 2, with pulmonary infections

204

2.22

5.87

1.1

0.49

1.23

u/ml

0.56

Hard cardiovascular diseases

334

2832

0.75

5.87

1.0

1.1

0.99

1.04

u/ml

0.05

124

1138

STROKE

275

2587

0.74

5.85

1.1

0.66

0.94

u/ml

0.67

114

1029

Female infertility

427

2045

1.30

5.82

1.0

1.1

1.16

1.23

u/ml

0.07

154

846

Injuries to the ankle and foot

875

6715

1.19

5.79

1.1

1.28

1.14

u/ml

0.21

426

2947

Peritonsillar abscess

204

1427

1.44

5.78

1.1

1.0

0.47

1.35

u/ml

2.87

516

Hypertrophy of breast

191

1321

1.46

5.78

1.1

1.15

0.91

u/ml

0.29

507

Benign neoplasm: Liver/bile ducts

132

2.56

5.76

1.0

1.1

0.34

0.95

u/ml

1.74

Internal derangement of knee

367

2814

1.31

5.70

1.1

1.02

1.25

u/ml

0.27

156

1135

Acute laryngitis and tracheitis

216

1510

1.42

5.68

1.2

1.1

1.19

1.29

u/ml

0.08

109

775

Stroke, including SAH

182

1942

0.69

5.66

1.0

1.1

0.62

1.05

u/ml

1.05

783

Generalized anxiety disorder

230

1653

1.40

5.65

1.1

1.19

1.18

u/ml

0.00

115

721

COPD, hospital admissions 1, only main diagnosis

141

780

1.54

5.61

1.0

1.1

0.58

1.03

u/ml

0.77

322

Dislocation, sprain and strain of joints and ligaments at neck level

207

1464

1.43

5.58

1.1

0.91

1.27

u/ml

0.68

630

Postviral fatigue syndrome

3.11

5.55

1.1

0.97

0.60

u/ml

0.19

Olecranon bursitis

216

2.15

5.55

1.0

1.1

3.47

1.68

u/ml

0.31

Benign neoplasm: Liver/bile ducts

135

2.50

5.51

1.0

1.1

0.34

0.93

u/ml

1.59

Substance abuse, excluding more controls

343

3886

0.77

5.39

1.1

0.95

1.10

u/ml

0.26

163

1612

Benign neoplasm of other and ill-defined parts of digestive system

111

694

1.61

5.37

1.1

0.62

0.93

u/ml

0.61

280

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

124

1536

0.65

5.28

1.1

1.53

0.79

u/ml

0.29

545

Care involving use of rehabilitation procedures

589

4585

1.22

5.27

1.1

0.89

1.01

u/ml

0.23

277

1934

Benign neoplasm: Liver

120

2.56

5.26

1.0

1.1

0.27

0.90

u/ml

1.61

Diseases of oral cavity, salivary glands and jaws

1014

4445

1.17

5.23

1.1

1.02

1.19

u/ml

0.41

459

1931

Other and unspecified drugs and medicaments

478

1.73

5.23

1.1

0.82

1.09

u/ml

0.17

199

Disorders of thyroid, IBD co-morbidities

224

1175

1.40

5.22

1.0

1.1

0.54

1.32

u/ml

2.23

517

Hypothyroidism, other/unspecified

935

5260

1.18

5.21

1.1

0.78

1.13

u/ml

1.30

366

2217

Benign neoplasm: Liver

121

2.54

5.18

1.0

1.1

0.27

0.95

u/ml

1.96

Dysphagia

157

1069

1.48

5.16

1.1

0.77

1.24

u/ml

0.89

439

COPD related to multimorbidity

147

827

1.50

5.15

1.0

1.1

0.87

1.02

u/ml

0.14

329

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

406

2922

1.28

5.14

1.1

1.95

1.19

u/ml

0.72

221

1484

Ocular pain

604

1.64

5.10

1.1

0.82

1.15

u/ml

0.33

264

Diseases of external ear

300

2284

1.32

5.07

1.1

1.54

1.33

u/ml

0.18

153

1039

Other degenerative diseases of the nervous system

957

0.58

5.07

1.0

0.20

1.26

u/ml

3.19

377

Restless leg syndrome

597

1.64

5.05

1.1

1.28

1.19

u/ml

0.04

249

Emergency coronary revascularization (for ACS)

1131

0.63

5.04

1.1

1.0

0.79

0.95

u/ml

0.19

456

Obesity, other/unspecified

360

2812

1.29

5.03

1.1

0.58

1.20

u/ml

2.82

166

1153

Otalgia

100

623

1.63

5.00

1.1

0.96

1.22

u/ml

0.35

317

Ganglion

220

1604

1.38

4.98

1.1

0.47

1.22

u/ml

2.87

641

Irregular menses

633

4261

1.21

4.98

1.1

0.80

1.05

u/ml

0.61

264

1727

Cervicalgia

166

1153

1.45

4.95

1.1

0.64

1.42

u/ml

1.75

457

Mental retardation, wide definition

578

0.41

4.89

1.2

0.23

1.24

u/ml

3.11

361

Inflammatory diseases of prostate (prostatitis)

457

1.72

4.89

1.1

0.44

1.53

u/ml

1.42

196

Continuous positive airway pressure

175

1058

1.43

4.88

1.1

0.73

0.94

u/ml

0.29

529

COPD-related respiratory insufficiency

222

2.04

4.80

1.0

1.1

0.17

1.76

u/ml

1.89

Subjective visual disturbances

216

1582

1.37

4.77

1.1

1.36

1.18

u/ml

0.08

108

663

Other inflammation of eyelid

114

740

1.55

4.77

1.1

1.49

1.20

u/ml

0.24

321

Other disorders of urethra and urinary system

671

4208

1.20

4.75

1.1

1.44

0.94

u/ml

0.66

272

1714

Correction of physiology of bite - very demanding therapy visit

204

2.10

4.75

1.1

0.21

1.24

u/ml

0.91

TMD related pain

266

1.95

4.73

1.1

0.82

1.28

u/ml

0.31

113

Benign neoplasm of colon, rectum, anus and anal canal

318

2219

1.30

4.73

1.1

0.72

1.06

u/ml

0.90

125

857

Other and unspecified polyneuropathies, also in other diseases

599

1.61

4.73

1.1

1.27

1.02

u/ml

0.21

240

Tinnitus

175

1239

1.42

4.72

1.1

0.66

1.27

u/ml

1.25

499

Renal failure

107

1498

0.65

4.71

1.0

1.1

0.98

1.04

u/ml

0.05

672

COPD, hospital admission 2, with asthma infections

129

731

1.51

4.71

1.1

1.03

1.08

u/ml

0.04

304

Epiphora

2.89

4.69

1.0

0.80

2.50

u/ml

—

Schizoaffective disorder

640

0.45

4.67

1.0

1.1

0.40

1.28

u/ml

1.87

271

Cervical disc disorders

253

1904

1.33

4.67

1.1

0.60

1.15

u/ml

1.68

104

730

Bruxism

134

2.37

4.66

1.0

1.1

0.21

1.70

u/ml

—

Any operation in hilmo

255

1.71

4.65

1.1

1.0

2.25

0.97

u/ml

0.39

102

Striking against or struck by other objects

385

3063

1.26

4.65

1.1

1.49

1.25

u/ml

0.22

182

1467

Insulin, combination of fast acting with intermediate-acting or long-acting

323

3803

0.78

4.64

1.0

1.1

0.67

1.15

u/ml

1.69

135

1714

Mental retardation

564

0.42

4.64

1.2

0.23

1.25

u/ml

3.10

356

Benign neoplasm of other and ill-defined parts of digestive system

111

721

1.55

4.62

1.1

0.62

0.80

u/ml

0.37

282

Vasomotor rhinitis (mode)

361

1.79

4.62

1.1

0.54

1.62

u/ml

1.14

152

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

780

6217

0.85

4.62

1.1

0.70

1.15

u/ml

2.63

357

2714

Coronary revascularization (ANGIO or CABG)

1040

0.64

4.59

1.1

1.0

0.81

0.92

u/ml

0.12

433

Oesophagitis

206

2.06

4.59

1.2

1.1

0.50

1.02

u/ml

1.08

Hypermobility syndrome

545

1.64

4.57

1.1

0.19

0.91

u/ml

2.27

233

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

728

0.49

4.56

1.1

0.88

1.52

u/ml

0.41

317

Unspecified chronic bronchitis

2.99

4.56

1.1

1.0

1.10

3.37

u/ml

—

Other/unspecified dorsalgia

331

2580

1.28

4.55

1.1

0.93

1.24

u/ml

0.60

167

1075

Other disorders of breast

130

878

1.49

4.54

1.1

1.45

1.04

u/ml

0.25

351

Benign neoplasm: Transverse colon

269

1.91

4.53

1.0

0.72

1.33

u/ml

0.57

105

Dementia, including avohilmo

581

0.52

4.53

1.0

0.46

0.97

u/ml

0.84

239

Other disorders of eye and adnexa

152

1061

1.44

4.49

1.1

0.66

1.01

u/ml

0.64

477

Hypothyreosis and Thyroxine purchase for inclusion criteria

949

5413

1.16

4.49

1.1

0.77

1.12

u/ml

1.31

371

2270

Type 2 diabetes, wide definition

398

3230

0.80

4.46

1.0

1.1

1.07

1.09

u/ml

0.03

142

1273

Stroke, excluding SAH

167

1734

0.71

4.45

1.0

1.1

0.61

1.10

u/ml

1.13

696

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

187

1754

0.73

4.44

1.0

1.1

0.92

0.98

u/ml

0.08

658

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

620

4240

1.20

4.42

1.0

1.1

1.17

0.98

u/ml

0.31

219

1712

Septicaemia

154

2084

0.71

4.38

1.1

1.64

1.00

u/ml

0.62

968

Dementia

538

0.51

4.37

1.1

1.0

0.46

1.03

u/ml

0.93

218

Fibromyalgia

621

1.58

4.36

1.1

0.94

1.17

u/ml

0.20

237

Benign neoplasm: Sigmoid colon

534

1.62

4.36

1.0

1.1

0.95

1.05

u/ml

0.09

212

Hypothyroidism, strict autoimmune

798

4518

1.17

4.36

1.1

0.69

1.15

u/ml

2.02

303

1898

Embedded and impacted teeth

463

3221

1.23

4.32

1.1

0.91

1.33

u/ml

1.39

217

1515

Impacted teeth

348

2573

1.27

4.32

1.1

0.89

1.38

u/ml

1.39

159

1234

Condition for Implicit Sepsis (Organ dysfunction codes)

558

4857

0.83

4.32

1.1

0.81

1.08

u/ml

1.00

249

2084

Mental retardation, excluding more controls

538

0.43

4.31

1.2

0.23

1.24

u/ml

3.13

341

Crossbite

156

1026

1.43

4.27

1.1

1.30

1.37

u/ml

0.05

105

603

Ischaemic Stroke, excluding all haemorrhages

147

1572

0.71

4.24

1.0

1.1

0.69

1.13

u/ml

0.78

628

Infections of the skin and subcutaneous tissue

611

5125

1.19

4.23

1.1

1.62

1.13

u/ml

0.55

314

2295

Mental and behavioural disorders due to opioids

371

0.32

4.22

1.0

1.1

0.15

1.52

u/ml

—

159

Spondylolisthesis/Spondylolysis

135

933

1.45

4.21

1.1

0.53

1.47

u/ml

1.83

366

Thyroiditis

463

1.66

4.21

1.0

1.1

0.30

1.05

u/ml

1.66

197

Other and unspecified disorders of vitreous body

204

1504

1.35

4.20

1.0

1.1

0.78

0.89

u/ml

0.16

555

Other enthesopathy of foot (+metatarsalgia)

603

1.57

4.20

1.1

0.36

1.25

u/ml

1.93

247

Benign neoplasm: Transverse colon

277

1.85

4.18

1.0

0.72

0.80

u/ml

0.10

108

Infective dermatitis

533

1.61

4.17

1.1

0.87

0.79

u/ml

0.06

189

Other disorders of eyelid

218

1581

1.34

4.12

1.1

2.02

0.97

u/ml

0.49

607

Recurring oral aphthae, including avohilmo

135

939

1.45

4.10

1.1

0.49

1.16

u/ml

1.90

440

Gingivitis and periodontal diseases

964

4328

1.15

4.07

1.1

0.95

1.24

u/ml

0.78

444

1835

Other respiratory disorders and diseases

647

1.54

4.06

1.1

0.57

1.24

u/ml

1.25

305

Other diseases of the respiratory system

647

1.54

4.06

1.1

0.57

1.24

u/ml

1.25

305

Inflammatory disease of uterus

177

1294

1.38

4.05

1.1

1.20

0.96

u/ml

0.17

501

Disturbance of activity and attention

221

1654

1.33

4.03

1.1

1.47

1.33

u/ml

0.08

130

889

General examination and investigation of persons without complaint and reported diagnosis

694

3137

1.18

4.02

1.1

0.78

1.22

u/ml

1.69

283

1248

Transplanted organ and tissue status

670

0.50

4.02

1.1

0.19

1.46

u/ml

3.31

335

Diseases of male genital organs

494

2055

1.22

4.02

1.1

1.24

1.29

u/ml

0.06

245

1027

905

4926

1.15

4.02

1.1

1.14

1.08

u/ml

0.12

450

2033

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

905

4926

1.15

4.02

1.1

1.14

1.08

u/ml

0.12

450

2033

Disorders of muscles

586

1.56

4.01

1.1

1.07

1.35

u/ml

0.23

245

Selective deficiency of immunoglobulin G [IgG] subclasses

3.77

3.97

1.2

1.1

0.64

0.66

u/ml

—

Panic disorder

214

1617

1.33

3.96

1.1

0.86

1.24

u/ml

0.92

105

690

Acute appendicitis, no complications

618

5232

1.18

3.95

1.1

1.37

1.08

u/ml

0.30

241

2181

Autoimmune diseases excluding thyroid diseases, strict definition

961

6118

0.87

3.95

1.1

1.05

1.19

u/ml

0.22

418

2738

Occupational exposure to risk-factors

144

2.18

3.95

1.1

0.29

0.95

u/ml

1.22

Nonsuppurative otitis media

378

2645

1.24

3.95

1.1

1.60

1.28

u/ml

0.26

213

1303

Autoimmune diseases excluding thyroid diseases

981

6212

0.87

3.95

1.1

1.09

1.19

u/ml

0.16

430

2780

Correction of physiology of bite - demanding therapy visit

558

1.58

3.94

1.1

0.52

1.09

u/ml

0.91

237

Injuries to the knee and lower leg

1321

6737

1.12

3.92

1.1

1.11

1.14

u/ml

0.04

574

2914

Subacute thyroiditis

185

2.03

3.91

1.0

1.1

0.39

1.59

u/ml

0.94

Other septicaemia

130

1807

0.70

3.90

1.1

1.69

1.04

u/ml

0.53

856

Acute tubulo-interstitial nephritis

377

4106

0.81

3.89

1.1

0.87

1.12

u/ml

0.40

173

1769

Visual disturbances

412

3375

1.22

3.89

1.1

1.11

1.15

u/ml

0.03

203

1497

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

327

2615

1.26

3.88

1.1

0.94

1.28

u/ml

0.65

162

1161

Seborrhoeic dermatitis

435

1.64

3.86

1.1

0.92

0.82

u/ml

0.10

170

ILD-related respiratory insufficiency

2.99

3.86

1.1

0.97

1.04

u/ml

—

Noninfective enteritis and colitis

478

3976

1.20

3.82

1.1

1.57

1.11

u/ml

0.50

224

1828

Chondrocostal junction syndrome [Tietze]

180

2.03

3.81

1.2

1.1

0.75

1.55

u/ml

0.50

Any dementia, excluding more controls

442

0.50

3.79

1.0

0.38

0.83

u/ml

—

179

Malaise and fatigue

395

2688

1.23

3.77

1.1

1.35

1.08

u/ml

0.26

184

1185

Hyperkinetic disorders

234

1785

1.31

3.75

1.1

1.49

1.39

u/ml

0.06

139

964

Anomalies of dental arch relationship, including avohilmo

298

2126

1.27

3.74

1.1

1.25

u/ml

0.01

161

1038

Unspecified privation

661

1.51

3.74

1.1

1.13

1.27

u/ml

0.08

271

Metatarsalgia

549

1.56

3.73

1.1

0.30

1.34

u/ml

2.22

225

All influenza

230

1770

1.31

3.73

1.1

0.96

1.06

u/ml

0.13

110

827

Otitis externa

217

1658

1.32

3.72

1.0

1.1

1.74

1.35

u/ml

0.25

107

742

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

217

1.92

3.72

1.0

1.1

2.12

1.10

u/ml

0.33

Pain, not elsewhere classified

265

2078

1.28

3.72

1.1

0.93

1.12

u/ml

0.34

116

904

Unspecified acute lower respiratory infection

143

1025

1.40

3.71

1.1

0.94

1.36

u/ml

0.57

453

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

748

6184

0.86

3.68

1.1

0.93

1.08

u/ml

0.25

353

2662

Other systemic involvement of connective tissue

198

1495

1.33

3.68

1.1

0.34

1.13

u/ml

2.98

608

Contracture of joint

3.31

3.65

1.0

1.1

3.12

1.36

u/ml

—

Erosion of teeth, including avohilmo

241

1810

1.29

3.63

1.1

0.63

1.37

u/ml

1.80

113

791

Excessive, frequent and irregular menstruation

514

2393

1.20

3.62

1.1

1.03

1.17

u/ml

0.17

207

1035

Erysipelas

228

2680

0.77

3.62

1.0

1.1

2.75

0.96

u/ml

1.20

108

1091

Excessive attrition of teeth

482

2176

1.21

3.62

1.1

1.32

1.35

u/ml

0.03

221

957

Impingement syndrome of shoulder

162

1190

1.37

3.62

1.0

0.33

1.20

u/ml

2.93

455

Any dementia

450

0.52

3.61

1.0

0.35

1.18

u/ml

1.36

181

Disorders of ocular muscles, binocular movement, accommodation and refraction

552

4644

1.18

3.61

1.1

0.90

1.19

u/ml

0.57

248

2160

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

553

0.49

3.59

1.0

1.1

1.46

0.77

u/ml

—

219

Fissure and fistula of anal and rectal regions

201

1527

1.32

3.59

1.1

0.62

1.09

u/ml

1.12

653

Dialysis, with operation codes

658

0.53

3.59

1.1

0.49

1.36

u/ml

1.36

311

Obsessive-compulsive disorder

112

775

1.46

3.59

1.1

0.63

1.45

u/ml

1.83

354

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

654

0.62

3.58

1.0

1.1

0.54

1.08

u/ml

0.56

255

Other systemic involvement of connective tissue (FG)

196

1474

1.33

3.58

1.1

0.35

0.96

u/ml

2.48

577

Postpartum care and examination

171

1461

0.74

3.58

1.1

1.25

0.96

u/ml

0.31

608

Other general symptoms and signs

535

1.56

3.56

1.1

0.62

1.05

u/ml

0.69

317

Other/unspecified enthesopathies, not elsewhere classified

383

1.66

3.56

1.3

1.1

0.46

1.00

u/ml

1.05

149

Hypothyroidism, levothyroxine purchases

460

2199

1.21

3.54

1.1

1.02

1.08

u/ml

0.08

194

1003

Hypothyroidism and >3 levothyroxin purchases

460

2199

1.21

3.54

1.1

1.02

1.08

u/ml

0.08

194

1003

Appendicitis, broad definition

767

6109

1.15

3.51

1.1

1.46

1.03

u/ml

0.50

301

2529

Complications predominantly related to the puerperium

311

2506

1.25

3.50

1.1

0.99

0.93

u/ml

0.08

132

1006

Benign neoplasm: Sigmoid colon

565

1.53

3.50

1.0

1.1

0.95

0.75

u/ml

0.28

219

Sub-endpoint used in defining T1D endpoints

197

2525

0.76

3.48

1.0

1.1

0.83

1.17

u/ml

0.54

1201

Substance use, excluding alcohol

125

1741

0.71

3.48

1.1

1.22

1.27

u/ml

0.03

752

Single spontaneous delivery

314

2075

0.80

3.47

1.1

1.70

1.01

u/ml

0.59

134

897

Inhalation and ingestion of food causing obstruction of respiratory tract

3.06

3.45

1.4

1.2

1.58

0.61

u/ml

—

Hypothyroidism (congenital or acquired)

464

2224

1.20

3.44

1.1

1.00

1.07

u/ml

0.10

198

1020

Visual disturbances and blindness

428

3568

1.20

3.43

1.1

1.10

1.15

u/ml

0.05

212

1588

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

282

1.76

3.43

1.1

0.67

1.30

u/ml

0.53

129

Noninflammatory disorders of female genital tract

597

2557

1.18

3.42

1.1

1.14

1.22

u/ml

0.10

242

1127

Myotonic disorders

3.19

3.41

1.3

1.0

0.21

0.94

u/ml

—

Diseases of appendix

769

6119

1.15

3.41

1.1

1.46

1.04

u/ml

0.49

301

2533

Immunodeficiencies

335

1.69

3.41

1.1

0.44

1.16

u/ml

1.12

171

Separation of retinal layers (serosa)

174

1.98

3.40

1.1

1.15

1.58

u/ml

0.16

Fall on same level involving ice and snow

493

4166

1.19

3.40

1.1

0.91

1.10

u/ml

0.43

224

1777

All influenza (not pneumonia)

162

1205

1.35

3.38

1.1

1.12

1.14

u/ml

0.01

574

Falls/tendency to fall

1380

6224

1.11

3.38

1.1

0.99

1.13

u/ml

0.40

639

2677

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

560

3096

1.18

3.37

1.1

0.76

1.06

u/ml

0.99

250

1266

Explicit Sepsis

194

2418

0.77

3.36

1.1

2.55

1.13

u/ml

0.87

1114

Keratitis

314

2545

1.24

3.35

1.1

2.36

1.11

u/ml

1.10

153

1076

Pulmonary eosinophilia, not elsewhere classified

3.50

3.35

1.2

1.0

0.50

1.01

u/ml

—

Other contact dermatitis

468

1.57

3.35

1.1

0.29

0.87

u/ml

1.16

169

Acute appendicitis

729

5995

1.15

3.34

1.1

1.49

1.04

u/ml

0.50

291

2483

Cerebrovascular diseases (FINNGEN)

186

1742

0.76

3.32

1.1

0.73

1.06

u/ml

0.52

708

Inflammation of lacrimal passages (acute and unspecified)

2.58

3.32

1.2

1.0

0.40

2.13

u/ml

—

Coronary artery bypass grafting

461

0.53

3.31

1.0

1.13

1.27

u/ml

0.07

185

Injury of muscle and tendon at shoulder and upper arm level

205

1581

1.30

3.31

1.1

0.69

1.23

u/ml

0.82

631

Peripheral artery disease

946

0.66

3.28

1.1

1.21

1.00

u/ml

0.13

385

Unspecific neurodegenerative disorder

417

0.53

3.28

1.0

0.61

1.03

u/ml

—

164

Other extrapyramidal and movement disorders in other diseases

145

1066

1.37

3.27

1.1

0.96

1.07

u/ml

0.08

445

Other and unspecified acute skin changes due to ultraviolet radiation

2.81

3.26

1.0

0.24

3.76

u/ml

—

Postmenopausal atrophic vaginitis

156

690

1.37

3.26

1.1

1.58

0.86

u/ml

0.46

259

Insulin, intermediate and long-acting

287

3479

0.81

3.26

1.0

1.1

0.65

1.20

u/ml

1.88

118

1561

Exclusions for E4_PCOS_CONSORTIUM

706

5078

0.87

3.25

1.1

1.29

1.03

u/ml

0.49

274

2199

Viral pneumonia

113

798

1.42

3.25

1.1

1.15

1.07

u/ml

0.06

361

Disorders of other endocrine glands

442

3657

1.19

3.24

1.1

1.15

1.18

u/ml

0.03

193

1734

Implicit Sepsis

412

3826

0.84

3.23

1.1

0.89

1.09

u/ml

0.47

184

1658

189

0.26

3.23

1.0

—

1.79

—

Parodontitis or operation codes

577

4939

0.86

3.22

1.1

1.14

1.06

u/ml

0.08

255

1963

Parodontitis

576

4935

0.86

3.22

1.1

1.15

1.06

u/ml

0.08

254

1960

Flat foot [pes planus] (acquired)

513

1.53

3.21

1.1

0.82

1.52

u/ml

0.78

211

Polyarthrosis

654

1.46

3.21

1.1

1.0

0.31

1.15

u/ml

2.34

230

Other reaction to severe stress, and adjustment disorders

453

3824

1.19

3.21

1.1

1.24

1.12

u/ml

0.10

203

1596

Other obstetric conditions, not elsewhere classified

565

3143

1.17

3.20

1.1

0.77

1.07

u/ml

0.98

251

1278

Disorders of refraction and accommodation

334

2731

1.22

3.20

1.1

0.67

1.28

u/ml

1.64

151

1328

Other deformities of toe(s)

130

2.10

3.19

1.0

1.1

0.41

0.90

u/ml

—

Dental operations, only avohilmo

623

2743

1.17

3.19

1.1

1.34

1.02

u/ml

0.40

275

1115

Other diseases of lip and oral mucosa

114

809

1.42

3.18

1.1

0.90

1.37

u/ml

0.52

323

Chronic periodontitis, including avohilmo

573

4925

0.86

3.18

1.1

1.15

1.06

u/ml

0.09

253

1958

Ovarian cyst

440

2130

1.20

3.18

1.1

0.83

1.11

u/ml

0.45

175

883

L04AD Calcineurin inhibitors

857

0.61

3.18

1.1

1.27

1.29

u/ml

0.01

437

Radiculopathy

660

1.46

3.18

1.2

1.1

0.66

1.15

u/ml

0.69

247

Sequelae of other external causes

251

1.77

3.17

1.1

0.43

1.21

u/ml

0.89

104

Candidiasis

120

861

1.40

3.16

1.1

0.77

1.26

u/ml

0.71

378

Other gastritis (incl. Duodenitis)

129

936

1.38

3.16

1.2

1.0

1.53

1.05

u/ml

0.30

374

Type 1 diabetes, wide definition

175

2279

0.76

3.16

1.1

1.52

1.10

u/ml

0.18

1106

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

566

0.53

3.15

1.1

0.35

1.20

u/ml

1.22

231

Nephropathy related operations

643

0.56

3.15

1.1

0.72

1.37

u/ml

0.75

309

Polyuria

130

945

1.38

3.15

1.1

1.07

0.98

u/ml

0.08

389

Other and unspecified trigeminal disorders

2.58

3.15

1.0

0.13

1.02

u/ml

—

Dyshidrosis [pompholyx]

2.33

3.13

1.0

1.1

0.18

0.78

u/ml

—

Other disorders of white blood cells

245

1.77

3.12

1.1

0.28

1.30

u/ml

1.48

115

Atypical facial pain

260

1.75

3.12

1.0

1.1

0.73

1.51

u/ml

0.66

112

Congenital malformations, deformations and chromosomal abnormalities

746

6276

1.14

3.11

1.1

1.24

1.13

u/ml

0.19

329

2828

Immunodeficiency with predominantly antibody defects

188

1.89

3.09

1.1

0.31

0.73

u/ml

1.53

Malignant neoplasm of digestive organs

1044

0.66

3.09

1.0

1.80

1.04

u/ml

0.46

421

Thyroiditis, ILD-related definition

126

917

1.38

3.07

1.1

0.33

0.97

u/ml

2.81

383

Abnormal findings in secretions and smears from cervix uteri vagina vulva

578

3919

1.16

3.04

1.0

1.1

1.21

0.97

u/ml

0.37

209

1565

Endocrine, nutritional and metabolic diseases

1174

5370

1.11

3.04

1.1

1.48

1.17

u/ml

0.53

518

2436

Polyneuropathies and other disorders of the peripheral nervous system

113

808

1.40

3.04

1.1

1.18

1.07

u/ml

0.10

345

Blepharochalasis

127

927

1.37

3.01

1.1

0.43

1.05

u/ml

1.77

355

Certain infectious and parasitic diseases

1223

5520

1.11

3.01

1.1

1.47

1.03

u/ml

1.00

528

2404

Urticaria due to cold and heat

2.71

3.01

1.1

0.67

0.61

u/ml

—

Ehlers-Danlos syndrome

2.35

2.99

1.1

1.0

0.88

0.56

u/ml

0.19

Metabolic disorders

681

4837

0.87

2.99

1.1

1.00

1.09

u/ml

0.14

284

2058

Other and unspecified nerve root and plexus disorders, also in other diseases

156

1181

1.33

2.94

1.1

0.71

1.45

u/ml

1.62

476

Pulmonary embolism

145

1085

1.34

2.94

1.0

1.1

0.87

0.99

u/ml

0.14

426

Redundant prepuce, phimosis and paraphimosis

185

1430

1.29

2.90

1.1

1.39

1.35

u/ml

0.03

692

Pulmonary heart disease

145

1088

1.34

2.89

1.0

1.1

0.87

0.98

u/ml

0.14

429

Other and unspecified mental retardation

315

0.40

2.89

1.2

0.31

1.10

u/ml

—

234

Appendectomy

695

5887

1.14

2.87

1.1

1.41

1.07

u/ml

0.41

290

2430

Pericarditis

129

2.03

2.87

1.2

1.1

0.54

0.96

u/ml

0.47

Other/unspecified soft tissue disorders related to use, overuse and pressure

157

1.94

2.87

1.1

0.62

1.12

u/ml

0.68

Disorders of sclera, cornea, iris and ciliary body

481

4125

1.17

2.85

1.1

1.69

1.03

u/ml

0.78

226

1743

Obesity due to excess calories

466

3988

1.17

2.84

1.1

0.77

1.20

u/ml

0.78

191

1679

TMD muscular pain linked with fibromyalgia

2.71

2.83

1.0

0.17

0.80

u/ml

—

Infections with a predominantly sexual mode of transmission

404

3417

1.19

2.83

1.1

1.69

1.17

u/ml

0.47

173

1435

Disorders of choroid and retina

397

3421

0.84

2.83

1.0

1.1

1.25

1.04

u/ml

0.16

160

1379

Major coronary heart disease event

237

1968

0.80

2.82

1.1

1.16

1.10

u/ml

0.04

791

Other immunodeficiencies

2.33

2.82

1.1

0.67

0.75

u/ml

0.05

ILD, hospital admissions 3, with pneumonia sepsis

172

1.87

2.81

1.2

1.1

0.39

2.07

u/ml

0.87

Persistent delusional disorders

385

0.46

2.80

1.1

0.30

1.56

u/ml

—

161

Benign neoplasm: Choroid

194

1.82

2.80

1.1

1.0

0.84

1.64

u/ml

0.44

Otitis media, unspecified

200

1452

1.28

2.80

1.2

1.1

1.59

1.43

u/ml

0.11

117

771

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

371

0.45

2.80

1.2

1.1

1.73

1.39

u/ml

—

171

Idiopathic pulmonary fibrosis

137

1.98

2.80

1.0

1.1

0.74

0.72

u/ml

0.02

Other specified/unspecified bacterial intestinal infections

284

1.67

2.80

1.1

0.44

1.25

u/ml

1.02

126

Dysplasia of cervi uteri

291

1845

1.22

2.79

1.1

1.29

1.18

u/ml

0.08

107

758

Suppurative otitis media, unspecified

210

1.79

2.77

1.0

1.1

0.36

1.76

u/ml

1.24

105

Disorders of parathyroid gland

687

1.41

2.77

1.1

0.52

1.27

u/ml

1.32

279

Major anomalies of jaw size

203

1.80

2.76

1.0

1.1

0.65

1.22

u/ml

0.34

Other diseases of intestines

1241

6548

1.10

2.76

1.1

1.14

1.12

u/ml

0.03

526

2912

Type 1 diabetes

199

2501

0.79

2.75

1.0

1.1

0.82

1.21

u/ml

0.68

1214

Other neurological diseases

347

3327

0.84

2.74

1.1

0.65

1.09

u/ml

1.51

152

1379

Dental operations

579

2574

1.16

2.74

1.1

1.32

1.05

u/ml

0.31

260

1048

Other symptoms and signs involving the circulatory and respiratory systems

309

1.63

2.73

1.1

1.0

0.24

1.85

u/ml

2.11

137

Spinal osteochondrosis

2.65

2.73

1.1

0.42

3.68

u/ml

—

Other arthrosis

375

2254

1.19

2.73

1.1

0.69

1.11

u/ml

0.59

152

847

Use of anticholinesterases

332

0.49

2.72

1.1

1.0

0.34

1.16

u/ml

—

127

N06DA Anticholinesterases

332

0.49

2.72

1.1

1.0

0.34

1.16

u/ml

—

127

Reimbursement for rheumatic diseases

364

4301

0.84

2.72

1.1

0.55

1.11

u/ml

2.24

137

1835

Sacrococcygeal disorders, not elsewhere classified

182

1.84

2.71

1.1

0.27

2.02

u/ml

1.64

Insulin, fast-acting (human)

1332

0.72

2.71

1.0

1.1

0.41

1.36

u/ml

3.44

598

Vulvovaginal ulceration/inflammation in other diseases

568

1.46

2.71

1.1

0.57

0.78

u/ml

0.31

238

Type 1 diabetes, wide definition, subgroup 1

171

2183

0.78

2.70

1.0

1.1

0.59

1.13

u/ml

1.51

1046

Testicular hypofunction

175

1.85

2.70

1.1

1.67

1.59

u/ml

0.02

Menorrhagia

363

1679

1.20

2.69

1.1

0.70

0.98

u/ml

0.44

132

677

Sicca syndrome [Sjögren]

413

1.54

2.69

1.1

0.58

1.10

u/ml

0.50

168

Injuries to the neck

246

1997

1.24

2.69

1.1

1.02

1.43

u/ml

0.84

108

867

Galactorrhea

2.39

2.69

1.1

6.35

0.82

u/ml

—

Uterine polyps

494

1.49

2.68

1.0

1.1

2.19

1.00

u/ml

0.36

202

Bleeding

475

4011

0.86

2.68

1.1

1.01

1.11

u/ml

0.16

210

1722

Suicide or other Intentional self-harm

180

2284

0.78

2.68

1.1

1.15

1.33

u/ml

0.10

974

Other/unspecified enthesopathies of lower limb, excluding foot

454

1.51

2.68

1.1

0.94

1.49

u/ml

0.44

180

L02BG Aromatase inhibitors

1272

0.71

2.67

1.0

1.1

2.18

0.87

u/ml

0.40

469

Sexual dysfunction

2.25

2.66

1.0

1.1

0.37

1.01

u/ml

—

Urethritis and urethral syndrome

2.15

2.66

1.1

0.36

1.04

u/ml

—

Endometriosis

390

1958

1.19

2.66

1.1

0.82

1.12

u/ml

0.63

155

802

Lateral epicondylitis

112

821

1.37

2.65

1.2

1.1

1.62

1.35

u/ml

0.08

314

Other abnormal products of conception

478

2739

1.17

2.65

1.1

1.14

1.00

u/ml

0.21

196

1086

Type 1 diabetes, strict (exclude DM2)

107

1447

0.73

2.64

1.1

0.68

1.31

u/ml

1.03

767

Malignant neoplasm of breast, HER-positive

122

1604

0.75

2.64

1.1

1.56

0.79

u/ml

0.30

580

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

2.50

2.64

1.1

1.0

0.22

1.21

u/ml

—

Other viral hepatitis

556

0.57

2.62

1.2

1.1

0.21

1.04

u/ml

2.33

230

Atherosclerosis, excluding cerebral and coronary sclerosis

762

0.67

2.62

1.1

1.0

1.45

0.93

u/ml

0.31

307

Other acute skin changes due to ultraviolet radiation

127

1.99

2.61

1.1

1.0

0.19

1.82

u/ml

0.85

L04AA Selective immunosuppressants

122

1622

0.75

2.61

1.0

1.1

0.25

1.32

u/ml

6.21

721

Adenomyosis (Endometriosis of uterus)

100

722

1.39

2.60

1.1

0.59

0.95

u/ml

0.51

290

Hyperparathyroidism

548

1.45

2.60

1.1

0.56

1.44

u/ml

1.26

226

Benign neoplasm: Small intestine

100

2.12

2.59

1.2

1.1

0.47

2.07

u/ml

—

Mycoses

209

1674

1.25

2.59

1.1

0.81

1.22

u/ml

0.78

729

Other retinal artery occlusion

2.92

2.59

1.0

1.1

0.07

1.09

u/ml

—

Sulfonylureas

653

0.65

2.59

1.0

1.1

0.49

0.86

u/ml

0.46

274

Benign neoplasm of eye and adnexa

409

1.52

2.58

1.1

0.76

0.77

u/ml

0.00

175

Certain disorders involving the immune mechanism

160

1242

1.29

2.57

1.1

1.41

1.10

u/ml

0.12

538

Other inflammation of vagina/vulva

339

1.58

2.57

1.1

1.0

0.39

0.71

u/ml

0.68

143

Disorders of eyelid in diseases classified elsewhere

164

1.85

2.55

1.1

7.53

0.85

u/ml

0.84

Type 1 diabetes, strict definition

1310

0.72

2.54

1.1

1.81

1.14

u/ml

0.19

712

Benign neoplasm of eye and adnexa

411

1.52

2.53

1.1

0.76

1.09

u/ml

0.29

175

Other and unspecified follicular disorders

224

1.71

2.52

1.1

0.14

2.00

u/ml

1.62

Short Achilles tendon (acquired)

122

1.99

2.52

1.0

1.1

0.43

1.05

u/ml

—

malignant neoplasm of male genital organs

677

0.69

2.50

1.0

1.1

0.58

1.02

u/ml

0.50

274

Other specified/unspecified soft tissue disorders

172

1.81

2.50

1.1

0.24

0.92

u/ml

1.66

Other diseases of stomach and duodenum

209

1.73

2.50

1.1

0.72

1.32

u/ml

0.68

Benign neoplasm: Choroid

202

1.75

2.49

1.1

1.0

0.84

0.96

u/ml

0.08

Benign neoplasm of middle ear and respiratory system

287

1.61

2.45

1.1

0.41

1.31

u/ml

1.24

125

Other complications of surgical and medical care, not elsewhere classified

596

1.42

2.45

1.1

1.45

0.92

u/ml

0.33

250

Deforming dorsopathies

244

2001

1.22

2.45

1.1

0.56

1.33

u/ml

3.19

110

873

Benign neoplasm: Ascending colon

342

1.56

2.45

1.1

0.93

1.16

u/ml

0.13

133

Impetigo

506

1.46

2.45

1.2

1.1

1.77

1.05

u/ml

0.33

268

Pre-eclampsia or poor fetal growth

279

3335

0.83

2.45

1.1

1.39

1.07

u/ml

0.16

104

1331

Other disorders of penis

613

1.41

2.44

1.1

2.86

1.60

u/ml

0.35

337

Use of disulfiram, acamprosate or naltrexone

582

0.60

2.44

1.1

0.34

1.68

u/ml

1.96

229

Thyroiditis, unspecified

2.21

2.43

1.0

1.1

0.22

0.92

u/ml

—

Degenerative diseases of the nervous system

384

0.57

2.43

1.0

0.38

1.22

u/ml

—

150

Alzheimer disease, including avohilmo

322

0.54

2.43

1.0

0.60

1.16

u/ml

—

126

Bacterial Sepsis

162

1829

0.79

2.42

1.0

1.1

1.29

1.09

u/ml

0.22

796

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

267

0.41

2.42

1.2

1.1

1.91

1.63

u/ml

—

132

Mixed conductive and sensorineural hearing loss

424

1.49

2.41

1.0

1.1

0.16

1.20

u/ml

2.70

185

Primary_lymphoid and hematopoietic malignant neoplasms

1013

0.70

2.39

1.1

0.73

0.95

u/ml

0.21

452

Other puerperal infections

121

916

1.33

2.39

1.1

1.00

0.95

u/ml

0.04

377

Type 1 diabetes, strict definition, subgroup 1

1238

0.73

2.38

1.1

0.40

1.17

u/ml

3.26

663

Fever of other and unknown origin

508

4116

1.15

2.37

1.1

0.72

1.21

u/ml

1.87

243

1830

Peroneal tendinitis

2.18

2.37

1.0

1.1

0.57

4.62

u/ml

—

Other acquired deformities of musculoskeletal system and connective tissue

236

1.67

2.36

1.1

0.24

1.86

u/ml

1.43

101

Complications of medical and surgical care

586

4910

1.13

2.36

1.1

0.88

1.08

u/ml

0.33

258

2021

Type 1 diabetes, definitions combined

110

1453

0.75

2.36

1.1

1.93

1.21

u/ml

0.24

768

Endometriosis of pelvic peritoneum

183

1443

1.26

2.36

1.1

0.94

1.05

u/ml

0.12

590

Atrial septal defect

508

0.58

2.36

1.0

1.2

1.41

0.99

u/ml

0.15

331

Acute alcohol intoxication

131

1698

0.77

2.36

1.1

1.14

1.19

u/ml

0.04

730

Meniscus derangement

450

2662

1.16

2.35

1.1

0.88

1.10

u/ml

0.30

179

1028

Other maternal disorders predominantly related to pregnancy

696

3893

1.13

2.35

1.1

0.94

1.10

u/ml

0.28

262

1565

Special screening examination for neoplasms

118

1.96

2.35

1.0

0.19

1.71

u/ml

—

Drug-induced adrenocortical insufficiency

2.12

2.35

1.1

0.10

1.79

u/ml

—

Mental and behavioural disorders due to cannabinoids

344

0.49

2.35

1.1

0.93

1.82

u/ml

0.66

154

Viral hepatitis

600

0.61

2.35

1.2

1.1

0.20

1.19

u/ml

2.48

249

Fracture of femur

706

0.66

2.35

1.0

1.1

0.34

1.15

u/ml

2.37

313

Non-selective monoamine reuptake inhibitors

250

2002

1.21

2.34

1.1

1.0

0.46

0.90

u/ml

2.40

121

746

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

221

1.68

2.34

1.0

0.50

1.34

u/ml

0.71

Type1 diabetes, definitions combined, early onset

1162

0.72

2.34

1.1

2.26

1.21

u/ml

0.30

645

Benign paroxysmal vertigo

168

1330

1.27

2.33

1.0

1.1

0.50

1.01

u/ml

1.82

530

Viral infections characterized by skin and mucous membrane lesions

392

3368

1.17

2.33

1.1

2.12

1.16

u/ml

0.82

192

1572

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

1102

0.72

2.32

1.0

1.1

1.26

0.78

u/ml

0.35

414

Systemic connective tissue disorders

243

2004

1.22

2.32

1.1

0.40

1.14

u/ml

3.34

100

820

Leiomyoma of uterus

386

2536

0.86

2.32

1.1

0.88

0.84

u/ml

0.07

130

969

Kidney transplant status

356

0.50

2.31

1.2

1.1

0.10

1.67

u/ml

—

190

Cardiovascular diseases

1055

5230

1.10

2.30

1.1

1.26

1.16

u/ml

0.18

463

2434

Other predominantly sexually transmitted diseases, not elsewhere classified

229

1882

1.22

2.30

1.1

2.38

1.20

u/ml

0.68

804

Impacted maxillary canine

135

1.92

2.29

1.0

1.1

1.68

0.71

u/ml

0.37

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

667

4873

0.89

2.29

1.1

1.17

0.99

u/ml

0.23

259

1943

Pulmonary heart disease, diseases of pulmonary circulation

155

1218

1.28

2.28

1.0

1.1

0.87

1.27

u/ml

0.60

505

Inflammatory disorders of breast

538

1.43

2.28

1.1

0.50

1.09

u/ml

1.03

228

Valvular heart disease excluding rheumatic fever

200

1801

0.81

2.28

1.0

1.1

1.00

1.10

u/ml

0.12

827

Gluteal tendinitis

163

1.80

2.28

1.0

1.1

1.58

1.97

u/ml

0.12

Coronary angioplasty

845

0.72

2.28

1.1

1.0

0.66

1.06

u/ml

0.58

351

Hypothyroidism, strict autoimmune, 3 medication purchases required

828

5086

1.11

2.28

1.1

0.69

1.12

u/ml

1.92

310

2110

Concussion

561

4284

1.14

2.27

1.1

0.89

1.32

u/ml

1.59

263

1967

Delivery

338

2104

0.85

2.27

1.1

1.67

1.02

u/ml

0.60

143

912

Other otitis externa (chronic)

390

1.50

2.26

1.0

1.1

1.33

1.43

u/ml

0.04

180

Benign neoplasm: Ascending colon

349

1.52

2.26

1.1

0.93

0.67

u/ml

0.18

140

Haemangioma, any site

522

1.43

2.26

1.1

0.26

1.41

u/ml

2.37

241

Contraceptive management

507

3122

1.14

2.25

1.1

1.04

1.03

u/ml

0.01

211

1275

Acute alcohol intoxication, ICD10

114

1493

0.76

2.24

1.1

1.24

1.21

u/ml

0.02

651

Acute renal failure

631

0.63

2.24

1.0

1.1

1.33

1.14

u/ml

0.09

280

Any mental disorder

1228

5638

1.09

2.23

1.1

1.28

1.06

u/ml

0.40

554

2436

Other and unspecified local infections of skin and subcutaneous tissue

574

1.40

2.22

1.1

0.82

1.04

u/ml

0.20

253

Rheumatism, unspecified

701

1.36

2.22

1.1

0.76

1.02

u/ml

0.33

276

Oligomenorrhoea

328

1.54

2.21

1.0

1.1

0.41

1.16

u/ml

1.10

145

Benign neoplasm: Small intestine

107

1.98

2.21

1.2

1.1

0.47

0.99

u/ml

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

150

1.81

2.21

1.0

0.48

1.90

u/ml

0.94

Certain conditions originating in the perinatal period

196

1412

1.24

2.21

1.2

1.1

0.85

1.57

u/ml

1.56

111

802

Cholecystectomy

516

4012

1.14

2.21

1.1

0.58

0.91

u/ml

1.60

194

1554

Testicular dysfunction

195

1.71

2.20

1.1

1.67

1.49

u/ml

0.05

Benign neoplasm: Colon

274

1756

1.20

2.20

1.0

1.1

0.77

1.06

u/ml

0.61

108

666

Other disorders of bone

197

1602

1.23

2.19

1.1

0.73

1.23

u/ml

1.26

677

Other disorders of teeth and supporting structures

149

1173

1.27

2.19

1.1

0.88

1.42

u/ml

0.79

484

Benign neoplasm: Stomach

320

1.54

2.19

1.1

0.81

1.40

u/ml

0.56

127

Haemangioma and lymphangioma, any site

593

1.39

2.18

1.1

0.24

1.29

u/ml

2.53

277

Insulin, fast-acting or short human

230

2771

0.83

2.18

1.0

1.1

0.71

1.19

u/ml

1.18

1297

Nonalcoholic fatty liver disease

551

1.41

2.18

1.1

0.97

1.29

u/ml

0.29

223

Retained placenta and membranes, without haemorrhage

117

894

1.32

2.18

1.1

0.43

0.83

u/ml

1.02

358

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

780

0.68

2.17

1.1

0.71

0.88

u/ml

0.23

298

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

151

1.80

2.17

1.0

1.1

0.48

1.14

u/ml

0.86

Oral leukoplakia and related diseases, including avohilmo

337

1.52

2.16

1.1

0.82

1.50

u/ml

0.53

140

Synovial cyst of popliteal space [Baker]

242

1.62

2.16

1.0

1.1

0.35

1.71

u/ml

1.41

101

Presence of other functional implants

184

1609

0.81

2.15

1.1

1.11

1.10

u/ml

0.00

652

Deep bite

181

1279

1.25

2.15

1.1

1.37

1.34

u/ml

0.02

713

Finngen Rheumatological endpoints

951

5951

0.91

2.13

1.1

0.77

1.18

u/ml

1.61

406

2513

Noninfectious colitis NAS

125

967

1.30

2.13

1.2

1.1

0.89

1.17

u/ml

0.33

439

Malignant neoplasm of skin

173

1616

0.80

2.13

1.0

1.1

0.82

0.92

u/ml

0.15

616

144

1.81

2.12

1.0

1.1

1.54

1.73

u/ml

0.04

Other infective otitis externa

323

1.53

2.12

1.0

1.1

2.08

1.37

u/ml

0.18

141

Extrapyramidal and movement disorders

199

1626

1.23

2.12

1.1

0.84

1.11

u/ml

0.34

666

Other local infections of skin and subcutaneous tissue

605

1.38

2.12

1.1

0.84

1.03

u/ml

0.19

263

Colonic or urogenital fistula

204

1672

1.22

2.11

1.1

0.65

1.20

u/ml

1.31

706

Nontoxic goitre/thyroid nodule

173

1393

1.25

2.11

1.1

0.90

0.93

u/ml

0.03

543

Complications associated with artificial fertilization

183

1.73

2.11

1.0

1.1

1.14

0.87

u/ml

0.09

Medicines for HER+ breast cancer

149

1823

0.79

2.10

1.1

1.46

0.89

u/ml

0.26

673

Diseases of arteries, arterioles and capillaries

250

2229

0.84

2.10

1.1

0.78

1.04

u/ml

0.52

907

Other disorders of the musculoskeletal system and connective tissue

648

1.36

2.10

1.1

0.93

1.17

u/ml

0.21

256

Anosmia

2.02

2.10

1.1

0.27

0.51

u/ml

—

Vascular disorders of the intestines

109

1.93

2.10

1.0

1.1

0.18

1.90

u/ml

—

Haemangioma and lymphangioma, any site

598

1.38

2.09

1.1

0.24

1.12

u/ml

2.42

276

Insulin, fast-acting

230

2757

0.83

2.09

1.0

1.1

0.71

1.20

u/ml

1.19

1294

Benign neoplasm: Duodenum

2.28

2.08

1.4

1.0

0.46

0.71

u/ml

—

Muscle strain

191

1.69

2.08

1.1

0.58

0.83

u/ml

0.28

Tramadol

705

4069

1.12

2.08

1.1

0.75

1.10

u/ml

1.00

309

1637

Nonorganic sleeping disorders, excluding more controls

202

1659

1.22

2.07

1.1

1.05

1.21

u/ml

0.20

722

Mental and behavioural disorders due to sedatives or hypnotics

519

0.61

2.07

1.0

1.1

0.72

1.24

u/ml

0.36

227

Autonomic disorders

103

1.97

2.07

1.1

0.79

1.65

u/ml

—

Benign neoplasm of other and unspecified female genital organs

199

1.67

2.06

1.1

1.26

1.33

u/ml

0.03

Benign neoplasm of middle ear and respiratory system

301

1.54

2.05

1.1

0.41

0.89

u/ml

1.16

128

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

531

0.70

2.05

1.0

1.1

0.56

0.96

u/ml

0.37

201

Perforation of tympanic membrane

643

1.36

2.05

1.1

1.23

1.26

u/ml

0.01

285

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

518

0.65

2.04

1.1

0.46

0.63

u/ml

0.38

207

Haemangioma, any site

533

1.40

2.04

1.1

0.26

1.20

u/ml

2.22

243

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

133

1683

0.79

2.04

1.1

0.61

1.36

u/ml

1.78

736

Spondylosis

320

2348

1.17

2.03

1.1

1.03

1.15

u/ml

0.11

127

893

Other factor of the environment

2.26

2.03

1.0

1.94

0.73

u/ml

—

Benign neoplasm: Duodenum

2.24

2.01

1.4

1.1

0.46

0.57

u/ml

—

Persons encountering health services in circumstances related to reproduction

734

4488

1.11

2.01

1.1

1.28

1.17

u/ml

0.14

334

2053

Fracture at wrist and hand level

327

2809

1.17

2.01

1.1

1.22

1.32

u/ml

0.08

163

1277

Agranulocytosis

600

0.65

2.00

1.2

1.1

0.61

1.32

u/ml

0.80

273

Haemorrhoids and perianal venous thrombosis

151

1205

1.25

2.00

1.0

1.1

0.41

1.07

u/ml

2.44

490

Benign mammary dysplasia

680

1.34

2.00

1.1

0.45

0.93

u/ml

0.86

271

Localized swelling, mass and lump of skin and subcutaneous tissue

243

2039

1.19

1.99

1.1

0.98

1.09

u/ml

0.17

123

871

Procedures for purposes other than remedying health state

126

1.85

1.99

1.0

1.1

0.23

2.21

u/ml

1.04

Secondary uncertain malignant neoplasm

402

0.57

1.98

1.1

0.47

1.70

u/ml

—

168

Primary_lymphoid and hematopoietic malignant neoplasms

976

0.73

1.98

1.1

0.73

1.11

u/ml

0.40

446

Polyp of the female genital tract

278

1366

1.19

1.97

1.1

0.86

0.89

u/ml

0.03

108

538

Patellar tendinitis

127

1.84

1.96

1.1

1.90

1.04

u/ml

—

Autoimmune thyroiditis

127

1.84

1.96

1.0

1.1

0.16

1.57

u/ml

—

Superficial injury of lower leg

239

2007

1.19

1.96

1.1

1.32

1.22

u/ml

0.05

103

908

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

160

1357

0.81

1.93

1.1

0.98

0.87

u/ml

0.14

513

Benign neoplasms

1146

5898

1.09

1.93

1.1

0.86

1.22

u/ml

1.69

477

2575

Speech and linguistic disorders, excluding more controls

154

1169

1.25

1.93

1.1

1.71

1.29

u/ml

0.28

677

Other spirochaetal diseases

177

1446

1.23

1.93

1.1

0.83

1.08

u/ml

0.44

603

Heart failure, strict

152

1358

0.80

1.91

1.0

1.1

0.74

1.15

u/ml

0.61

577

Abnormal findings on diagnostic imaging of central nervous system

275

1.54

1.90

1.0

1.1

0.51

1.57

u/ml

1.03

124

Heart failure,strict

148

1328

0.80

1.90

1.0

1.1

0.72

1.19

u/ml

0.70

568

Generalized epilepsy, strict definition

236

1.59

1.90

1.1

1.2

0.28

1.59

u/ml

1.50

129

Other noninflammatory disorders of vulva and perineum

652

1.34

1.90

1.0

1.1

0.82

0.95

u/ml

0.11

275

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

243

2050

1.19

1.90

1.1

0.41

1.23

u/ml

4.88

889

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

316

1.50

1.89

1.0

1.1

0.78

1.44

u/ml

—

134

Benign neoplasm: Stomach

332

1.48

1.88

1.1

0.81

0.96

u/ml

0.16

136

Premenstrual syndrome

100

1.94

1.88

1.0

1.1

0.38

0.61

u/ml

—

Demyelinating diseases of the central nervous system

756

0.70

1.88

1.0

1.1

0.05

1.16

u/ml

4.33

324

Benign neoplasm of mouth and pharynx

499

1.39

1.88

1.0

1.1

1.48

1.38

u/ml

0.05

206

Familial hypercholesterolemia

423

1.42

1.88

1.0

1.1

0.96

1.33

u/ml

0.17

196

Persistent mood disorders

165

1343

1.23

1.87

1.1

0.53

1.25

u/ml

2.48

549

Parodontitis and operation codes

553

4802

0.89

1.87

1.1

1.17

1.07

u/ml

0.09

243

1905

Mucosal proctocolitis

1090

0.75

1.86

1.1

0.48

1.16

u/ml

1.97

469

Lifestyle-related condition

2.24

1.86

1.0

1.1

1.94

0.88

u/ml

—

Non-rheumatic valve diseases

196

1724

0.83

1.86

1.0

1.1

1.04

1.11

u/ml

0.08

769

Other diseases of jaws

383

1.44

1.85

1.0

1.1

0.56

1.41

u/ml

1.00

152

Contact with and exposure to communicable diseases

381

4325

0.87

1.85

1.1

0.91

1.21

u/ml

0.65

174

2019

Injury of muscle and tendon at ankle and foot level

152

1.73

1.85

1.0

1.1

0.92

1.73

u/ml

0.35

Neuralgia and neuritis, unspecified

253

1.55

1.84

1.1

3.09

1.16

u/ml

0.36

103

Other diseases of anus and rectum

179

1470

1.22

1.84

1.1

0.64

0.97

u/ml

0.80

623

Use of biperiden

250

0.48

1.84

1.0

1.1

2.27

1.34

u/ml

—

107

Poor fetal growth

122

1536

0.79

1.84

1.1

0.38

1.01

u/ml

2.97

638

Poisoning by drugs, medicaments and biological substances

198

2373

0.83

1.83

1.1

0.70

1.29

u/ml

1.61

1035

Disorders of gallbladder, biliary tract and pancreas

693

4929

0.90

1.83

1.1

0.58

1.07

u/ml

2.89

264

2000

Fibroblastic disorders

116

909

1.28

1.83

1.1

0.61

1.24

u/ml

1.17

351

Chronic viral hepatitis

477

0.62

1.83

1.2

1.1

0.18

1.18

u/ml

2.40

193

Atrial fibrillation and flutter

185

1461

0.82

1.82

1.0

1.1

0.70

1.13

u/ml

0.93

585

Other superficial mycoses

123

1.81

1.1

0.36

1.90

u/ml

—

Congenital absence, atresia and stenosis of large intestine

0.00

1.81

0.0

1.3

—

0.50

—

Residual foreign body in soft tissue

311

1.49

1.81

1.1

0.31

1.45

u/ml

1.62

138

Scleritis and episcleritis

377

1.44

1.81

1.1

0.80

1.53

u/ml

0.47

151

Ulcerative colitis (strict definition, all Crohn cases excluded)

1254

0.77

1.81

1.1

0.48

1.30

u/ml

2.76

548

LeFortI or BSSRO operation

361

1.45

1.80

1.0

1.1

0.31

1.65

u/ml

1.59

143

Benign neoplasm of other and unspecified female genital organs

207

1.61

1.80

1.1

1.26

0.94

u/ml

0.21

Congenital malformations of trachea and bronchus

2.22

1.80

1.2

0.82

1.76

u/ml

—

Alcoholic liver disease

326

0.55

1.79

1.1

0.32

1.24

u/ml

—

134

Benign neoplasm: Scapula and long bones of upper limb

2.38

1.79

1.1

1.0

1.51

3.04

u/ml

—

Budesonide

116

913

1.28

1.78

1.1

2.81

1.12

u/ml

0.40

356

Intracranial injury

520

4494

1.12

1.78

1.1

0.94

1.16

u/ml

0.62

252

2024

MS-disease / Multiple Sclerosis

642

0.68

1.78

1.0

1.1

0.07

1.21

u/ml

—

277

Adrenocortical insufficiency

208

1.60

1.78

1.1

0.14

1.24

u/ml

1.48

105

Bacterial infection, other or unspecified

237

2517

0.85

1.77

1.0

1.1

0.85

1.01

u/ml

0.29

106

1109

Struck by thrown, projected or falling objec

354

1.45

1.77

1.1

0.86

1.18

u/ml

0.21

160

Coronary atherosclerosis

250

1895

0.85

1.77

1.1

1.11

u/ml

0.00

757

Open wound of wrist and hand

425

3723

1.13

1.77

1.0

1.1

0.74

1.23

u/ml

1.77

191

1639

Horner syndrome

2.47

1.76

1.1

1.0

0.10

4.47

u/ml

—

Antihypertensive medication - note that there are other indications

996

5019

1.09

1.76

1.1

0.90

1.23

u/ml

0.99

424

2308

Chronic kidney disease

962

0.74

1.75

1.1

0.68

1.33

u/ml

0.73

443

Severe mental retardation

0.00

1.75

0.0

1.1

—

1.66

—

Other viral diseases

374

3277

1.14

1.75

1.1

0.98

1.24

u/ml

0.60

176

1576

Other skin changes

101

783

1.29

1.75

1.1

2.64

1.04

u/ml

0.35

336

Single delivery by caesarean section

231

1578

0.84

1.75

1.1

0.81

1.06

u/ml

0.47

691

Anogenital herpesviral [herpes simplex] infection

619

1.34

1.74

1.1

1.05

0.88

u/ml

0.17

269

Intermittent heterotropia

766

0.71

1.74

1.1

0.79

1.33

u/ml

0.76

431

Invasive ventilation

410

0.61

1.74

1.1

0.29

1.48

u/ml

2.22

232

Other specified and unspecified disorders of eye and adnexa

178

1.64

1.73

1.1

0.25

0.79

u/ml

1.79

Syncope and collapse

310

2380

1.16

1.73

1.1

0.81

1.16

u/ml

0.86

137

1021

Coeliac disease

120

953

1.27

1.73

1.1

1.56

1.25

u/ml

0.18

447

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

148

1255

0.81

1.73

1.1

0.80

0.89

u/ml

0.13

473

Lichen planus

490

1.37

1.73

1.0

1.1

2.00

1.40

u/ml

0.25

200

Drug-induced cataract

103

1.86

1.73

1.2

1.0

1.74

1.82

u/ml

—

Presence of cardiac and vascular implants and grafts

118

1124

0.79

1.72

1.0

1.1

0.69

1.20

u/ml

0.81

463

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

407

3560

1.13

1.72

1.1

1.04

1.20

u/ml

0.24

204

1655

Complications of procedures, not elsewhere classified

698

5487

1.10

1.72

1.1

0.96

1.04

u/ml

0.12

289

2238

Other diseases of peritoneum

194

1.61

1.72

1.0

1.1

0.35

1.41

u/ml

—

Kyphosis

0.00

1.70

0.0

1.1

—

1.46

—

Polyarthritis, unspecified

179

1.63

1.70

1.1

0.38

0.98

u/ml

1.29

Second line medication for Crohn's disease

422

4748

0.89

1.69

1.1

2.19

1.08

u/ml

0.95

181

2097

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

468

4172

1.12

1.69

1.1

1.42

1.18

u/ml

0.24

228

1873

Biomechanical lesions, not elsewhere classified

187

1.61

1.69

1.2

1.1

1.54

2.33

u/ml

0.25

Melanocytic naevi

265

2278

1.17

1.69

1.1

0.86

1.19

u/ml

0.68

110

979

Hypertensive diseases

685

4264

0.91

1.69

1.1

1.03

1.09

u/ml

0.09

280

1795

Oxycodone

115

1396

0.80

1.69

1.0

0.57

1.13

u/ml

1.21

551

Major coronary heart disease event excluding revascularizations

208

1704

0.84

1.68

1.1

1.0

1.26

1.05

u/ml

0.15

669

Disorders of vitreous body and globe

247

2058

1.17

1.68

1.0

1.1

0.80

0.94

u/ml

0.24

101

775

Other hammer toe(s) (acquired)

501

1.35

1.68

1.1

1.0

1.88

0.97

u/ml

0.26

190

Pain associated with micturition

683

1.31

1.68

1.1

1.06

1.33

u/ml

0.21

309

Iron deficiency

212

1.58

1.67

1.0

1.1

0.85

0.65

u/ml

0.15

Viral pneumonia (unknown virus, not influenza)

434

1.39

1.67

1.1

1.66

1.64

u/ml

0.01

182

Vitiligo

2.13

1.67

1.0

1.1

0.68

0.88

u/ml

—

Cholecystitis

459

1.38

1.67

1.1

0.82

1.14

u/ml

0.23

188

Other specified/unspecified hearing loss

284

1.49

1.66

1.1

0.41

1.64

u/ml

1.28

127

Contusion of toe(s) with damage to nail

2.07

1.66

1.1

0.39

0.57

u/ml

—

Disorders of vitreous body

239

1996

1.17

1.66

1.0

1.1

0.82

0.95

u/ml

0.21

753

Hypersomnia

2.00

1.66

1.2

1.1

0.28

0.95

u/ml

—

Impacted cerumen

443

1.38

1.66

1.1

0.91

1.67

u/ml

0.61

232

Varicose veins

297

2583

0.87

1.65

1.1

1.44

0.86

u/ml

0.43

969

Postpartum haemorrhage due to anatomy

144

1176

1.23

1.65

1.1

2.33

1.02

u/ml

0.39

467

Other diseases of intestine

401

1.40

1.65

1.1

0.45

1.15

u/ml

0.95

178

Other bursopathies

555

1.34

1.64

1.0

1.1

0.26

1.13

u/ml

2.13

211

Panniculitis affecting regions of neck and back

189

1.60

1.63

1.2

1.1

0.70

1.80

u/ml

0.77

Hyperlipidaemia, other/unspecified

160

1248

1.22

1.63

1.1

0.36

1.14

u/ml

2.65

514

Drug-induced neutropenia

290

0.55

1.63

1.1

1.18

1.83

u/ml

—

121

Convergence insufficiency and excess

113

1.80

1.62

1.2

1.1

0.20

1.61

u/ml

0.89

Carpal tunnel syndrome

451

3634

1.12

1.62

1.1

0.37

0.99

u/ml

5.93

152

1419

119

894

1.25

1.62

1.0

1.98

1.11

u/ml

0.26

361

Acne

173

1441

1.21

1.62

1.1

0.93

1.45

u/ml

0.84

694

Spinal instabilities

143

1.69

1.62

1.0

0.03

2.19

u/ml

—

Chondropathies

151

1241

1.22

1.62

1.1

0.74

1.13

u/ml

0.80

531

Helminthiases

1.89

1.62

1.1

0.67

0.58

u/ml

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

427

3042

0.89

1.61

1.1

1.20

1.04

u/ml

0.17

158

1229

Pedestrian injured in other and unspecified transport accidents

2.36

1.61

1.2

1.1

0.05

3.57

u/ml

—

Examination and encounter for administrative purposes

143

1.69

1.61

1.0

1.1

0.62

1.02

u/ml

—

Dental caries 1 and operation codes

855

4029

1.09

1.61

1.1

1.24

1.09

u/ml

0.22

387

1713

Heart failure and coronary heart disease

471

0.70

1.61

1.0

1.1

0.76

1.31

u/ml

0.43

193

Glucagon-like peptide-1 (GLP-1) analogues

182

1786

0.84

1.61

1.0

1.1

1.24

1.19

u/ml

0.04

720

Lyme disease

170

1414

1.21

1.60

1.1

0.84

1.10

u/ml

0.44

585

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

151

1.67

1.60

1.0

1.1

0.98

1.48

u/ml

0.22

Postpartum hemorraghe, parous women as controls

321

2460

1.15

1.60

1.1

1.40

1.05

u/ml

0.20

125

960

Hypertension

686

4255

0.91

1.60

1.1

1.03

1.09

u/ml

0.10

281

1787

Emotional disorders starting during childhood or adolecense, excluding more controls

104

806

1.28

1.59

1.1

1.58

1.52

u/ml

0.04

464

Injury of muscle and tendon at lower leg level

108

857

1.26

1.59

1.1

0.46

0.97

u/ml

1.55

362

Leiomyoma of uterus

451

2872

0.89

1.59

1.1

0.81

0.83

u/ml

0.05

155

1098

Chronic iridocyclitis

300

0.56

1.59

1.1

0.31

1.53

u/ml

—

137

Poisoning by medicine

182

2163

0.84

1.59

1.1

0.71

1.33

u/ml

1.53

944

Pregnancy, childbirth and the puerperium

261

1585

0.86

1.58

1.0

1.1

1.64

1.08

u/ml

0.38

105

692

Benign neoplasm: Skin of eyelid, including canthus

602

1.32

1.58

1.1

0.90

1.25

u/ml

0.26

241

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

412

3667

1.12

1.57

1.1

0.97

1.01

u/ml

0.04

179

1473

Benign neoplasm of mouth and pharynx

516

1.34

1.57

1.0

1.1

1.48

1.11

u/ml

0.23

211

Implicit bacterial Sepsis

125

1413

0.81

1.57

1.0

1.1

1.29

0.84

u/ml

0.54

592

Campylobacter enteritis

129

1.72

1.57

1.1

0.72

0.75

u/ml

—

Psychiatric diseases

1207

5634

1.07

1.57

1.1

1.21

1.08

u/ml

0.21

549

2433

All-cause Heart Failure

151

1319

0.82

1.57

1.0

1.1

0.74

1.18

u/ml

0.65

564

Covid-19 confirmed case

237

2033

1.17

1.57

1.1

0.65

1.36

u/ml

2.15

104

903

Dislocation, sprain and strain of joint and ligaments of hip

114

1.77

1.57

1.2

1.1

0.98

2.10

u/ml

—

Puerperal sepsis

102

806

1.27

1.56

1.1

1.03

1.09

u/ml

0.04

315

Behavioural syndromes associated with physiological disturbances and physical factors

397

3530

1.13

1.56

1.1

0.92

1.33

u/ml

1.14

189

1599

Crohn disease (strict definition, all UC cases excluded)

432

1.38

1.56

1.1

4.77

1.46

u/ml

0.44

180

Hallux rigidus

500

1.34

1.55

1.1

0.50

1.10

u/ml

1.20

195

Alcohol abuse, main dg

1181

0.78

1.55

1.1

1.24

1.31

u/ml

0.04

515

Other specified and unspecified retinal disorders

107

1.79

1.55

1.0

0.39

1.72

u/ml

—

Glucosamine medication

179

1195

1.20

1.55

1.1

1.0

0.45

0.90

u/ml

0.99

447

Superficial injury of wrist and hand

227

1945

1.17

1.55

1.1

0.63

1.38

u/ml

2.60

108

910

Other and specified injuries of hip and thigh

1.99

1.54

1.1

0.09

2.05

u/ml

—

Abnormal findings on diagnostic imaging of other body structures

570

1.32

1.54

1.1

0.17

1.45

u/ml

2.86

241

Congenital ichthyosis

2.70

1.54

1.1

1.0

3.27

0.96

u/ml

—

Spirochaetal infections, other/unspecified

390

1.39

1.54

1.1

0.79

1.77

u/ml

0.98

177

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

157

1301

0.83

1.53

1.1

0.75

0.89

u/ml

0.26

489

Hernia of abdominal wall

295

2578

1.15

1.53

1.1

2.17

1.00

u/ml

0.97

134

1066

Malignant neoplasm of respiratory system and intrathoracic organs

387

0.64

1.52

1.1

1.0

0.57

1.15

u/ml

0.71

155

Other and/or unspecified nontoxic goitre

349

1.41

1.51

1.0

1.23

1.12

u/ml

0.06

135

Alzheimer disease

262

0.60

1.51

1.0

0.53

1.30

u/ml

—

Diabetic nephropathy, excluding more controls

460

0.69

1.51

1.0

1.1

2.63

0.64

u/ml

0.70

174

Faecal incontinence

291

1.45

1.50

1.0

0.50

1.32

u/ml

1.00

126

Other demyelinating diseases of the central nervous system

319

0.59

1.50

1.1

0.04

1.42

u/ml

—

134

Acute otitis externa, noninfective

2.02

1.49

1.1

1.0

9.82

0.49

u/ml

—

Dermatitis herpetiformis

2.02

1.49

1.1

1.0

0.47

0.75

u/ml

—

Other and unspecified erythematous conditions

139

1.67

1.49

1.1

1.51

2.71

u/ml

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

256

0.55

1.48

1.0

1.79

0.87

u/ml

—

100

Ulcerative colitis (strict definition, require KELA)

120

1472

0.81

1.48

1.1

0.43

1.41

u/ml

3.95

653

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

235

1.50

1.48

1.1

0.28

1.74

u/ml

1.61

121

Congenital malformations of the urinary system

558

0.69

1.48

1.1

3.49

1.48

u/ml

0.54

303

Dialysis

242

0.53

1.47

1.3

1.1

0.12

1.68

u/ml

—

129

Cholera

124

1.70

1.47

1.0

1.1

0.59

1.78

u/ml

—

Acute generalized exanthematous pustulosis

268

1.47

1.1

0.65

1.61

u/ml

0.88

126

L04AX Other immunosuppressants

408

4552

0.89

1.47

1.1

2.24

1.08

u/ml

0.97

176

2014

Congenital malformations of the musculoskeletal system, not elsewhere classified

148

1.65

1.46

1.1

0.75

0.65

u/ml

0.06

Adhesive capsulitis of shoulder

751

1.27

1.46

1.1

1.08

1.05

u/ml

0.02

279

Calculus of kidney and ureter

172

1447

1.19

1.46

1.1

2.05

1.00

u/ml

0.50

606

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

271

3098

0.87

1.45

1.1

0.91

1.27

u/ml

0.35

112

1332

Persons encountering health services in other circumstances

374

3330

1.12

1.45

1.1

1.57

1.22

u/ml

0.29

159

1464

Benign neoplasms

1043

5497

1.07

1.45

1.1

0.89

1.23

u/ml

1.44

441

2414

Inflammatory disease of cervix uteri

302

1.43

1.45

1.1

0.22

0.85

u/ml

1.47

115

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

204

1.53

1.44

1.1

0.41

0.84

u/ml

0.53

Benign neoplasm: Spinal meninges

2.76

1.44

1.0

—

1.24

—

Injury of muscle and tendon at hip and thigh level

542

1.32

1.44

1.2

1.1

1.70

1.26

u/ml

0.13

227

Other noninflammatory disorders of vagina

490

1.33

1.44

1.0

1.1

0.32

1.06

u/ml

1.60

199

Family history of malignant neoplasm

831

0.75

1.43

1.1

0.16

1.26

u/ml

3.87

327

Dental caries 1, only avohilmo

769

3619

1.09

1.43

1.1

1.40

0.97

u/ml

0.74

353

1532

Other specified disorders of muscle

133

1.67

1.43

1.0

1.1

1.75

1.11

u/ml

—

Retinal breaks without detachment

621

1.29

1.43

1.1

0.55

1.15

u/ml

1.13

259

Myopia

157

1315

1.20

1.43

1.1

0.94

1.28

u/ml

0.30

584

Other functional intestinal disorders

358

3032

1.13

1.43

1.1

1.41

1.13

u/ml

0.19

165

1421

Burn and corrosion confined to eye and adnexa

149

1.63

1.42

1.1

0.95

0.93

u/ml

—

Tobacco use

321

1.41

1.40

1.0

1.1

0.67

1.77

u/ml

1.04

123

Other protozoal intestinal diseases

1.80

1.40

1.1

1.62

0.71

u/ml

0.53

Benign neoplasm: Scapula and long bones of upper limb

2.11

1.40

1.1

1.0

1.51

2.96

u/ml

—

Other disorders of adrenal gland

330

1.40

1.1

0.24

1.25

u/ml

1.67

171

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

117

1428

0.82

1.39

1.1

0.43

1.36

u/ml

3.61

636

Ovarian hyperstimulation (induction)

190

1.55

1.39

1.0

1.1

1.14

0.82

u/ml

0.11

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

131

1581

0.83

1.39

1.1

0.60

1.40

u/ml

2.03

702

Melanocytic naevi of other and unspecified parts of face

381

1.37

1.39

1.2

1.1

0.95

1.55

u/ml

0.38

157

Maternal care for other known or suspected fetal problems

316

2291

0.88

1.39

1.1

0.53

0.98

u/ml

1.91

121

968

Haemorrhage in early pregnancy

309

2665

1.13

1.39

1.1

0.72

1.06

u/ml

0.96

111

1074

Rash and other nonspecific skin eruption

598

1.29

1.39

1.1

0.71

1.29

u/ml

0.65

277

Acute lymphadenitis

546

1.31

1.38

1.1

2.95

1.35

u/ml

0.26

245

Burns and corrosions confined to eye and internal organs

174

1.57

1.38

1.1

0.80

1.54

u/ml

0.42

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

433

0.67

1.37

1.0

1.1

1.75

1.26

u/ml

—

194

Colorectal cancer, excluding all cancers (controls excluding all cancers)

810

0.76

1.37

1.0

1.1

1.85

0.98

u/ml

0.60

309

Postprocedural disorders of nervous system

722

0.74

1.37

1.0

1.1

0.21

1.19

u/ml

3.16

319

Benign lipomatous neoplasm

183

1559

1.18

1.37

1.0

1.1

0.44

1.10

u/ml

2.33

639

Aplastic and other anaemias

160

1796

0.84

1.36

1.1

0.64

1.05

u/ml

1.10

764

Other/unspecified rheumatoid arthritis

444

0.67

1.36

1.1

0.39

1.19

u/ml

—

178

Amblyopia ex anopsia

426

1.35

1.36

1.1

0.73

1.32

u/ml

0.68

243

Malignant neoplasm of breast, HER-negative

869

0.77

1.36

1.1

1.43

0.84

u/ml

0.31

328

Rheumatoid arthritis

158

1702

0.84

1.36

1.1

0.55

1.15

u/ml

1.51

633

Alopecia areata

191

1.53

1.36

1.0

1.1

0.76

1.29

u/ml

0.34

Hydronephrosis

514

0.70

1.36

1.0

1.1

0.32

1.34

u/ml

2.06

220

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

467

0.68

1.35

1.0

1.1

1.15

0.83

u/ml

0.23

182

Exposure to other and unspecified inanimate mechanical forces

548

1.30

1.35

1.1

0.48

1.22

u/ml

1.40

249

Malignant neoplasm of bladder

1.83

1.35

1.1

1.0

1.11

0.86

u/ml

—

Other neurotic disorders

199

1.52

1.35

1.3

1.1

0.87

1.89

u/ml

0.51

Toxic effect of contact with venomous animals

257

1.45

1.34

1.1

0.83

1.22

u/ml

0.26

118

Sequelae of cerebrovascular disease

891

0.79

1.34

1.1

0.61

0.90

u/ml

0.42

361

Endometriosis of ovary

155

1302

1.19

1.34

1.0

1.1

0.60

0.92

u/ml

0.67

522

Disorders of orbit

249

1.46

1.33

1.0

1.1

0.73

1.74

u/ml

0.77

113

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

121

1.69

1.33

1.0

1.2

4.17

0.58

u/ml

0.44

Pilonidal cyst

888

0.77

1.33

1.1

0.61

1.15

u/ml

1.22

378

Umbilical hernia

186

1591

1.17

1.33

1.1

1.66

1.16

u/ml

0.39

662

Unspecified fall

408

3646

1.11

1.33

1.1

1.00

1.23

u/ml

0.53

219

1718

Convergent concomitant strabismus

615

0.73

1.33

1.0

1.1

3.53

1.14

u/ml

0.36

303

Tooth agenesis EXCLUDE clefts and syndromes

577

1.30

1.33

1.1

0.85

1.33

u/ml

0.52

301

Other sleep disorders

664

1.27

1.33

1.1

1.52

1.21

u/ml

0.14

277

Other retinal disorders

279

2542

0.88

1.32

1.0

1.1

0.88

1.12

u/ml

0.44

110

1071

DVT of lower extremities and pulmonary embolism

202

1734

1.16

1.32

1.0

1.1

0.83

1.11

u/ml

0.51

688

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

246

0.57

1.32

1.0

1.79

0.89

u/ml

—

Other disorders of breast and lactation associated with childbirth

193

1.52

1.31

1.0

1.1

1.28

0.62

u/ml

0.49

Delayed milestone in childhood

519

0.71

1.30

1.2

2.67

1.00

u/ml

0.42

389

Other disorders starting during childhood or adolecense, excluding more controls

113

895

1.23

1.30

1.1

2.15

1.34

u/ml

0.38

540

Lichen ruber planus, wide definition including periferal and oral lichen planus

118

971

1.22

1.30

1.0

1.1

1.34

1.18

u/ml

0.10

376

Fitting and adjustment of other devices

141

1097

1.20

1.30

1.1

0.71

0.90

u/ml

0.28

440

Seborrhoeic keratosis

746

1.25

1.30

1.1

1.0

1.32

1.10

u/ml

0.12

295

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

232

0.56

1.30

1.0

1.1

1.79

1.46

u/ml

—

Nausea and vomiting

225

1925

1.15

1.29

1.1

0.80

1.33

u/ml

1.18

105

948

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

378

1.36

1.28

1.1

0.73

1.61

u/ml

0.86

158

Use of pramipexole

106

864

1.23

1.28

1.1

1.28

1.03

u/ml

0.14

350

Achilles tendinitis

517

1.30

1.28

1.1

3.71

1.70

u/ml

0.40

194

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

405

0.70

1.28

1.1

0.46

0.67

u/ml

0.39

163

Other disorders of prostate

1.94

1.28

1.1

1.0

0.19

0.66

u/ml

—

Benign neoplasm: Vulva

1.80

1.28

1.1

1.33

0.74

u/ml

—

Early lumbar disc prolapse, operated

121

1002

1.21

1.27

1.1

1.07

1.36

u/ml

0.28

403

Congenital malformations of great arteries

437

0.68

1.27

1.0

1.2

1.48

1.05

u/ml

0.24

313

Care involving dialysis

365

0.65

1.27

1.2

1.1

0.55

1.65

u/ml

0.98

174

Carcinoma in situ of breast, intraductal

353

0.65

1.27

1.0

1.77

0.84

u/ml

—

136

Diseases of tongue

277

1.41

1.26

1.0

1.1

2.27

1.36

u/ml

0.21

108

Spinal stenosis

223

1519

1.15

1.26

1.1

0.82

1.13

u/ml

0.46

566

Diseases of pulp and periapical tissues

281

2487

1.13

1.26

1.1

0.55

1.34

u/ml

3.49

128

1032

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

634

1.27

1.26

1.1

3.53

1.20

u/ml

0.41

280

Overexertion and strenuous or repetitive movements

705

1.25

1.26

1.1

0.48

1.31

u/ml

1.60

297

Crohn's disease of large intestine

423

1.33

1.26

1.1

4.14

1.22

u/ml

0.38

183

Other and unspecified mononeuropathies, also in other diseases

107

1.69

1.26

1.1

1.0

0.26

2.34

u/ml

—

Dementia in Alzheimer disease

137

0.50

1.25

1.0

—

1.78

—

Colorectal adenocarcinoma

459

0.70

1.25

1.0

1.1

1.15

0.97

u/ml

0.11

184

Glomerular diseases

1047

0.80

1.25

1.1

1.24

1.28

u/ml

0.02

490

Stenosis and insufficiency of lacrimal passages

432

1.32

1.25

1.1

0.77

1.09

u/ml

0.36

198

Unspecified kidney failure

229

0.57

1.25

1.1

1.0

1.25

1.95

u/ml

—

100

Benign neoplasm: Spinal meninges

2.42

1.25

1.0

1.1

—

1.39

—

Cellulitis

179

1537

1.17

1.25

1.1

1.58

1.03

u/ml

0.34

697

Atrial fibrillation and flutter with reimbursement

112

872

0.82

1.24

1.0

0.95

1.32

u/ml

0.41

354

Congenital malformations of cardiac septa

892

0.79

1.24

1.0

1.2

1.31

1.15

u/ml

0.10

545

Delivery, wide proxy

302

1809

0.89

1.24

1.1

1.83

1.03

u/ml

0.65

123

791

Fasciculation

1.93

1.24

1.0

0.70

0.65

u/ml

—

Cysts of oral region, not elsewhere classified

220

1.46

1.24

1.0

1.1

0.31

1.57

u/ml

1.12

Benign neoplasm: Vulva

1.78

1.23

1.1

1.33

0.95

u/ml

—

Disturbances of smell and taste

171

1.53

1.23

1.0

1.1

0.31

1.84

u/ml

—

Cardiomyopathy (excluding other)

469

0.70

1.23

1.1

1.18

1.27

u/ml

0.04

215

Bilateral sagittal split ramus osteotomy operation

296

1.40

1.23

1.0

1.1

0.36

1.87

u/ml

1.39

118

Fall on and from stairs and steps

184

1585

1.16

1.23

1.1

0.86

1.20

u/ml

0.38

687

Dental caries 3 and operation codes

911

4362

1.07

1.23

1.1

1.21

1.12

u/ml

0.13

412

1870

Ulcer of oesophagus

171

1.53

1.23

1.2

1.1

0.64

1.07

u/ml

0.42

Other and unspecified iridocyclitis

237

1.44

1.23

1.1

3.16

1.95

u/ml

0.21

104

Lichen planus, including avohilmo

797

1.23

1.0

1.1

1.59

1.22

u/ml

0.21

313

Otitis externa, unspecified

103

843

1.23

1.22

1.1

1.14

1.22

u/ml

0.06

391

Exposure to other and unspecified man-made environmental factors

1.74

1.22

1.1

0.66

2.23

u/ml

—

Other and unspecified injuries of ankle and foot

391

1.34

1.22

1.1

1.13

1.22

u/ml

0.04

185

Malignant neoplasm of prostate

571

0.78

1.22

1.0

1.1

0.57

0.89

u/ml

0.34

231

Dislocation, sprain and strain of joints and ligaments of thorax

180

1.51

1.21

1.0

1.1

1.07

1.00

u/ml

0.04

Ulcer of lower limb, not elsewhere classified

385

0.67

1.21

1.0

1.1

1.78

1.28

u/ml

0.17

157

Sequelae of injuries of upper limb

620

1.26

1.21

1.1

0.51

1.33

u/ml

1.43

255

Other diseases of gallbladder

140

1.58

1.20

1.2

1.1

0.30

1.79

u/ml

—

Melanocytic naevi of other and unspecified parts of face

392

1.33

1.20

1.2

1.1

0.95

1.17

u/ml

0.14

169

Generalized skin eruption due to drugs and medicaments

247

1.43

1.19

1.1

0.70

1.70

u/ml

0.84

118

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

275

0.62

1.19

1.2

1.1

0.62

0.63

u/ml

—

115

Crohn disease (strict definition, require KELA)

595

1.27

1.19

1.1

3.88

1.21

u/ml

0.43

265

False labour

461

2638

1.10

1.19

1.1

1.42

1.03

u/ml

0.36

191

1089

Polyarteritis nodosa and related conditions

1.90

1.19

1.3

1.1

0.52

2.12

u/ml

—

Other congenital malformations of skin

367

1.35

1.19

1.1

0.92

1.31

u/ml

0.31

190

Other benign neoplasms of skin

223

1954

1.14

1.19

1.1

0.57

1.18

u/ml

1.79

800

Melanocytic naevi

265

2349

1.13

1.19

1.1

0.86

1.18

u/ml

0.63

110

990

Ulcer of vagina/vulva

165

1.53

1.18

1.0

1.1

0.71

0.66

u/ml

0.06

Extracorporeal dialysis

262

0.61

1.18

1.2

1.1

0.71

1.43

u/ml

—

119

Nontoxic multinodular goitre

102

837

1.22

1.18

1.1

0.89

0.98

u/ml

0.08

317

Alcohol abuse, main dg, excluding more controls

1138

0.81

1.18

1.1

1.24

1.20

u/ml

0.02

502

Disorders of vestibular function (Vertigo)

264

2323

1.13

1.18

1.1

0.60

1.00

u/ml

1.69

105

904

Other shoulder lesions

604

1.26

1.18

1.1

0.26

1.03

u/ml

2.13

239

Lymphoid leukaemia

237

0.59

1.18

1.2

0.12

1.53

u/ml

—

135

Unknown and unspecified causes of morbidity

419

1.32

1.18

1.1

0.58

1.17

u/ml

0.77

180

Other disorders of Eustachian tube

149

1.56

1.18

1.1

0.34

2.86

u/ml

1.33

Dental caries 1

750

3560

1.08

1.17

1.1

1.43

0.97

u/ml

0.78

343

1506

Conotruncal defects

271

0.61

1.17

1.0

1.2

2.03

1.24

u/ml

0.19

193

Sleep disorders

222

1948

1.14

1.17

1.1

0.98

1.46

u/ml

0.82

100

846

Otorrhagia

0.00

1.17

0.0

1.1

—

0.56

—

Gastric ulcer

454

1.30

1.17

1.1

0.30

1.09

u/ml

1.62

192

Other diseases of liver

124

1039

1.20

1.17

1.1

0.73

1.36

u/ml

1.10

420

Congenital malformations and deformations of the musculoskeletal system

144

1218

1.18

1.17

1.1

0.72

1.33

u/ml

1.33

676

Other orthopaedic follow-up care

265

1.40

1.16

1.1

0.21

2.04

u/ml

1.86

110

Abnormalities of forces of labour

116

967

1.20

1.16

1.1

0.67

0.84

u/ml

0.29

377

Bicipital tendinitis

190

1.48

1.16

1.1

1.0

0.08

1.14

u/ml

3.53

Intentional self-harm by jumping from a high place

0.00

1.16

0.0

1.1

—

0.60

—

Dental caries, including avohilmo

749

3559

1.08

1.15

1.1

1.43

0.97

u/ml

0.79

342

1506

Other and unspecified visual disturbances

509

1.28

1.14

1.1

0.44

1.32

u/ml

1.44

212

Seropositive rheumatoid arthritis, strict definition

757

0.78

1.14

1.0

1.1

0.58

1.13

u/ml

0.97

303

Presbyopia

326

1.36

1.14

1.1

0.53

1.39

u/ml

0.98

128

Benign neoplasm: Tongue

1.70

1.14

1.0

1.1

0.54

2.60

u/ml

—

Benign neoplasm: Tongue

1.70

1.14

1.0

1.1

0.54

1.54

u/ml

—

Other diseases of pleura

190

1462

1.15

1.14

1.0

1.1

0.42

1.12

u/ml

2.70

627

Cerebral cysts

422

1.31

1.14

1.1

0.83

1.39

u/ml

0.46

185

Other peripheral vertigo

352

1.34

1.13

1.1

0.33

1.17

u/ml

1.54

149

Pacemaker

768

0.78

1.13

1.0

1.1

0.67

1.02

u/ml

0.44

339

Biological medication for rheuma

126

1490

0.84

1.13

1.1

0.63

1.16

u/ml

1.04

654

Amputation

234

0.60

1.13

1.0

1.1

2.79

1.44

u/ml

—

Septal defects

857

0.79

1.13

1.0

1.2

1.40

1.14

u/ml

0.18

534

Palmar fascial fibromatosis [Dupuytren]

370

1.33

1.12

1.0

1.1

0.32

0.87

u/ml

2.11

147

Adenocarcinoma and papilloma adenocarcinoma of rectum

221

0.59

1.12

1.0

1.1

1.79

1.33

u/ml

—

Other erythematous conditions

151

1.53

1.12

1.1

1.51

2.55

u/ml

—

Nonorganic sleeping disorders

202

1769

1.15

1.11

1.1

1.05

1.43

u/ml

0.54

776

Emotional disorders and disorders of social functioning with onset specific to childhood

115

952

1.20

1.11

1.1

1.40

1.36

u/ml

0.02

530

Other disorders of conjunctiva

485

1.28

1.10

1.0

1.1

0.49

1.49

u/ml

1.26

183

Cystic kidney disease

207

0.58

1.10

1.0

1.1

11.12

1.12

u/ml

—

110

Other or ill-defined heart diseases

251

1.40

1.10

1.2

1.1

1.45

1.60

u/ml

0.05

114

Dizziness and giddiness

572

4291

1.08

1.10

1.1

0.70

1.08

u/ml

1.96

247

1758

Non-follicular lymphoma, hilmo, excluding all cancers

293

0.65

1.10

1.0

1.1

2.70

1.70

u/ml

—

128

Diagnoses used for exclusion with ILD

138

1175

1.18

1.10

1.1

1.88

1.09

u/ml

0.23

492

Chronic mastoiditis

1.74

1.09

1.0

1.1

0.47

0.77

u/ml

—

Crohn disease (strict definition, require KELA, min 2 HDR)

585

1.26

1.09

1.1

3.88

1.22

u/ml

0.42

259

Focal epilepsy

134

1570

0.85

1.09

1.1

0.55

1.14

u/ml

2.37

762

Benign neoplasm: Conjunctiva

136

1.55

1.09

1.0

1.1

0.69

1.92

u/ml

—

Benign neoplasm: Skin of eyelid, including canthus

638

1.24

1.09

1.1

0.90

1.16

u/ml

0.19

250

Mixed specific developmental disorders

528

0.75

1.09

1.1

1.2

0.26

1.12

u/ml

2.60

368

Secondary and unspecified malignant neoplasm of lymph nodes

304

0.66

1.09

1.1

0.53

2.06

u/ml

—

133

Cardiomyopathies, Primary/intrinsic

445

0.72

1.08

1.1

1.18

1.30

u/ml

0.05

210

Myocardial infarction, unclassifiable

356

0.70

1.08

1.0

1.1

2.75

1.23

u/ml

—

147

Other congenital malformations of ear

186

1.48

1.08

1.1

0.96

0.59

u/ml

0.41

102

Hordeolum and other deep inflammation of eyelid

408

1.31

1.08

1.1

0.33

1.19

u/ml

1.27

193

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

434

3958

1.09

1.08

1.1

0.92

1.08

u/ml

0.19

189

1584

Other bursitis of hip

1.88

1.08

1.0

1.1

0.18

1.39

u/ml

—

Urolithiasis

176

1530

1.15

1.08

1.1

2.03

1.05

u/ml

0.46

646

Erythema intertrigo

1.88

1.07

1.0

1.1

0.12

0.70

u/ml

—

Other follicular disorders

550

1.26

1.07

1.1

1.62

1.30

u/ml

0.12

233

Pre-eclampsia

163

1879

0.87

1.07

1.1

2.26

1.03

u/ml

0.38

757

Secondary hypertension

496

0.74

1.07

1.0

1.1

1.09

1.50

u/ml

0.27

249

Dental caries 3

824

3942

1.07

1.1

1.33

1.02

u/ml

0.52

384

1684

Other congenital malformations

123

1041

1.19

1.07

1.1

1.33

1.20

u/ml

0.11

556

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

474

0.73

1.05

1.1

1.2

1.97

1.25

u/ml

0.31

287

Disorder of lipoprotein metabolism, unspecified

374

1.31

1.05

1.0

1.1

0.72

0.75

u/ml

0.02

164

Episcleritis

331

1.34

1.05

1.1

0.98

1.69

u/ml

0.36

135

Tumor necrosis factor alpha inhibitors

116

1371

0.84

1.05

1.1

0.68

1.04

u/ml

0.54

608

Other/unspecified synovitis and tenosynovitis

677

1.23

1.05

1.0

1.1

0.37

1.15

u/ml

1.96

275

Monoamine oxidase A inhibitors

587

1.25

1.05

1.0

1.89

1.17

u/ml

0.39

223

Myocarditis

305

1.35

1.05

1.0

1.1

1.36

1.17

u/ml

0.11

127

Osteopathies and chondropathies

395

3419

1.10

1.05

1.1

1.15

1.21

u/ml

0.06

180

1457

Dental caries 3, only avohilmo

833

3992

1.07

1.05

1.1

1.30

1.02

u/ml

0.46

387

1708

Congenital malformations of breast

179

1.47

1.04

1.1

1.49

0.88

u/ml

0.43

Cerebral palsy

215

0.60

1.04

1.2

0.41

1.56

u/ml

—

133

Hyperhidrosis

229

1.41

1.04

1.1

0.27

1.53

u/ml

1.36

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

521

0.75

1.04

1.1

0.47

0.95

u/ml

0.81

230

Tongue abnormality

246

1.39

1.03

1.0

1.1

0.62

1.33

u/ml

0.65

101

Benign neoplasm: Larynx

1.64

1.03

1.1

0.22

1.13

u/ml

—

Diseases of salivary glands

139

1192

1.17

1.03

1.1

0.62

1.64

u/ml

2.00

483

Symptoms and signs involving emotional state

238

1.40

1.03

1.2

1.1

1.29

1.71

u/ml

0.15

110

Carcinoma in situ of breast, intraductal

335

0.68

1.02

1.0

1.1

1.77

1.20

u/ml

—

129

Bulimia nervosa (incl. atypical)

430

1.29

1.02

1.1

0.96

1.06

u/ml

0.07

181

Myocardial infarction

157

1301

0.87

1.02

1.1

1.0

1.39

1.06

u/ml

0.19

521

Open wound of abdomen, lower back and pelvis

222

1.41

1.01

1.2

1.1

0.81

1.30

u/ml

0.35

106

Statin medication

648

3899

0.93

1.01

1.1

0.99

1.09

u/ml

0.15

266

1617

Benign lipomatous neoplasm of other sites/unspecified

290

1.35

1.01

1.1

0.41

1.23

u/ml

1.06

120

Erythema nodosum

147

1.51

1.01

1.1

0.25

0.71

u/ml

1.32

Unspecified/other endometriosis

110

928

1.19

1.01

1.1

1.09

1.08

u/ml

0.02

382

Ischemic heart diseases

377

2588

0.91

1.01

1.0

1.1

1.05

1.07

u/ml

0.02

131

1015

Streptococcal septicaemia

380

0.71

1.00

1.0

1.1

1.05

1.37

u/ml

0.19

192

Maternal care for other conditions predominantly related to pregnancy

276

2451

1.11

1.00

1.1

0.58

1.23

u/ml

2.39

111

995

Malignant neoplasm of bronchus and lung

312

0.69

1.00

1.0

0.63

1.24

u/ml

—

124

Crushed, pushed or stepped on by crowd or human stampede

792

1.21

1.00

1.1

0.57

1.35

u/ml

1.82

379

Superficial injury of hip and thigh

709

1.22

0.99

1.1

0.94

1.19

u/ml

0.25

295

Other specified/unspecified dorsopathies

164

1.47

0.99

1.2

1.1

1.27

2.29

u/ml

0.43

Misadventures to patients during surgical and medical care

746

1.21

0.99

1.1

0.51

0.99

u/ml

1.07

312

Other specified/unspecified systemic involvement of connective tissue

326

1.33

0.99

1.1

0.21

1.31

u/ml

1.79

133

Maternal care for (suspected) damage to fetus from alcohol

0.00

0.99

0.0

1.0

—

0.60

—

Non-follicular lymphoma

285

0.66

0.99

1.0

1.1

2.70

2.20

u/ml

—

126

Retinal detachments and breaks

152

1318

1.15

0.98

1.1

1.91

1.01

u/ml

0.34

516

Cardiac murmurs and other cardiac sounds

102

847

1.19

0.98

1.1

0.82

1.59

u/ml

1.13

425

Acute gastritis

283

1.35

0.98

1.1

0.64

1.33

u/ml

0.70

115

Other disorders of electrolyte and fluid balance, not elsewhere classified

0.00

0.98

0.0

1.1

—

1.19

—

Alzheimer’s disease, wide definition, excluding more controls

162

0.63

0.98

1.0

0.33

1.22

u/ml

—

Acute nasopharyngitis (common cold)

104

870

1.19

0.98

1.1

2.54

1.17

u/ml

0.40

404

Benign neoplasm: Conjunctiva

140

1.51

0.98

1.0

1.1

0.69

1.08

u/ml

—

Malignant neoplasm of larynx

0.00

0.97

0.0

1.1

—

1.31

—

Pre-eclampsia or eclampsia

173

1969

0.88

0.97

1.1

2.09

1.03

u/ml

0.35

785

Disorders of lipoprotein metabolism and other lipidaemias

465

3168

0.92

0.97

1.1

0.92

1.08

u/ml

0.23

193

1273

5-aminosalicylic acid

189

1668

1.14

0.96

1.1

0.85

1.11

u/ml

0.39

686

Post-traumatic stress disorder

112

952

1.18

0.96

1.1

0.46

1.27

u/ml

2.23

416

Benign neoplasm: Parotid gland

293

1.34

0.96

1.1

0.10

1.69

u/ml

1.97

125

Speech and linguistic disorders

162

1360

1.15

0.95

1.1

1.62

1.24

u/ml

0.26

782

Malignant neoplasm of eye and adnexa

0.00

0.95

0.0

1.1

—

4.05

—

Ingrowing nail

381

1.29

0.95

1.1

0.41

1.65

u/ml

1.55

171

Rheumatoid arthritis, including avohilmo

184

2084

0.88

0.95

1.1

0.47

0.99

u/ml

1.90

829

Mumps

141

1.50

0.95

1.1

1.0

0.25

1.00

u/ml

—

Female infertility, tubal origin

408

1.28

0.95

1.0

1.1

1.24

1.17

u/ml

0.02

171

Scleritis

1.79

0.95

1.0

1.1

2.23

2.84

u/ml

—

Other and unspecified nail disorders

1.66

0.95

1.1

0.36

0.93

u/ml

—

Intestinal malabsorption

268

1.35

0.94

1.1

3.22

1.65

u/ml

0.48

126

Small fibre neuropathy

1.66

0.94

1.2

1.0

1.15

0.58

u/ml

—

Sequelae of external causes of morbidity and mortality

150

1305

1.15

0.94

1.1

0.52

1.08

u/ml

1.92

554

Retinal haemorrhage

1.78

0.94

1.0

1.1

0.34

0.51

u/ml

—

Disorders of lens

324

2247

0.91

0.94

1.1

1.49

1.01

u/ml

0.36

137

863

Other arrhythmias

545

3879

1.08

0.94

1.1

1.11

1.06

u/ml

0.05

216

1605

Hypoplasia of dental enamel, prenatal , including avohilmo

154

0.56

0.94

1.1

1.3

0.55

0.95

u/ml

—

118

Nontoxic single thyroid nodule

364

1.30

0.94

1.1

1.11

1.06

u/ml

0.03

151

Delayed puberty

134

1.53

0.94

1.1

4.03

1.26

u/ml

0.75

Juvenile arthritis (FINNGEN)

622

0.78

0.93

1.1

0.18

1.46

u/ml

4.18

314

Dental pulpitis 3

246

1969

0.90

0.93

1.1

1.05

1.56

u/ml

0.57

128

1079

Contact with machinery

516

1.24

0.93

1.1

1.16

1.50

u/ml

0.25

220

Astigmatism

643

1.22

0.93

1.1

0.51

1.38

u/ml

1.48

357

Other and unspecified myopathies

304

0.69

0.92

1.0

1.1

0.22

1.25

u/ml

1.69

126

Cardiac arrest

201

0.64

0.92

1.0

1.1

0.57

1.53

u/ml

—

Use of hypnotics and sedatives

901

5510

0.94

0.92

1.1

0.77

1.09

u/ml

1.22

360

2288

599

0.78

0.92

1.1

1.2

0.42

1.11

u/ml

2.09

413

Bullous disorders

192

1.41

0.92

1.1

0.63

1.48

u/ml

0.63

Other female pelvic inflammatory diseases

123

1057

1.17

0.92

1.1

0.68

0.86

u/ml

0.26

406

Burn and corrosion of trunk

184

1.42

0.92

1.1

0.55

1.28

u/ml

0.66

L04AC Interleukin inhibitors

361

0.72

0.92

1.0

1.1

0.28

1.47

u/ml

1.54

147

Maxillary retrognathism

210

1.40

0.91

1.0

1.1

0.19

0.80

u/ml

2.87

118

Heart failure and antihypertensive medication

106

824

0.85

0.91

1.0

1.1

0.76

1.51

u/ml

0.85

344

Benign neoplasm of major salivary glands

366

1.29

0.91

1.1

0.13

1.50

u/ml

2.20

156

Abnormal results of function studies

509

1.24

0.91

1.0

1.1

0.33

1.54

u/ml

2.14

234

Benign neoplasm: Larynx

102

1.58

0.90

1.1

0.22

1.12

u/ml

—

Lymphoid leukaemia

219

0.64

0.90

1.2

0.12

1.56

u/ml

—

134

Tic and related disorders

194

1.41

0.90

1.1

1.2

0.76

1.81

u/ml

0.74

125

Endometriosis ASRM stages 1,2

185

1640

1.13

0.90

1.1

0.93

0.97

u/ml

0.05

657

Wide developmental disorders

584

0.78

0.90

1.0

1.2

0.52

1.11

u/ml

0.89

356

Operations 2 for CAVS

560

1.22

0.90

1.0

1.1

0.47

1.46

u/ml

1.78

237

Calcific aortic valvular stenosis, diagnosis (helper)

560

1.22

0.90

1.0

1.1

0.47

1.46

u/ml

1.78

237

Tic disorders

186

1.42

0.89

1.1

1.2

0.80

1.40

u/ml

0.39

121

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

108

1262

0.85

0.89

1.0

1.1

0.66

1.14

u/ml

0.76

496

Chronic periodontitis, complicated

359

0.72

0.89

1.0

1.1

0.18

1.20

u/ml

—

146

Phobic anxiety disorders

176

1557

1.13

0.89

1.1

0.37

1.33

u/ml

5.00

712

Thyrotoxicosis

179

1585

1.13

0.88

1.0

1.1

0.64

1.06

u/ml

1.02

640

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

473

0.76

0.88

1.0

1.1

0.50

0.70

u/ml

0.32

185

Focal epilepsy, mode (most common among epilepsy diagnosis)

114

1325

0.86

0.88

1.1

0.54

1.15

u/ml

2.10

645

Other/unspecified seropositive rheumatoid arthritis

109

1272

0.86

0.88

1.0

1.1

0.66

1.14

u/ml

0.75

498

Endometriosis of rectovaginal septum and vagina

466

1.25

0.88

1.1

0.43

1.03

u/ml

0.83

196

Early syphilis

1.80

0.88

1.1

11.43

0.91

u/ml

—

Insomnia

158

1389

1.14

0.88

1.1

1.12

1.20

u/ml

0.07

578

Female genital prolapse

210

1080

1.12

0.87

1.1

0.41

0.88

u/ml

1.91

413

Viral hepatitis, IBD co-morbidity

460

0.76

0.87

1.2

1.1

0.20

2.15

u/ml

3.19

208

Contact with other sharp object(s)

605

0.79

0.87

1.0

1.1

0.64

1.54

u/ml

1.36

250

Unspecified event, undetermined intent

161

1.44

0.87

1.2

1.1

1.29

1.68

u/ml

0.16

Mandibular retrognathia AND surgery (BSSRO)

212

1.38

0.87

1.0

1.1

0.50

1.24

u/ml

—

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

323

0.71

0.87

1.0

1.1

0.84

1.13

u/ml

—

139

Crohn's disease of small intestine

585

1.22

0.87

1.1

3.94

1.20

u/ml

0.44

242

Abnormal involuntary movements

777

1.19

0.86

1.1

0.67

1.01

u/ml

0.58

335

Chondromalacia

153

1.45

0.86

1.1

1.0

0.20

1.74

u/ml

—

Benign neoplasm: Long bones of lower limb

221

1.37

0.86

1.0

1.1

0.55

1.89

u/ml

0.94

103

Focal epilepsy, strict definition

121

1396

0.86

1.1

0.51

1.11

u/ml

2.30

685

Ptosis of eyelid

334

1.29

0.86

1.1

0.34

1.69

u/ml

1.87

145

Other disorders of cornea

459

1.25

0.86

1.1

4.06

1.48

u/ml

0.41

186

Calcific aortic valvular stenosis, including rheumatic fever

563

1.22

0.86

1.0

1.1

0.47

1.44

u/ml

1.77

240

Chalazion

741

1.19

0.86

1.1

0.68

1.15

u/ml

0.48

308

Heterophoria

760

1.19

0.85

1.1

0.97

1.20

u/ml

0.14

384

Alzheimer’s disease, wide definition

221

0.68

0.85

1.0

0.28

1.37

u/ml

—

Superficial injury of shoulder and upper arm

769

1.19

0.85

1.1

0.52

1.29

u/ml

1.64

327

Prepatellar bursitis

204

1.38

0.85

1.0

1.1

1.01

0.97

u/ml

—

Viral meningitis

291

1.31

0.85

1.1

1.23

1.41

u/ml

0.10

122

Combinations of oral blood glucose lowering drugs

1084

0.85

1.0

1.1

1.15

1.26

u/ml

0.04

440

Malignant melanoma, excluding all cancers (controls excluding all cancers)

570

0.79

0.85

1.0

1.1

0.64

0.69

u/ml

0.07

221

Anorexia (incl.atypical)

690

0.81

0.84

1.1

1.05

1.55

u/ml

0.38

307

Benign neoplasm: salivary glands, exclude unknown (D119)

335

1.29

0.84

1.1

0.14

1.60

u/ml

2.12

143

Meralgia paraesthetica

162

1.43

0.84

1.1

1.0

0.24

1.81

u/ml

—

Benzodiazepine use

848

6366

0.95

0.84

1.1

0.67

1.16

u/ml

3.36

345

2644

Varicose veins of other sites

344

1.28

0.84

1.1

0.58

1.29

u/ml

0.84

142

Diffuse brain injury

203

0.64

0.84

1.0

0.84

1.44

u/ml

—

Other congenital malformations of tongue, mouth and pharynx

300

1.31

0.84

1.2

0.31

1.12

u/ml

1.49

209

Benign neoplasm of bone and articular cartilage

578

1.22

0.84

1.0

1.1

1.98

1.37

u/ml

0.23

250

Benign neoplasm: Long bones of lower limb

222

1.36

0.84

1.0

1.1

0.55

1.89

u/ml

0.94

104

malignant neoplasm of female genital organs

502

0.78

0.84

1.1

1.0

0.71

1.13

u/ml

0.46

200

Disorders of lacrimal system and orbit in diseases classified elsewhere

129

1.48

0.84

1.0

1.1

0.49

1.81

u/ml

0.68

Congenital malformations of heart and great arteries

125

1389

0.87

0.83

1.0

1.1

1.16

1.11

u/ml

0.05

777

Lesion of radial nerve

154

1.44

0.83

1.1

1.0

0.71

1.90

u/ml

0.61

Primary open-angle glaucoma

694

0.81

0.83

1.0

0.45

0.93

u/ml

1.09

284

KRA_PSY_EATING, excluding more controls

128

1112

1.15

0.83

1.1

0.98

1.22

u/ml

0.30

531

Sarcoidosis

707

1.19

0.83

1.1

2.69

0.98

u/ml

0.34

276

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

501

0.78

0.83

1.0

1.1

1.63

0.81

u/ml

0.35

205

Pedestrian injured in collision with pedal cycle

163

1.42

0.82

1.1

0.19

2.44

u/ml

1.44

Malignant melanoma of skin

365

0.74

0.82

1.0

1.1

0.53

1.19

u/ml

—

148

Other (seronegative) rheumatoid arthritis, wide

896

0.84

0.82

1.1

0.29

1.15

u/ml

2.74

363

Injuries to the abdomen, lower back, lumbar spine and pelvis

285

2585

1.10

0.82

1.1

1.14

1.24

u/ml

0.11

133

1138

Algoneurodystrophy

232

1.34

0.81

1.1

0.34

1.62

u/ml

1.36

Parkinson's disease, including avohilmo

307

0.72

0.81

1.0

0.90

1.13

u/ml

—

119

Lesion of ulnar nerve

773

1.18

0.81

1.1

0.28

1.74

u/ml

2.99

294

Other keratitis

801

1.18

0.81

1.0

1.1

3.32

1.35

u/ml

0.54

341

Benign neoplasm of other and unspecified sites

130

1.47

0.81

1.1

1.0

0.14

2.10

u/ml

—

Collagenous colitis

463

1.23

0.81

1.1

0.58

1.40

u/ml

1.09

192

Explicit bacterial Sepsis

532

0.79

0.80

1.0

1.1

1.12

1.45

u/ml

0.21

247

Benign lipomatous neoplasm

183

1635

1.12

0.80

1.0

1.1

0.44

1.02

u/ml

2.15

657

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.00

0.80

0.0

1.1

—

0.74

—

Marasmic kwashiorkor

0.00

0.80

0.0

1.1

—

1.08

—

Lung cancer and mesothelioma

228

1.31

0.80

1.1

1.0

0.44

1.53

u/ml

0.91

Unspecified protein-energy malnutrition

0.00

0.80

0.0

1.1

—

0.63

—

Follicular adenocarcinoma of thyroid gland

0.00

0.79

0.0

1.0

—

0.78

—

Enlarged lymph nodes

125

1091

1.15

0.79

1.1

2.52

1.13

u/ml

0.48

487

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

0.79

0.0

1.0

—

1.09

—

Calcific aortic valvular stenosis, operated

569

1.20

0.79

1.0

1.1

0.47

1.46

u/ml

1.84

243

Calcific aortic valvular stenosis

569

1.20

0.79

1.0

1.1

0.47

1.46

u/ml

1.84

243

Long labour

301

2410

1.09

0.79

1.1

1.18

0.95

u/ml

0.14

133

962

Pervasive developmental disorders excl. Autism + Asperger

290

0.71

0.79

1.0

1.3

0.63

0.80

u/ml

0.10

211

Sequelae of injuries, of poisoning and of other consequences of external causes

187

1675

1.12

0.79

1.1

0.55

1.26

u/ml

2.53

710

Secondary malignant neoplasm of other and unspecified sites

0.00

0.79

0.0

1.1

—

1.00

—

Medial epicondylitis

190

1.37

0.79

1.3

1.0

0.20

1.27

u/ml

1.81

Adult respiratory distress syndrome

0.00

0.78

0.0

1.1

—

1.07

—

Benign neoplasm of other and unspecified sites

131

1.46

0.78

1.1

1.0

0.14

2.88

u/ml

—

Circumscribed brain atrophy

0.00

0.78

0.0

1.1

—

0.98

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

322

1.28

0.78

1.1

0.57

1.43

u/ml

1.04

166

Lesion of plantar nerve

251

1.32

0.78

1.1

1.0

0.16

1.57

u/ml

1.66

Parkinson's disease

293

0.72

0.78

1.0

0.90

1.23

u/ml

—

109

Vascular dementia (undefined)

0.00

0.78

0.0

1.0

—

1.13

—

Pure hypercholesterolaemia

363

2634

0.92

0.78

1.1

1.01

1.02

u/ml

0.01

157

1052

Macular hole

1.56

0.78

1.0

1.1

0.42

2.29

u/ml

—

Seropositive rheumatoid arthritis

112

1285

0.87

0.78

1.0

1.1

0.64

1.04

u/ml

0.64

488

Lower leg

0.00

0.78

0.0

1.1

—

1.04

—

Graves ophthalmopathy

123

1.47

0.78

1.0

0.49

1.97

u/ml

0.70

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

0.78

0.0

1.0

—

1.15

—

Scabies

331

1.28

0.78

1.1

0.66

1.21

u/ml

0.39

141

Benign lipomatous neoplasm of other sites/unspecified

304

1.29

0.78

1.1

0.41

0.75

u/ml

0.86

132

Other specified/unspecified disorders of bone/cartilage

123

1.47

0.78

1.1

1.0

1.25

0.78

u/ml

—

Mixed disorders of conduct and emotions

416

0.76

0.78

1.0

1.1

1.03

1.23

u/ml

0.13

217

Ischaemic heart disease, wide definition

367

2483

0.92

0.77

1.0

1.1

1.06

u/ml

0.01

128

974

Open wound of hip and thigh

243

1.33

0.77

1.1

1.05

1.21

u/ml

0.05

109

Malignant neoplasm of rectum

234

0.68

0.77

1.1

1.77

1.45

u/ml

—

Spermatocele

208

1.35

0.77

1.1

1.0

1.59

0.93

u/ml

—

Other heart diseases

538

3787

0.94

0.77

1.1

1.10

1.13

u/ml

0.07

227

1720

Persons with potential health hazards related to communicable diseases

457

4848

0.93

0.77

1.1

1.36

1.22

u/ml

0.15

225

2256

Transient ischemic attack

168

1560

0.89

0.77

1.1

0.65

1.01

u/ml

0.62

607

Seropositive rheumatoid arthritis, wide

112

1286

0.87

0.76

1.0

1.1

0.64

1.14

u/ml

0.82

500

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

124

1.47

0.76

1.1

1.2

0.54

1.30

u/ml

—

Hypopituitarism

659

0.82

0.76

1.0

1.1

2.78

1.14

u/ml

0.55

364

140

1237

1.14

0.76

1.1

1.06

0.98

u/ml

0.06

494

Glaucoma

199

1937

0.90

0.76

1.0

1.1

0.80

1.05

u/ml

0.36

774

Influenza and pneumonia

1107

6962

1.05

0.76

1.1

1.13

1.10

u/ml

0.05

552

3001

Undescended testicle

242

0.69

0.76

1.1

1.2

3.70

1.60

u/ml

—

183

Vitreous haemorrhage

382

0.76

1.0

1.1

1.06

1.05

u/ml

0.00

157

677

0.82

0.76

1.1

1.2

0.37

1.06

u/ml

2.54

465

Cardiac arrhythmias

650

4547

0.94

0.75

1.1

1.16

1.09

u/ml

0.09

265

1980

Postpartum haemorrhage

321

2577

1.09

0.75

1.1

1.40

0.98

u/ml

0.25

125

1036

Dental pulpitis 3, only avohilmo

229

1839

0.91

0.75

1.1

1.13

1.61

u/ml

0.48

117

1018

Thyrotoxicosis, other and/or unspecified

149

1322

1.13

0.75

1.1

0.47

1.02

u/ml

2.07

531

Congenital hydrocephalus

2.12

0.75

1.0

1.1

—

0.18

—

Benign neoplasm: Other and unspecified parts of mouth

124

1.46

0.75

1.0

3.74

1.07

u/ml

—

Diabetic nephropathy

486

0.79

0.74

1.0

1.1

2.63

1.10

u/ml

0.47

182

Juvenile osteochondrosis

334

1.27

0.74

1.0

1.1

0.44

1.07

u/ml

0.86

154

Glomerular disorders in diseases classified elsewhere

569

0.81

0.73

1.0

1.1

1.93

1.46

u/ml

0.12

245

Other/unspecified disorders of vestibular function

133

1.43

0.73

1.2

1.0

0.78

1.68

u/ml

—

Autoimmune diseases related-to ILD

795

6649

1.05

0.73

1.1

0.94

1.15

u/ml

0.31

318

2831

Lesion of femoral nerve

2.02

0.73

1.0

—

1.36

—

Left bundle-branch block

193

1.35

0.73

1.0

0.71

1.47

u/ml

0.42

Other abnormal immunological findings in serum

142

1.42

0.73

1.1

0.49

0.56

u/ml

—

Haemolytic anaemias

176

1.37

0.73

1.1

1.13

1.33

u/ml

0.08

Maternal care for known or suspected abnormality of pelvic organs

338

2157

1.08

0.73

1.1

1.13

1.02

u/ml

0.17

143

882

Personality disorders, excluding more controls

283

2603

1.09

0.73

1.1

0.85

1.10

u/ml

0.48

129

1085

Other abnormal auditory perceptions

1.68

0.72

1.1

0.99

2.56

u/ml

—

Supervision of normal pregnancy

301

1868

0.92

0.72

1.1

1.74

1.00

u/ml

0.67

124

753

Premature rupture of membranes

266

2131

0.92

0.72

1.1

1.11

1.03

u/ml

0.06

100

898

Diseases of arteries, arterioles and capillaries (FINNGEN)

121

963

0.88

0.72

1.1

0.98

1.27

u/ml

0.27

406

Striae atrophicae

1.60

0.72

1.1

0.20

0.74

u/ml

—

Varicella [chickenpox]

416

1.23

0.72

1.1

1.00

1.24

u/ml

0.18

217

Contact with other hot fluids

264

1.30

0.72

1.1

1.03

1.13

u/ml

0.06

133

Peripheral artery operations in Hilmo

276

0.72

0.71

1.1

1.82

1.43

u/ml

0.11

109

Sequelae of injuries of lower limb

608

1.19

0.71

1.1

0.51

1.26

u/ml

1.24

242

Postmenopausal bleeding

132

638

1.14

0.71

1.1

1.14

0.85

u/ml

0.12

237

Ulcerative colitis

182

2016

0.90

0.71

1.1

0.58

1.33

u/ml

2.46

886

IgA nephropathy (IgA glomerulonephritis)

109

1.48

0.71

1.0

0.47

2.06

u/ml

—

Other congenital malformations of the digestive system

569

1.20

0.71

1.1

1.2

0.65

1.37

u/ml

1.16

359

Other disorders of bladder

400

0.77

0.71

1.2

1.1

0.48

0.96

u/ml

0.79

167

Gout, idiopatic and unspecified

610

0.82

0.71

1.1

0.49

1.25

u/ml

1.41

237

Diseases of inner ear

310

2805

1.08

0.71

1.1

0.57

0.98

u/ml

2.20

122

1100

Fracture of skull and facial bones

142

1594

0.89

0.70

1.1

1.57

1.36

u/ml

0.12

716

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

252

0.71

0.70

1.0

1.1

0.46

0.86

u/ml

—

111

Retinal detachment with retinal break

426

1.22

0.70

1.1

3.77

1.06

u/ml

0.36

175

Loose body in joint

101

1.49

0.70

1.2

1.1

0.58

2.67

u/ml

—

Bitten or struck by other mammals

114

1001

1.14

0.70

1.1

1.12

1.23

u/ml

0.07

432

Other complications of labour and delivery, not elsewhere classified

140

1513

0.89

0.70

1.0

1.1

1.47

1.03

u/ml

0.20

621

Sacroiliitis, not elsewhere classified

418

1.23

0.69

1.0

1.1

0.87

1.50

u/ml

0.65

175

Optic neuritis

342

0.76

0.69

1.0

1.1

0.27

1.27

u/ml

—

143

Other bullous disorders

118

1.45

0.69

1.1

1.0

0.47

0.82

u/ml

—

Keratoconus

152

1.39

0.69

1.1

9.54

1.90

u/ml

0.52

Fracture of neck

193

0.67

0.69

1.1

1.42

1.04

u/ml

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

510

1.18

0.69

1.0

1.1

1.00

1.31

u/ml

0.19

216

Crowding of teeth, including avohilmo

180

1341

1.11

0.69

1.1

1.23

1.43

u/ml

0.15

115

742

Benign neoplasm: Parotid gland

310

1.26

0.69

1.1

0.10

1.23

u/ml

1.82

129

Melanoma in situ

1.53

0.69

1.1

1.0

1.02

2.68

u/ml

—

Oral lichen ruber planus

1.57

0.69

1.0

1.1

0.34

0.60

u/ml

—

Diseases of the digestive system

291

2682

1.08

0.68

1.1

1.52

1.17

u/ml

0.39

127

1224

Aortic aneurysm

537

1.19

0.68

1.0

0.56

1.30

u/ml

1.15

218

Single delivery by forceps and vacuum extractor

212

1417

0.91

0.68

1.1

0.50

1.06

u/ml

1.85

628

Wide developmental disorders, excluding more controls

555

0.81

0.68

1.0

1.2

0.52

1.15

u/ml

0.92

339

Emotional disorders starting during childhood or adolescence

105

913

1.15

0.68

1.1

1.56

1.51

u/ml

0.03

504

Benign neoplasm of major salivary glands

383

1.23

0.67

1.1

0.13

1.17

u/ml

2.17

158

Hypertensive diseases (excluding secondary)

576

3542

0.94

0.67

1.1

1.14

1.15

u/ml

0.02

236

1536

Cerebral palsy and other paralytic syndromes

757

0.84

0.67

1.1

0.47

1.38

u/ml

1.82

355

Skin changes due to chronic exposure to nonionizing radiation

772

1.15

0.67

1.0

2.54

0.88

u/ml

0.42

312

SLE, strict definition

191

0.68

0.67

1.2

1.1

0.13

1.53

u/ml

—

SLE, ICD10

191

0.68

0.67

1.2

1.1

0.13

1.53

u/ml

—

Tic and related disorders

206

1.33

0.67

1.1

1.2

0.76

1.25

u/ml

0.34

136

Abnormal blood-pressure reading, without diagnosis

214

1.31

0.67

1.1

0.25

2.61

u/ml

1.86

103

Recurring oral aphthae

312

1.26

0.66

1.2

1.1

0.64

1.35

u/ml

0.60

156

Anterior Iridocyclitis

116

1312

0.88

0.66

1.1

0.64

1.01

u/ml

0.58

549

Pneumonia due to Streptococcus pneumoniae

188

1.33

0.66

1.0

1.1

0.76

1.28

u/ml

—

Viral conjunctivitis

145

1.39

0.66

1.1

1.75

1.38

u/ml

—

Other juvenile arthritis

527

0.81

0.66

1.1

0.18

1.29

u/ml

3.12

275

Nerve, nerve root and plexus disorders

921

5536

1.05

0.66

1.1

0.65

1.11

u/ml

3.51

337

2284

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

339

0.77

0.65

1.1

2.11

1.11

u/ml

0.42

139

Right ventricular outflow tract obstruction

177

0.66

0.65

1.0

1.2

3.17

1.44

u/ml

—

131

Symptoms and signs involving cognition, perception, emotional state and behaviour

794

5828

0.95

0.65

1.1

0.79

1.13

u/ml

1.75

358

2432

Plantar fascial fibromatosis

522

1.19

0.65

1.1

0.87

1.21

u/ml

0.36

197

Stomatitis and related lesions

596

1.18

0.65

1.1

1.86

1.18

u/ml

0.33

268

Deficiency of other B group vitamins

1.62

0.65

1.2

1.0

0.09

0.81

u/ml

—

Oral leukoplakia and related diseases

180

1.34

0.65

1.0

1.1

0.47

1.54

u/ml

0.79

Parkinson's disease, strict definition

259

0.73

0.64

1.0

1.1

1.04

1.34

u/ml

—

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

293

0.75

0.64

1.0

1.1

0.84

1.19

u/ml

—

127

Inguinal hernia

407

2927

0.94

0.64

1.1

0.90

1.15

u/ml

0.52

175

1293

Other noninflammatory disorders of uterus, except cervix

113

679

1.14

0.64

1.1

1.0

0.21

0.81

u/ml

2.30

262

Contusion of toe(s) without damage to nail

207

1.31

0.64

1.1

0.16

1.62

u/ml

1.15

Gonarthrosis [arthrosis of knee](FG)

476

2975

0.94

0.64

1.1

0.85

1.03

u/ml

0.25

190

1100

Coxarthrosis, primary

223

1773

1.09

0.64

1.1

1.0

0.78

1.09

u/ml

0.61

677

Acute pancreatitis (for exclusion)

925

0.86

0.64

1.1

1.03

1.27

u/ml

0.12

377

Myocardial infarction, without ST-elevation

109

886

1.14

0.64

1.1

1.0

1.75

0.84

u/ml

0.53

347

Benign neoplasm: Caecum

260

1.27

0.64

1.0

1.1

0.62

1.43

u/ml

0.81

100

Other disorders of veins

255

2351

1.08

0.63

1.1

1.01

0.97

u/ml

0.03

110

891

Fall on same level

1204

6981

0.96

0.63

1.1

1.03

1.13

u/ml

0.25

569

3038

Open wound of ankle and foot

747

1.15

0.63

1.0

1.1

2.12

1.35

u/ml

0.26

332

Papulosquamous disorders

263

2431

1.08

0.63

1.1

0.80

1.09

u/ml

0.47

120

1008

Other congenital malformations of integument

0.00

0.62

0.0

1.0

—

3.69

—

325

1.24

0.62

1.1

1.67

1.54

u/ml

0.04

177

Hirsprung

0.00

0.62

0.0

1.1

—

0.86

—

Cluster headache, strict, including avohilmo

379

1.22

0.62

1.1

0.58

1.30

u/ml

0.88

153

Alport

0.00

0.62

0.0

1.2

—

0.21

—

Other and unspecified coagulation defects

361

1.22

0.61

1.2

1.1

0.88

1.23

u/ml

0.25

152

Nontraumatic intracranial haemmorrhage

588

0.83

0.61

1.1

0.36

1.26

u/ml

1.98

250

Hypoparathyroidism

130

1.39

0.61

1.2

1.1

0.30

1.48

u/ml

—

Noonan syndrome

0.00

0.61

0.0

1.0

—

3.43

—

Gout

684

0.85

0.61

1.1

1.0

0.48

1.40

u/ml

1.68

274

Nontoxic diffuse goitre

113

1.42

0.61

1.1

1.98

1.66

u/ml

—

Fracture of shoulder and upper arm

218

2369

0.92

0.61

1.1

0.94

1.41

u/ml

1.18

1103

Valvular operations

533

0.82

0.61

1.0

1.1

0.24

1.35

u/ml

2.59

271

Excessive vomiting in pregnancy

797

1.15

0.60

1.1

0.24

1.35

u/ml

3.27

324

Benign neoplasm: Endocrine pancreas

0.00

0.60

0.0

1.1

—

0.85

—

Rheumatic fever incl heart disease

1.48

0.60

1.1

0.53

0.61

u/ml

—

severe traumatic brain injury, does not include concussion

813

0.86

0.60

1.1

0.77

1.29

u/ml

0.78

337

Nail disorders

564

1.17

0.60

1.1

0.37

1.47

u/ml

2.05

242

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

0.60

0.0

1.0

—

0.91

—

Spina bifida

0.00

0.60

0.0

1.0

—

0.18

—

Congenital deformities of feet

254

1.27

0.60

1.0

1.1

0.43

1.28

u/ml

1.04

129

Nonischemic cardiomyopathy

221

0.72

0.60

1.1

0.29

1.41

u/ml

—

Failed attempted abortion

131

1.39

0.60

1.1

0.16

1.28

u/ml

—

Sequelae of injuries of head

300

0.76

0.60

1.1

0.46

1.27

u/ml

0.99

128

Foreign body in alimentary tract

326

1.23

0.60

1.1

0.48

1.75

u/ml

1.48

167

Gout, FINNGEN

748

0.85

0.60

1.1

0.48

1.08

u/ml

1.41

308

Polymyalgia rheumatica

255

0.74

0.59

1.0

1.1

0.54

1.40

u/ml

—

104

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

0.59

0.0

1.0

—

0.92

—

Cluster headache, wide,, including avohilmo

390

1.21

0.59

1.1

0.58

1.28

u/ml

0.87

158

Other bursitis of elbow

0.00

0.59

0.0

1.0

—

1.09

—

Alcohol-induced chronic pancreatitis

266

0.75

0.59

1.0

1.1

0.17

0.94

u/ml

—

100

Fall on and from ladder

290

1.24

0.59

1.1

1.02

1.82

u/ml

0.48

121

Myocardial infarction, strict

147

1188

0.90

0.59

1.1

1.0

1.52

1.03

u/ml

0.28

480

Benign neoplasm: Other and unspecified parts of mouth

131

1.38

0.59

1.0

1.1

3.75

0.90

u/ml

—

Thoracic aortic aneurysm

390

1.21

0.59

1.1

0.59

1.58

u/ml

1.15

159

Habitual aborter

228

1.28

0.59

1.1

1.46

0.87

u/ml

0.31

Other and unspecified mononeuropathies of lower limb

114

1.41

0.59

1.0

0.11

2.27

u/ml

—

Ulcerative ileocolitis

299

0.77

0.59

1.1

1.06

1.62

u/ml

0.32

123

Other disorders of pigmentation

210

1.29

0.59

1.2

1.1

0.48

2.55

u/ml

1.50

Placental disorders

1.48

0.59

1.1

1.0

0.72

1.15

u/ml

—

Rheumatic fever with heart involvement

0.00

0.58

0.0

1.0

—

1.19

—

Burn and corrosion of wrist and hand

332

0.78

0.58

1.2

1.1

1.62

1.41

u/ml

0.11

165

Hyperplasia of prostate

138

706

1.12

0.58

1.1

1.0

0.92

1.07

u/ml

0.14

276

Prolonged pregnancy

190

1891

0.91

0.58

1.1

0.92

1.09

u/ml

0.24

806

Acquired absence of limb

0.00

0.58

0.0

1.0

—

0.91

—

Other and unspecified acne

123

1.39

0.58

1.1

0.08

0.82

u/ml

—

Benign neoplasm: Bladder

0.00

0.58

0.0

1.1

—

1.04

—

Benign neoplasm: Bladder

0.00

0.58

0.0

1.0

—

1.39

—

Symptoms and signs concerning food and fluid intake

677

1.15

0.58

1.1

0.59

1.09

u/ml

0.64

365

Other symptoms and signs involving the digestive system and abdomen

111

988

1.13

0.58

1.1

1.36

1.20

u/ml

0.07

438

Oral lichen ruber planus, including avohilmo

246

1.26

0.58

1.0

1.1

0.26

1.68

u/ml

1.65

Radial styloid tenosynovitis [de Quervain]

382

1.21

0.58

1.1

0.30

1.32

u/ml

1.76

156

Thrombocytopenia, unspecified

343

0.78

0.58

1.1

0.41

1.71

u/ml

—

170

Acute peritonitis

242

0.74

0.58

1.2

1.1

0.10

1.80

u/ml

—

107

Acute pancreatitis

916

0.87

0.58

1.1

1.03

1.28

u/ml

0.13

371

Benign neoplasm of bone and articular cartilage

604

1.16

0.58

1.0

1.1

1.98

1.17

u/ml

0.34

257

Autoimmune diseases

1192

6305

0.96

0.57

1.1

0.93

1.18

u/ml

0.90

521

2826

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

637

0.85

0.57

1.1

1.20

0.96

u/ml

0.14

257

Congenital malformations of the nervous system

286

0.76

0.57

1.1

1.2

0.98

0.51

u/ml

—

173

Corneal ulcer

149

1350

1.11

0.57

1.1

1.91

1.20

u/ml

0.42

575

Congenital deformities of hip

265

1.26

0.57

1.2

0.30

1.45

u/ml

1.51

156

Unstable angina pectoris

839

0.88

0.57

1.1

1.0

1.05

0.99

u/ml

0.05

331

Congenital malformations of the respiratory system

176

1.32

0.57

1.2

0.63

1.01

u/ml

—

115

Other malignant neoplasms of skin (=non-melanoma skin cancer)

146

1273

0.90

0.57

1.1

0.86

0.91

u/ml

0.06

486

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

218

0.73

0.57

1.0

1.1

0.86

u/ml

—

Enterocolitis due to Clostridium difficile

364

0.80

0.56

1.1

0.51

1.45

u/ml

0.91

156

Symptoms and signs involving the nervous and musculoskeletal systems

450

4256

1.06

0.56

1.1

0.68

1.12

u/ml

2.09

207

1878

Other benign neoplasms of uterus

115

1.39

0.56

1.1

1.0

0.40

2.16

u/ml

—

Peripheral arterial reconstruction

286

0.77

0.56

1.2

1.0

0.29

1.32

u/ml

—

104

Other bacterial intestinal infections

101

896

1.13

0.56

1.1

0.45

0.92

u/ml

1.25

384

Disorders of tooth development and eruption

754

1.14

0.56

1.1

0.33

1.26

u/ml

2.78

433

Benign neoplasm: Rectum

522

1.17

0.56

1.0

1.1

0.33

1.06

u/ml

1.65

212

Exposure to other and unspecified animate mechanical forces

275

1.24

0.56

1.1

0.56

1.67

u/ml

0.98

129

Mixed disorders of conduct and emotions, excluding more controls

395

0.80

0.56

1.0

1.1

1.03

1.16

u/ml

0.08

210

Chronic tubulo-interstitial nephritis

150

1.34

0.55

1.1

0.38

1.56

u/ml

—

Later onset COPD

286

1.21

0.55

1.0

0.16

1.31

u/ml

1.95

118

Dystonia

302

1.23

0.55

1.0

1.1

0.55

1.74

u/ml

1.14

133

Carbimazole or st.post thyroidectomy, condition for graves disease

156

1420

1.10

0.55

1.0

1.1

0.66

1.13

u/ml

1.04

558

Obstructed labour due to maternal pelvic abnormality

106

945

1.12

0.55

1.1

2.02

0.74

u/ml

0.59

348

Benign neoplasm: Caecum

266

1.24

0.55

1.0

1.1

0.62

0.84

u/ml

0.40

107

Antenatal screening

321

1930

0.93

0.55

1.1

1.61

1.00

u/ml

0.57

131

781

Other anaemias

154

1631

0.91

0.55

1.1

0.67

0.98

u/ml

0.77

697

Non-ischemic cardiomyopathy

784

0.88

0.55

1.0

1.1

0.46

1.12

u/ml

1.56

342

Basal cell carcinoma

151

1323

0.91

0.55

1.1

0.79

0.89

u/ml

0.17

509

Other disorders of binocular vision

1.43

0.54

1.1

1.0

0.48

2.11

u/ml

—

Maternal care for known or suspected disproportion

450

1.18

0.54

1.0

1.1

1.38

0.85

u/ml

0.50

174

Other and unspecified mood [affective] disorders

758

1.14

0.54

1.0

1.1

1.18

1.42

u/ml

0.14

328

Venous thromboembolism

278

2519

1.07

0.54

1.0

1.1

0.88

1.00

u/ml

0.22

120

994

Lactose intolerance

231

1.26

0.54

1.1

0.63

1.68

u/ml

0.88

122

Other Crohn's disease

627

1.15

0.54

1.1

0.99

1.22

u/ml

0.15

265

Viral agents as the cause of diseases classified to other chapters

160

1.32

0.54

1.0

1.1

0.88

1.35

u/ml

0.27

Supplementary factors related to causes of morbidity and mortality classified elsewhere

261

2434

1.07

0.53

1.1

1.38

1.31

u/ml

0.07

128

1094

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

193

0.72

0.53

1.0

0.36

1.02

u/ml

—

Recurrent dislocation of patella

600

1.15

0.53

1.1

0.34

1.11

u/ml

2.03

247

Other appendicitis

525

1.16

0.53

1.0

1.1

0.71

1.05

u/ml

0.34

208

Viral and other specified intestinal infections

300

2746

1.07

0.53

1.1

1.07

1.41

u/ml

0.43

135

1408

Acute and subacute iridocyclitis

113

1257

0.90

0.53

1.1

0.65

1.08

u/ml

0.67

513

Acute alcohol intoxication ICD-9

108

1.39

0.53

1.1

0.16

1.44

u/ml

—

Systemic lupus erythematosus

204

0.73

0.53

1.1

0.12

1.47

u/ml

—

Melanoma in situ

1.43

0.53

1.1

1.0

1.02

0.98

u/ml

—

Volume depletion

327

0.79

0.53

1.1

2.74

1.43

u/ml

0.35

172

Other epidermal thickening

205

1.27

0.52

1.1

2.42

1.25

u/ml

0.35

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

271

2897

0.93

0.52

1.1

0.91

1.07

u/ml

0.14

112

1208

Other and unspecified injuries of abdomen, lower back and pelvis

1.46

0.52

1.1

0.04

0.79

u/ml

—

Other abnormal uterine and vaginal bleeding

156

1015

1.10

0.52

1.1

0.85

0.95

u/ml

0.13

398

Vitamin B12 deficiency anaemia

293

0.78

0.52

1.1

0.15

1.17

u/ml

—

113

Complications following abortion and ectopic and molar pregnancy

161

1.31

0.52

1.1

0.26

1.01

u/ml

—

Overjet

451

1.18

0.52

1.2

3.28

1.06

u/ml

0.66

281

SLE (Finngen)

203

0.74

0.52

1.1

0.13

1.51

u/ml

—

Bacterial intestinal infections, IBD co-morbidities

100

893

1.12

0.51

1.1

0.48

1.07

u/ml

1.50

370

Carcinoma in situ of skin of other and unspecified parts of face

1.45

0.51

1.0

0.82

0.76

u/ml

—

Gout, strict definition

381

0.81

0.51

1.1

0.48

1.20

u/ml

0.98

144

Open wound of lower leg

107

960

1.12

0.51

1.0

1.1

0.58

1.25

u/ml

1.17

443

Lichen sclerosus et atrophicus

434

1.18

0.51

1.1

0.51

1.25

u/ml

0.95

179

Extreme obesity with alveolar hypoventilation

157

0.70

0.51

1.1

0.49

2.11

u/ml

—

Polycystic ovarian syndrome

703

0.86

0.51

1.1

0.06

1.07

u/ml

4.09

305

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

307

0.80

0.51

1.0

1.1

0.47

0.87

u/ml

—

120

Congenital malformations of aortic and mitral valves

347

0.80

0.51

1.0

1.2

1.16

1.20

u/ml

0.02

209

Hyperprolactinaemia

315

1.21

0.51

1.1

2.08

1.34

u/ml

0.16

128

Implicit fungal Sepsis

109

1.38

0.51

1.1

2.13

0.84

u/ml

—

Crohn disease

126

1142

1.11

0.50

1.1

2.72

1.07

u/ml

0.49

500

Pedal cyclist injured in noncollision transport accidents

894

0.88

0.50

1.1

1.10

1.32

u/ml

0.19

402

Ankyloglossia

361

1.20

0.50

1.2

3.37

1.12

u/ml

0.32

241

Follicular cysts of skin and subcutaneous tissue

124

1123

1.11

0.50

1.1

1.20

1.38

u/ml

0.10

471

Other and unspecified anaemias

153

1616

0.92

0.50

1.1

0.67

0.99

u/ml

0.79

692

Caught, crushed, jammed or pinched in or between objects

389

1.19

0.50

1.1

1.42

u/ml

0.00

178

Other peripheral vascular diseases

426

1.18

0.50

1.1

0.78

1.17

u/ml

0.40

176

Benign neoplasm of ovary

867

1.12

0.50

1.0

1.1

1.48

0.95

u/ml

0.31

333

Congenital malformations of eye, ear, face and neck

792

1.13

0.50

1.1

1.08

1.22

u/ml

0.12

413

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

163

1715

0.92

0.50

1.0

1.1

1.68

1.30

u/ml

0.30

936

Actinic keratosis

715

1.13

0.50

1.0

2.67

0.84

u/ml

0.45

286

Benign neoplasm: Skin, unspecified

180

1.28

0.49

1.0

1.1

0.32

1.39

u/ml

—

Ventral hernia

122

1105

1.11

0.49

1.0

1.1

3.12

1.15

u/ml

0.60

452

Other hearing loss

843

1.12

0.49

1.1

0.92

1.10

u/ml

0.13

338

Habit and impulse disorders

144

0.69

0.49

1.0

1.1

0.23

1.90

u/ml

—

Ascites

224

0.76

0.49

1.1

0.47

1.69

u/ml

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

726

1.13

0.49

1.0

1.1

0.64

1.09

u/ml

0.65

289

Direct fill therapy

106

1176

0.90

0.49

1.1

0.83

1.30

u/ml

0.83

592

Trigger finger

745

1.13

0.49

1.0

1.1

0.47

1.06

u/ml

1.58

281

Glomerulonephritis

594

0.86

0.49

1.1

0.35

1.38

u/ml

2.18

291

Malignant neoplasm of urinary organs

246

0.77

0.49

1.1

0.93

1.40

u/ml

—

101

Gout, unspecified

476

0.84

0.49

1.1

0.35

1.37

u/ml

1.72

187

Polycystic ovarian syndrome, consortium definition

774

4491

1.04

0.49

1.1

0.93

1.04

u/ml

0.21

304

1821

Vestibular neuronitis

378

0.82

0.49

1.1

1.00

1.18

u/ml

0.15

153

Atrophic disorders of skin

831

1.12

0.49

1.1

0.88

1.11

u/ml

0.19

348

Left ventricular outflow tract obstruction (LVOTO), broad definition

732

0.87

0.48

1.0

1.1

0.40

1.33

u/ml

2.30

370

Corns and callosities

301

0.80

0.48

1.1

0.74

1.17

u/ml

—

125

Car occupant injured in other and unspecified transport accidents

188

1740

1.08

0.48

1.1

0.98

1.53

u/ml

0.87

752

Endometriosis diagnosis and infertility diagnosis occurring together

1059

0.89

0.48

1.1

1.45

0.95

u/ml

0.43

423

Hypertrichosis

217

1.25

0.48

1.0

1.1

2.05

0.75

u/ml

—

Mixed connective tissue disease

363

1.19

0.48

1.1

0.23

1.32

u/ml

2.02

147

Gonarthrosis,primary

466

3078

0.95

0.48

1.1

0.87

0.99

u/ml

0.14

178

1130

Other maltreatment syndromes

256

0.78

0.48

1.1

0.40

1.83

u/ml

1.19

107

Malignant neoplasm of kidney, except renal pelvis

234

0.77

0.48

1.1

0.93

1.39

u/ml

—

Benign neoplasm: Skin, unspecified

181

1.27

0.48

1.0

1.1

0.32

2.06

u/ml

—

Disorders in reading

227

1.24

0.47

1.1

1.81

1.43

u/ml

0.12

136

Cholelithiasis, broad definition with cholecystitis

600

4289

0.96

0.47

1.1

0.49

1.00

u/ml

4.30

229

1689

Dental pulpitis 4

1123

6018

0.97

0.47

1.1

0.99

1.17

u/ml

0.37

494

2617

Colorectal cancer

592

0.86

0.47

1.0

1.1

1.67

1.03

u/ml

0.34

240

Dental pulpitis 1

1123

6019

0.97

0.47

1.1

0.99

1.17

u/ml

0.37

494

2618

Cluster headache, wide

254

1.22

0.47

1.1

0.58

1.60

u/ml

0.82

Myocardial infarction, with ST-elevation

387

0.83

0.47

1.0

1.1

0.62

1.21

u/ml

0.48

155

Use of levodopa decarboxylase inhibitor

233

0.77

0.47

1.0

1.05

1.38

u/ml

—

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

244

0.78

0.47

1.0

1.1

0.41

0.99

u/ml

—

Benign leiomyoma with endometriosis

793

0.88

0.46

1.1

0.72

0.85

u/ml

0.16

311

Other fall from one level to another

192

2065

0.93

0.46

1.1

1.03

1.34

u/ml

0.40

1030

Precocious puberty

0.58

0.46

1.2

0.89

0.67

u/ml

—

Use of fingolimod

0.61

0.46

1.0

1.1

—

0.62

—

Respiratory and cardiovascular disorders specific to the perinatal period

611

1.14

0.46

1.2

0.93

1.01

u/ml

0.06

430

Diabetic retinopathy, excluding more controls

101

632

0.90

0.46

1.0

2.78

0.63

u/ml

0.58

236

Other and unspecified mononeuropathies of upper limb

153

0.72

0.45

1.2

1.0

0.02

2.11

u/ml

—

Cluster headache, strict

246

1.22

0.45

1.1

0.58

1.63

u/ml

0.84

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

301

1.20

0.45

1.0

1.1

5.61

0.93

u/ml

0.42

120

Fracture of lumbar spine and pelvis

822

0.89

0.45

1.0

1.1

0.89

1.04

u/ml

0.14

338

Complications of labour and delivery

655

3508

1.04

0.45

1.1

1.36

0.92

u/ml

0.73

250

1408

Infectious mononucleosis

124

1132

1.10

0.45

1.1

1.41

1.46

u/ml

0.03

522

Vasculitis limited to skin, not elsewhere classified

103

1.36

0.45

1.1

0.16

1.10

u/ml

—

Abdominal aortic aneurysm (AAA)

102

1.36

0.45

1.1

1.0

0.42

1.05

u/ml

—

Early lumbar disc prolapse operation

124

1132

1.10

0.45

1.1

1.05

1.17

u/ml

0.10

464

Malignant neoplasm of endocrine gland

374

0.83

0.45

1.0

1.1

0.93

1.52

u/ml

0.35

165

Arthropathy in Crohn disease

1.41

0.45

1.0

—

0.78

—

Hypoplasia of dental enamel, including avohilmo

295

0.80

0.45

1.2

0.07

1.22

u/ml

2.80

231

Congenital malformations of pulmonary and tricuspid valves

163

0.72

0.45

1.0

1.3

3.17

1.41

u/ml

—

119

Need for other prophylactic measures

366

1.18

0.45

1.1

0.35

1.63

u/ml

1.80

200

Graves disease, strict definition

770

1.12

0.45

1.0

1.1

0.50

0.97

u/ml

1.07

316

Personal history of other diseases and conditions

159

1462

1.09

0.45

1.1

0.71

1.16

u/ml

1.08

762

Use of antiglaucoma preparations and miotics

164

0.73

0.45

1.0

1.1

0.32

2.44

u/ml

—

Disorders of psychological development

203

1754

1.07

0.45

1.1

1.68

1.37

u/ml

0.24

114

989

Cyst of kidney

183

1.26

0.45

1.1

0.07

1.78

u/ml

—

Other and unspecified injuries of head

395

0.83

0.44

1.1

0.70

1.66

u/ml

0.97

191

Primary open-angle glaucoma, strict

566

0.86

0.44

1.0

0.46

0.96

u/ml

0.89

229

Congenital malformations of eyelid, lacrimal apparatus and orbit

148

1.30

0.44

1.1

1.2

0.19

1.10

u/ml

0.99

Colon adenocarcinoma

242

0.78

0.44

1.0

1.1

0.41

1.57

u/ml

—

Ovarian dysfunction

894

0.89

0.44

1.1

0.14

1.19

u/ml

4.05

374

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

265

2495

1.06

0.44

1.0

1.1

1.12

1.09

u/ml

0.04

113

1110

Malnutrition

139

1.30

0.44

1.3

1.2

3.76

1.11

u/ml

0.69

Other and unspecified disorders of psychological development

279

0.80

0.44

1.2

0.59

0.84

u/ml

0.31

200

Other heart diseases, wide

943

6038

0.97

0.43

1.1

1.16

1.11

u/ml

0.10

394

2648

In situ neoplasms

181

1856

0.93

0.43

1.0

1.1

1.65

0.80

u/ml

0.60

719

Abrasion of teeth

225

1548

1.07

0.43

1.0

1.1

0.90

1.25

u/ml

0.57

101

632

Gonococcal infection

175

1.26

0.43

1.0

1.1

1.16

1.56

u/ml

0.16

Basal cell carcinoma, including avohilmo

161

1370

0.92

0.43

1.0

1.1

0.73

0.88

u/ml

0.29

519

Intracerebral haemorrhage

285

0.81

0.43

1.1

1.0

0.26

1.69

u/ml

1.50

117

Drug-induced osteoporosis with pathological fracture

1.62

0.43

1.0

—

0.70

—

Burn and corrosion of head and neck

151

0.72

0.43

1.0

1.1

0.48

0.86

u/ml

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

257

1.21

0.43

1.1

0.36

1.45

u/ml

—

Ulcerative colitis, NAS

104

1144

0.91

0.43

1.1

0.52

1.22

u/ml

1.62

495

Other disorders of bone density and structure

151

0.73

0.43

1.0

1.1

0.36

2.63

u/ml

—

Other congenital malformations of face and neck

239

1.22

0.43

1.1

0.60

1.59

u/ml

0.75

108

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

899

6520

0.97

0.43

1.1

1.09

1.12

u/ml

0.05

446

2824

Burkitt lymphoma

0.00

0.42

0.0

1.1

—

6.02

—

Burkitt lymphoma, excluding all cancers (controls excluding all cancers)

0.00

0.42

0.0

1.1

—

6.02

—

Burkitt lymphoma, helper endpoint

0.00

0.42

0.0

1.1

—

6.02

—

Abnormal findings on antenatal screening of mother

119

1089

1.10

0.42

1.1

0.42

1.14

u/ml

2.75

464

Left ventricular outflow tract obstruction, narrow definition

446

0.85

0.42

1.0

1.2

0.87

1.11

u/ml

0.16

259

Retinoblastoma, excluding all cancers (controls excluding all cancers)

0.00

0.42

0.0

1.0

—

5.41

—

Arthropathic psoriasis

670

0.88

0.42

1.1

1.41

1.15

u/ml

0.08

276

Trigeminal neuralgia

276

1.20

0.42

1.0

1.1

1.54

1.52

u/ml

0.01

110

Other congenital malformations of circulatory system

131

1.30

0.42

1.1

1.68

1.87

u/ml

—

Hallux valgus (acquired)

214

1449

1.07

0.42

1.1

1.37

0.89

u/ml

0.30

515

Hypoglycaemia, other or unspecified

467

0.85

0.42

1.1

0.63

1.37

u/ml

1.07

242

Kidney diseases associated to Fabry's disease

0.00

0.42

0.0

1.1

—

1.22

—

Cerebral oedema

0.00

0.42

0.0

1.0

—

1.29

—

Sequelae of poisoning by drugs, medicaments and biological substances

0.00

0.42

0.0

1.1

—

1.01

—

Other conjunctival vascular disorders and cysts

1.43

0.42

1.2

1.1

0.16

1.01

u/ml

—

Sphingolipidosis, other/unspecified

0.00

0.42

0.0

1.1

—

1.22

—

Other benign neoplasms of skin

223

2053

1.07

0.41

1.1

0.57

1.10

u/ml

1.50

826

Benign neoplasm: Descending colon

167

1.26

0.41

1.0

1.1

0.86

1.57

u/ml

0.37

Sequelae with surgical and medical care as external cause

102

927

1.10

0.41

1.0

1.1

0.56

1.02

u/ml

0.98

389

Traumatic subarachnoid haemorrhage

1.36

0.41

1.0

1.49

2.35

u/ml

—

Speech disturbances, not elsewhere classified

305

0.82

0.41

1.0

1.1

1.14

1.88

u/ml

—

126

L02BA Anti-estrogens

848

0.89

0.41

1.1

0.46

1.02

u/ml

1.19

314

Disorders of optic nerve and visual pathways

732

0.89

0.41

1.1

2.10

1.22

u/ml

0.23

351

Benign neoplasm: Endocrine gland, other/unspecified

0.00

0.41

0.0

1.1

—

0.92

—

Disorders of purine and pyrimidine metabolism

0.00

0.41

0.0

1.1

—

1.48

—

Hereditary hypogammaglobulinemia

0.00

0.41

0.0

1.1

—

0.96

—

Retinoblastoma

0.00

0.41

0.0

1.1

—

4.96

—

Diplopia

661

1.12

0.41

1.1

1.17

1.15

u/ml

0.01

269

Lack of expected normal physiological development

498

0.87

0.41

1.1

1.2

2.65

0.85

u/ml

0.59

356

Chromosomal abnormalities, not elsewhere classified

357

0.83

0.41

1.0

1.2

4.99

1.09

u/ml

0.93

234

Supervision of high-risk pregnancy

274

1754

0.94

0.41

1.1

0.94

0.96

u/ml

0.03

101

705

Other drug-induced secondary parkinsonism

0.00

0.41

0.0

1.1

—

1.46

—

Labyrinthitis

0.00

0.41

0.0

1.0

—

1.21

—

Other and unspecified injuries of wrist and hand

305

1.18

0.41

1.2

1.1

2.14

1.53

u/ml

0.17

146

Idiopathic peripheral autonomic neuropathy

0.00

0.41

0.0

1.1

—

0.40

—

Anisometropia and aniseikonia

213

1.23

0.41

1.0

1.1

0.16

1.08

u/ml

—

103

Findings of drugs and other substances, not normally found in blood

0.00

0.41

0.0

1.0

—

1.09

—

Etanercept

519

0.86

0.41

1.0

1.1

0.23

1.17

u/ml

1.92

231

Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.1

—

0.99

—

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

0.00

0.40

0.0

1.1

—

1.75

—

Mandibular prognathia

168

1.26

0.40

1.0

1.2

3.88

0.62

u/ml

0.43

104

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

186

1.24

0.40

1.0

1.1

0.50

1.27

u/ml

0.61

Spondylopathies

567

3310

1.04

0.40

1.1

0.97

1.11

u/ml

0.19

211

1316

Superficial injury of abdomen, lower back and pelvis

127

1169

1.09

0.40

1.1

1.59

1.24

u/ml

0.23

524

Foreign object accidentally left in body during surgical and medical care

0.00

0.40

0.0

1.1

—

0.96

—

Isolated proteinuria

150

1.27

0.40

1.0

1.1

0.43

0.78

u/ml

—

Internuclear ophthalmoplegia

0.00

0.40

0.0

1.1

—

1.25

—

Other and unspecified abdominal hernia

141

1.28

0.40

1.2

1.1

0.28

1.53

u/ml

—

Typhoid and paratyphoid fevers

0.00

0.40

0.0

1.1

—

0.93

—

Blindness or visual impairment, binocular

0.00

0.40

0.0

1.0

—

0.13

—

Postpartum hemorraghe, all women as controls

321

3038

1.05

0.40

1.1

1.40

0.96

u/ml

0.27

125

1216

Unattended death

0.00

0.40

0.0

1.1

—

0.90

—

Cholelithiasis

576

4195

0.96

0.40

1.1

0.50

1.00

u/ml

3.91

221

1646

Assault by bodily force

782

0.89

0.40

1.1

1.19

1.33

u/ml

0.08

334

Hodgkin lymphoma

160

0.75

0.40

1.3

1.1

0.69

2.08

u/ml

—

Unspecified haematuria

194

1555

1.07

0.39

1.1

1.27

1.25

u/ml

0.01

675

Benign neoplasm of colon, rectum, anus and anal canal

308

2087

1.05

0.39

1.1

0.73

1.08

u/ml

0.86

119

776

Adalimumab

792

0.89

0.39

1.1

0.50

1.22

u/ml

1.32

349

Chronic lymphocytic leukaemia

1.43

0.39

1.2

1.1

—

1.31

—

Dental caries 1 and operation codes, only avohilmo

323

1541

1.05

0.39

1.1

1.81

1.12

u/ml

0.55

145

715

Erythema multiforme

106

1.33

0.39

1.2

1.1

3.81

0.60

u/ml

—

Benign neoplasm: Endocrine pancreas

0.00

0.39

0.0

1.1

—

0.95

—

Hydrocephalus

270

0.81

0.39

1.0

1.1

1.31

1.95

u/ml

—

133

Disorders of calcium metabolism

259

0.81

0.39

1.1

0.95

1.72

u/ml

—

119

Coxarthrosis [arthrosis of hip](FG)

239

1833

0.94

0.39

1.1

0.68

1.10

u/ml

1.03

669

Sudden idiopathic hearing loss

381

1.16

0.39

1.1

1.0

1.54

1.33

u/ml

0.07

155

Asymmetry of jaw

133

1.29

0.39

1.0

1.1

0.28

1.63

u/ml

—

Malignant melanoma

453

0.86

0.39

1.0

1.1

0.77

1.07

u/ml

0.29

181

Pathological resorption of teeth

178

1.24

0.39

1.0

1.1

0.17

0.73

u/ml

—

Essential (haemorrhagic) thrombocythaemia

115

1.31

0.39

1.1

1.0

0.19

1.05

u/ml

—

Malignant neoplasm of mesothelium and soft tissue

115

1.31

0.39

1.1

1.0

0.26

2.08

u/ml

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

779

1.11

0.39

1.1

0.81

1.30

u/ml

0.44

296

Infections, IBD-co-morbidities

127

852

1.09

0.39

1.1

0.51

1.65

u/ml

2.50

385

Anomalies of pupillary function

142

1.27

0.39

1.1

0.14

1.75

u/ml

—

Superficial injury of forearm

865

1.10

0.38

1.1

0.50

1.32

u/ml

2.14

406

Pneumonia due to other infectious organisms, not elsewhere classified

124

1.29

0.38

1.3

1.1

0.42

2.75

u/ml

—

Parkinson's disease, excluding more controls

252

0.81

0.38

1.0

0.90

1.18

u/ml

—

Cardiomyopathy

717

0.89

0.38

1.1

1.51

1.38

u/ml

0.08

323

Conduction disorders

139

1070

1.08

0.38

1.1

1.41

0.95

u/ml

0.47

484

Persons encountering health services for specific procedures, not carried out

533

1.13

0.38

1.1

0.28

1.29

u/ml

2.05

220

Female infertility, associated with anovulation

106

972

1.09

0.38

1.0

1.1

0.72

1.09

u/ml

0.58

416

Chronic respiratory disease originating in the perinatal period

0.61

0.37

1.2

0.16

1.14

u/ml

—

Corneal scars and opacities

1.33

0.37

1.0

1.1

0.67

0.89

u/ml

—

Injuries to the shoulder and upper arm

673

5457

1.03

0.37

1.1

0.68

1.22

u/ml

3.30

270

2378

Dental caries 3 and operation codes, only avohilmo

392

1882

1.05

0.37

1.1

1.56

1.16

u/ml

0.35

177

877

Memory loss

234

1.20

0.37

1.1

0.41

1.44

u/ml

1.03

Systemic lupus erythematosus, unspecified

169

0.77

0.37

1.2

1.1

0.13

1.67

u/ml

—

Other lack of coordination

1.40

0.37

1.0

1.1

0.11

0.65

u/ml

—

Degenerative macular diseases

262

1.18

0.37

1.0

1.1

1.49

1.33

u/ml

0.06

105

Perineal laceration during delivery

210

1985

0.94

0.37

1.1

1.42

1.06

u/ml

0.40

821

Melanocytic naevi of trunk

840

0.90

0.36

1.1

0.74

1.09

u/ml

0.40

356

Salpingitis and oophoritis

1080

0.92

0.36

1.1

1.40

0.79

u/ml

0.23

407

Mandibular retrognathia

795

0.90

0.36

1.1

0.32

1.44

u/ml

3.60

399

Other embolism and thrombosis

563

1.12

0.36

1.1

1.12

0.77

u/ml

0.26

231

Anaemias

298

2082

0.95

0.36

1.1

0.89

1.03

u/ml

0.21

140

1005

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

234

0.81

0.36

1.1

1.2

1.93

1.42

u/ml

0.18

145

Herpesviral keratitis and keratoconjunctivitis

189

1.22

0.36

1.0

1.1

4.99

1.69

u/ml

0.40

Acne vulgaris

123

1139

1.08

0.36

1.1

1.02

1.53

u/ml

0.59

531

Other congenital malformations, not elsewhere classified

126

1.28

0.36

1.1

1.2

0.36

0.80

u/ml

—

Artificial opening status

245

0.81

0.36

1.1

1.00

1.51

u/ml

—

129

Other meningitis

1.34

0.36

1.0

2.92

0.81

u/ml

—

Early complications of trauma

223

0.80

0.35

1.1

0.77

1.35

u/ml

0.38

!Aliquae complicationes praecoces traumatis

223

0.80

0.35

1.1

0.77

1.35

u/ml

0.38

conjunctival haemorrhage

226

1.20

0.35

1.0

1.1

0.36

2.51

u/ml

1.42

Dental pulpitis 2

659

3263

1.03

0.35

1.1

1.23

0.99

u/ml

0.34

298

1380

Other and unspecified corneal deformities and disorders

162

1.24

0.35

1.0

1.1

0.15

1.74

u/ml

1.35

Bacterial pneumonia (organism specified)

261

2256

1.05

0.35

1.1

1.00

1.16

u/ml

0.21

129

960

Pneumonitis due to solids and liquids

223

0.81

0.35

1.1

0.73

1.75

u/ml

—

106

Bursitis of shoulder

108

1.30

0.35

1.1

1.0

0.46

1.34

u/ml

—

Eustachian salpingitis and obstruction

842

1.10

0.35

1.0

1.1

0.57

1.21

u/ml

1.40

387

Viral Sepsis

112

1034

1.08

0.35

1.1

2.04

1.02

u/ml

0.35

479

Other diseases of blood and blood-forming organs

273

1.17

0.35

1.0

1.1

0.11

1.99

u/ml

2.04

113

Sulfasalazine

197

1857

1.06

0.35

1.0

1.1

0.70

0.96

u/ml

0.29

701

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

114

1040

1.08

0.35

1.1

2.12

1.33

u/ml

0.37

604

Other disorders of amniotic fluid and membranes

160

1691

0.94

0.34

1.1

0.95

1.08

u/ml

0.12

702

Viral infections of the central nervous system

499

1.12

0.34

1.0

1.1

0.78

1.32

u/ml

0.59

225

Pneumococcal septicemia

178

0.78

0.34

1.0

1.1

0.91

0.93

u/ml

—

Macular pucker

292

1.17

0.34

1.0

1.1

0.27

1.29

u/ml

1.62

126

Diseases of peritoneum

433

1.13

0.34

1.1

0.22

1.45

u/ml

2.18

185

Diseases of pulp and periapical tissues, including avohilmo

1129

6009

0.98

0.34

1.1

0.99

1.17

u/ml

0.38

496

2616

Paralytic strabismus

276

0.83

0.34

1.2

1.1

0.27

1.85

u/ml

—

127

Other disorders starting during childhood or adolescence

113

1038

1.08

0.34

1.1

2.15

1.18

u/ml

0.48

610

Cramp and spasm

274

1.17

0.34

1.1

0.50

1.39

u/ml

1.06

122

Pregnancy examination and test

264

1567

1.05

0.33

1.1

1.38

0.95

u/ml

0.40

117

651

Syphilis

118

1.28

0.33

1.1

7.13

0.99

u/ml

—

Other vitreous opacities

127

1.26

0.33

1.1

0.33

1.72

u/ml

—

Hodgkin lymphoma, hilmo

155

0.77

0.33

1.3

1.1

0.69

2.16

u/ml

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

559

3180

1.04

0.33

1.1

1.17

1.00

u/ml

0.24

209

1280

Other symptoms and signs involving the nervous and musculoskeletal systems

333

3189

1.04

0.33

1.1

0.61

1.16

u/ml

2.11

144

1397

Normotensive glaucoma

166

0.78

0.33

1.0

0.04

1.64

u/ml

—

Benign neoplasm: Skin of other and unspecified parts of face

444

1.13

0.33

1.1

0.65

1.41

u/ml

0.70

188

Non-small cell lung cancer

307

0.85

0.33

1.0

1.1

0.47

1.29

u/ml

—

122

Thyrotoxicosis with diffuse goitre

109

1009

1.08

0.33

1.0

1.1

0.49

1.19

u/ml

1.95

398

Infections of breast associated with childbirth

369

1.14

0.33

1.1

0.61

1.27

u/ml

0.87

153

Sleep disorders, other/unspecified

294

1.16

0.32

1.2

1.1

0.92

1.45

u/ml

0.45

129

Hypertension, essential

659

3877

0.97

0.32

1.1

0.76

1.10

u/ml

1.23

270

1556

Other viral diseases, not elsewhere classified

208

1965

1.06

0.32

1.1

0.75

1.29

u/ml

1.32

982

Other disorders involving the immune mechanism, not elsewhere classified

201

1.20

0.32

1.0

1.1

0.48

1.29

u/ml

0.70

Effects of other external causes

229

1.18

0.32

1.0

1.1

1.18

1.88

u/ml

0.25

100

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

176

0.79

0.32

1.1

1.2

0.07

1.69

u/ml

—

114

Chronic pancreatitis

497

0.88

0.32

1.0

1.1

0.26

1.23

u/ml

1.97

212

Pedestrian injured in transport accident

417

1.13

0.32

1.1

0.74

1.49

u/ml

0.59

178

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

732

1.10

0.32

1.1

0.87

1.35

u/ml

0.38

278

Allergic purpura

220

1.19

0.32

1.1

2.28

1.79

u/ml

—

100

Other aneurysm

128

1.25

0.32

1.1

1.0

1.61

0.81

u/ml

—

Sixth [abducent] nerve palsy

110

1.28

0.31

1.1

1.0

0.40

0.58

u/ml

—

Haemorrhage, not elsewhere classified

101

1.29

0.31

1.1

0.07

1.07

u/ml

—

Other disorders of glucose regulation and pancreatic internal secretion

570

0.89

0.31

1.1

0.54

1.33

u/ml

1.45

282

Other and unspecified injuries of lower leg

589

1.11

0.31

1.0

1.1

1.25

1.16

u/ml

0.04

264

Manic episode

208

0.81

0.31

1.0

1.1

0.53

1.55

u/ml

—

Visual impairment including blindness (binocular or monocular)

294

0.85

0.31

1.0

1.1

0.59

1.56

u/ml

0.95

149

Rare circulating lymphoid malignancy

175

0.80

0.31

1.1

1.2

0.07

1.72

u/ml

—

111

Other symptoms and signs involving the urinary system

456

1.12

0.31

1.0

1.1

0.50

1.26

u/ml

1.11

196

Disorders of continuity of bone

647

1.10

0.31

1.0

1.1

1.09

1.35

u/ml

0.12

269

Implicit viral Sepsis

111

1032

1.08

0.31

1.1

0.77

1.03

u/ml

0.35

478

Benign neoplasm of meninges

352

1.14

0.31

1.1

0.92

1.14

u/ml

0.12

143

Artrosis, including avohilmo

735

3921

1.03

0.30

1.1

0.71

1.10

u/ml

1.22

297

1565

Other and unspecified epidermal thickening

138

1.24

0.30

1.2

1.1

1.41

1.25

u/ml

—

Other endocrine disorders

799

1.09

0.30

1.1

1.2

2.07

1.10

u/ml

0.30

506

Other arthritis (FG)

216

2271

0.95

0.30

1.1

0.73

1.24

u/ml

1.01

958

Contact with heat and hot substances

438

1.12

0.30

1.1

1.03

1.18

u/ml

0.12

219

Exclusion endpoint for supernumerary teeth

174

0.80

0.30

1.2

1.1

1.72

1.64

u/ml

—

110

Maternal care for known or suspected fetal abnormality and damage

195

1828

0.95

0.30

1.1

0.49

1.00

u/ml

2.13

760

Fentanyl

250

0.84

0.30

1.0

0.65

1.00

u/ml

—

105

Other and unspecified vascular occlusions

196

0.82

0.30

1.1

1.60

1.76

u/ml

0.04

Dental pulpitis 2, only avohilmo

666

3311

1.03

0.30

1.1

1.22

0.98

u/ml

0.33

301

1396

Iridocyclitis

138

1469

0.94

0.29

1.1

1.39

1.07

u/ml

0.15

620

Superficial injury of ankle and foot

135

1267

1.07

0.29

1.1

1.20

1.46

u/ml

0.15

609

Benign neoplasm: Rectum, anus and anal canal

620

1.10

0.29

1.0

1.1

0.36

1.17

u/ml

1.71

256

Cholangitis (primary sclerosing, PSC)

271

0.85

0.29

1.0

1.1

0.88

1.55

u/ml

—

134

Problems related to lifestyle

869

0.92

0.29

1.1

1.56

1.35

u/ml

0.09

356

Abnormal findings on examination of urine, without diagnosis

222

1.17

0.29

1.0

1.1

0.32

1.30

u/ml

1.13

101

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

363

1.13

0.29

1.1

0.23

0.91

u/ml

1.84

151

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

755

1.09

0.29

1.0

1.1

0.64

0.88

u/ml

0.32

292

Assault

126

1344

0.94

0.29

1.1

1.02

1.42

u/ml

0.41

601

Other benign neoplasms of connective and other soft tissue

556

0.90

0.29

1.0

1.1

0.42

1.07

u/ml

1.33

222

Benign neoplasm: Cerebral meninges

316

1.14

0.29

1.1

0.92

1.22

u/ml

0.17

126

Specific development disorders of scholastic skills

757

1.09

0.29

1.1

1.58

1.30

u/ml

0.19

445

Other infectious diseases

345

0.87

0.29

1.0

1.1

0.70

1.44

u/ml

0.65

153

Barrett oesophagus

139

1.23

0.29

1.1

1.0

0.27

1.24

u/ml

—

Effects of foreign body entering through natural orifice

206

1960

1.05

0.29

1.1

0.92

1.17

u/ml

0.38

936

Contusion of other and unspecified parts of foot

497

1.11

0.29

1.2

1.1

2.25

1.74

u/ml

0.13

228

Other disorders of binocular movement

204

1.18

0.29

1.2

1.1

0.20

2.07

u/ml

1.68

Other facial nerve disorders

130

1.23

0.29

1.4

1.1

0.13

2.87

u/ml

—

Endometriosis of intestine

162

0.80

0.28

1.0

0.27

0.65

u/ml

—

Vitamin D deficiency

112

1.26

0.28

1.2

1.1

4.28

1.73

u/ml

—

Respiratory tuberculosis, confirmed and not-confirmed

112

1.25

0.28

1.1

0.46

2.19

u/ml

—

Respiratory tuberculosis

112

1.25

0.28

1.1

0.46

2.19

u/ml

—

Myositis

1.28

0.28

1.3

1.0

1.68

0.91

u/ml

—

Gonarthrosis, primary, with knee surgery

182

1566

0.95

0.28

1.0

1.41

0.90

u/ml

0.28

559

Disorders of speech understanding and production

625

0.91

0.28

1.2

2.11

1.15

u/ml

0.30

399

Benign neoplasm of brain and other parts of central nervous system

354

0.87

0.27

1.1

0.43

1.10

u/ml

0.83

165

Ménière disease

346

1.13

0.27

1.0

1.1

0.62

1.26

u/ml

0.66

143

Toxic effect of ethanol

322

0.87

0.27

1.0

1.1

0.46

1.07

u/ml

0.64

137

Disorder of the sleep-wake schedule

172

0.81

0.27

1.1

1.04

1.36

u/ml

—

Benign neoplasm: Descending colon

177

1.19

0.27

1.0

1.1

0.86

0.81

u/ml

0.03

Torsion of ovary, ovarian pedicle and fallopian tube

196

1.18

0.27

1.1

1.87

1.26

u/ml

0.16

Acute appendicitis, with complications

111

1185

0.94

0.27

1.1

2.07

1.09

u/ml

0.27

475

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

271

1.15

0.27

1.1

0.36

0.85

u/ml

—

106

Accidental poisoning by and exposure to alcohol

139

0.79

0.27

1.0

1.1

0.22

1.53

u/ml

—

Benign leiomyoma with endometriosis

761

0.92

0.27

1.1

0.72

0.99

u/ml

0.33

309

Fungal Sepsis

122

1.23

0.27

1.1

2.13

1.66

u/ml

—

Coxarthrosis

228

1618

0.96

0.27

1.1

0.71

1.23

u/ml

1.21

590

Gingival hyperplasia

268

0.86

0.27

1.0

1.2

0.64

1.35

u/ml

—

153

Abnormal findings on examination of blood, without diagnosis

243

2177

1.04

0.27

1.1

0.53

1.26

u/ml

2.72

957

Phlebitis and thrombophlebitis (not including DVT)

110

1174

0.94

0.27

1.1

0.57

1.02

u/ml

0.59

470

Benign neoplasm: Rectum

557

1.10

0.26

1.0

1.1

0.33

0.78

u/ml

1.58

225

Multiple delivery

729

0.92

0.26

1.1

0.92

0.72

u/ml

0.16

299

Parkinson's disease, strict definition, excluding more controls

221

0.84

0.26

1.0

1.04

1.32

u/ml

—

Gastroduodenal ulcer

738

1.08

0.26

1.1

1.0

0.56

0.90

u/ml

0.52

299

Azathioprine

116

1235

0.94

0.26

1.1

0.86

1.31

u/ml

0.52

548

Blood alcohol or alcohol intoxication level

182

0.82

0.26

1.1

4.04

1.46

u/ml

—

Other specified congenital malformation syndromes affecting multiple systems

267

0.86

0.26

1.1

1.2

1.57

1.13

u/ml

0.12

177

Causalgia

1.27

0.26

1.0

0.34

0.72

u/ml

—

Systemic sclerosis (FG)

1.27

0.26

1.0

1.1

1.35

0.90

u/ml

—

Benign neoplasm of ovary

905

1.07

0.26

1.0

1.1

1.48

0.81

u/ml

0.42

350

Scissor bite

480

1.11

0.26

1.1

0.70

1.52

u/ml

1.47

298

Carcinoma in situ of other and unspecified genital organs

0.70

0.26

1.0

—

0.56

—

Hyphaema and other vascular disorders of iris and ciliary body

0.70

0.26

1.2

1.0

2.78

4.03

u/ml

—

Other acute disseminated demyelination

0.67

0.26

1.0

—

0.61

—

Abnormal spermatozoa

253

1.15

0.26

1.0

1.1

0.40

0.90

u/ml

—

114

Venous complications and haemorrhoids in pregnancy

203

0.83

0.26

1.1

0.13

0.88

u/ml

—

Amenorrhoea

809

1.08

0.26

1.1

0.88

1.34

u/ml

0.40

367

Other cataract

172

1401

0.95

0.26

1.1

2.15

1.08

u/ml

0.42

561

Other mental disorders due to brain damage and dysfunction and to physical disease

299

0.87

0.26

1.0

1.1

1.26

1.78

u/ml

0.18

116

Disorders resulting from impaired renal tubular function

149

0.80

0.26

1.0

1.1

0.87

1.37

u/ml

—

Endometriosis ASRM stages 3,4

190

1812

1.05

0.25

1.0

1.1

0.73

0.92

u/ml

0.36

723

Other pulmonary heart/vessel disease

132

1.21

0.25

1.0

1.1

0.73

1.30

u/ml

—

Psoriatic and enteropathic arthropathies

779

0.92

0.25

1.1

1.22

1.14

u/ml

0.03

297

Heart failure and bmi 25plus

723

0.93

0.25

1.0

1.1

0.94

1.22

u/ml

0.20

282

Vitamin deficiency, wide

235

1.15

0.25

1.2

1.1

2.47

1.82

u/ml

0.15

110

Vitamin deficiency

235

1.15

0.25

1.2

1.1

2.47

1.82

u/ml

0.15

110

Nonspecific lymphadenitis

406

1.11

0.25

1.1

1.51

1.22

u/ml

0.14

160

Pedal cyclist injured in other and unspecified transport accidents

820

1.07

0.25

1.1

0.66

1.32

u/ml

1.23

355

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

368

1.12

0.25

1.1

0.23

1.22

u/ml

1.79

158

Other disorders of fluid, electrolyte and acid-base balance

114

1168

0.94

0.25

1.1

1.72

0.87

u/ml

0.31

520

Reactive arthropathies, FINNGEN

483

1.10

0.25

1.0

1.1

0.65

1.14

u/ml

0.68

197

Other/unspecified reactive arthropathies

416

1.11

0.25

1.0

1.1

0.67

1.48

u/ml

0.94

174

Colectomy operation

591

0.91

0.24

1.1

0.27

1.26

u/ml

2.31

246

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

476

0.90

0.24

1.0

1.1

0.73

1.08

u/ml

0.28

209

Mixed and other personality disorders

705

1.08

0.24

1.1

0.55

1.26

u/ml

1.48

297

Other, unspecified and serous retinal detachments

1.25

0.24

1.1

11.90

1.88

u/ml

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

302

1.13

0.24

1.0

1.1

2.54

1.47

u/ml

0.21

128

Benign neoplasm of other and unspecified endocrine glands

628

1.08

0.24

1.0

1.1

2.01

1.19

u/ml

0.30

262

Osteoporosis

746

1.07

0.24

1.1

2.51

1.25

u/ml

0.32

318

Ankylosing spondylitis

580

1.09

0.24

1.0

1.1

0.61

1.76

u/ml

1.59

242

Use of other anti-dementia drugs

222

0.86

0.24

1.0

0.80

1.27

u/ml

—

Use of memantine

222

0.86

0.24

1.0

0.80

1.27

u/ml

—

Medical abortion

658

3490

1.03

0.24

1.1

1.38

0.93

u/ml

0.51

276

1407

Malignant neoplasm of thyroid gland

339

0.88

0.24

1.0

1.1

0.93

1.25

u/ml

0.18

141

Male infertility

398

1.11

0.24

1.1

0.77

1.95

u/ml

1.13

191

Other dialysis

169

0.83

0.24

1.3

1.1

0.12

1.37

u/ml

—

LSIL lesion of the cervix uteri

121

1143

1.06

0.24

1.1

0.48

1.00

u/ml

1.10

463

Other disorders of nervous system

265

0.87

0.24

1.1

0.28

1.84

u/ml

—

109

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

475

0.90

0.24

1.1

0.28

1.44

u/ml

1.98

198

Tuberculosis

124

1.21

0.24

1.1

0.46

2.01

u/ml

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

227

1.15

0.24

1.0

1.1

0.46

1.13

u/ml

—

Placenta praevia

495

0.91

0.23

1.0

1.1

0.38

0.89

u/ml

0.89

210

Other diseases of biliary tract

284

1.13

0.23

1.1

0.54

1.72

u/ml

1.14

125

Benign neoplasm: Skin of other and unspecified parts of face

456

1.10

0.23

1.1

0.65

1.14

u/ml

0.44

189

Thyrotoxicosis with toxic multinodular goitre

199

1.16

0.23

1.0

1.76

1.63

u/ml

—

Orchitis and epididymitis

422

0.90

0.23

1.0

1.1

0.29

1.73

u/ml

2.10

198

Congenital iodine-deficiency syndrome/hypothyroidism

143

1.19

0.23

1.1

0.27

2.27

u/ml

—

Other salmonella infections

171

1.17

0.23

1.1

0.17

2.52

u/ml

—

Disorders of puberty, all

323

1.12

0.23

1.1

1.2

2.65

1.27

u/ml

0.64

193

Other diseases of spinal cord

136

0.81

0.23

1.0

1.1

0.54

2.87

u/ml

—

Complications of the puerperium, not elsewhere classified

428

1.10

0.23

1.0

1.1

0.48

0.83

u/ml

0.61

182

Sequelae of other and unspecified infectious and parasitic diseases

390

0.90

0.23

1.1

0.20

1.27

u/ml

2.04

149

Injury of intra-abdominal organs

168

0.83

0.23

1.1

1.29

1.63

u/ml

—

Tuberculosis, IBD comorbidity

162

1.17

0.22

1.1

0.36

1.99

u/ml

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

681

0.92

0.22

1.0

1.1

0.55

1.04

u/ml

0.96

288

Type of accident

233

2242

1.04

0.22

1.1

1.15

1.35

u/ml

0.24

114

1001

Chronic ulcer of skin, not elsewhere classified

200

0.85

0.22

1.1

0.90

2.43

u/ml

0.69

Inguinal hernia, bilateral

323

1.12

0.22

1.1

0.10

1.10

u/ml

1.93

139

Inflammatory diseases of the central nervous system

525

0.91

0.22

1.1

2.15

1.26

u/ml

0.49

227

All dysplastic lesions of the vulva

274

0.87

0.22

1.0

1.1

0.03

1.28

u/ml

—

118

Pediculosis, acariasis and other infestations

419

1.10

0.22

1.1

0.63

1.06

u/ml

0.33

175

Androgen resistance syndrome

0.00

0.22

0.0

1.0

—

0.09

—

Generalized epilepsy

458

1.09

0.22

1.1

0.47

1.30

u/ml

1.43

229

Superficial injury of thorax

903

1.06

0.22

1.1

1.95

1.22

u/ml

0.23

387

Other diseases of arteries and capillaries

362

1.11

0.22

1.1

0.41

1.72

u/ml

1.63

148

Vertical strabismus

191

1.15

0.22

1.1

0.50

0.72

u/ml

—

Benign neoplasm: Cerebral meninges

324

1.11

0.22

1.1

0.92

0.82

u/ml

0.06

134

Benign neoplasm: Pituitary gland, craniopharyngeal duct

305

1.12

0.21

1.0

1.1

2.54

1.47

u/ml

0.21

135

Disorder of amino-acid metabolism, other/unspecified

0.00

0.21

0.0

1.0

—

5.30

—

Fracture of rib(s), sternum and thoracic spine

128

1347

0.95

0.21

1.1

0.49

0.99

u/ml

1.54

564

Unspecified urinary incontinence

372

1.10

0.21

1.0

1.1

0.56

1.40

u/ml

1.05

169

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

229

1.14

0.21

1.0

1.1

0.46

1.35

u/ml

—

Failure of sterile precautions during surgical operation

0.00

0.21

0.0

1.0

—

1.37

—

Disorders of copper metabolism

0.00

0.21

0.0

1.0

—

1.39

—

Malignant neoplasm of meninges, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.0

—

1.60

—

Other sideroblastic anaemias

0.00

0.21

0.0

1.0

—

1.62

—

Postinflammatory hyperpigmentation

0.00

0.21

0.0

1.1

—

1.42

—

Recurrent cholesteatoma of postmastoidectomy cavity

0.00

0.21

0.0

1.0

—

1.46

—

Other or unspecified ileus, impaction or obstruction

613

1.08

0.21

1.1

0.22

1.17

u/ml

2.48

267

Thromboangiitis obliterans

0.00

0.21

0.0

1.1

—

0.24

—

Carcinoma in situ of prostate

0.00

0.21

0.0

1.1

—

0.39

—

Complications peculiar to reattachment and amputation

0.00

0.21

0.0

1.1

—

0.27

—

Injury of muscle and tendon at wrist and hand level

874

0.94

0.21

1.1

0.47

1.39

u/ml

2.11

370

Nutritional anaemias

262

2637

0.97

0.21

1.1

0.95

1.06

u/ml

0.13

113

1122

Physiological and behavioural disorders associated with sexual development and orientation

0.00

0.21

0.0

1.0

—

0.33

—

Chronic lymphocytic leukaemia, helper endpoint

1.16

0.21

1.2

1.0

—

1.11

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

1.16

0.21

1.2

1.0

—

1.11

—

Other disorders of gingiva or/and edentulous alveolar ridge

356

0.90

0.21

1.0

1.2

0.68

1.23

u/ml

0.43

192

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

0.00

0.21

0.0

1.1

—

1.48

—

Malignant neoplasm of hypopharynx, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.2

—

1.27

—

Melanocytic naevi of lower limb, including hip

287

1.12

0.21

1.0

1.1

0.54

1.48

u/ml

1.06

122

Other benign neoplasms of connective and other soft tissue

543

0.92

0.20

1.0

1.1

0.42

1.28

u/ml

1.53

223

Maternal care for cervical incompetence

268

1.12

0.20

1.0

1.1

2.03

1.36

u/ml

—

102

Methotrexate

801

0.94

0.20

1.0

0.23

1.22

u/ml

3.05

306

Measles

1.26

0.20

1.1

1.0

17.99

1.87

u/ml

—

Encephalitis

166

0.84

0.20

1.1

1.54

1.25

u/ml

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

404

1.10

0.20

1.1

1.2

1.00

1.11

u/ml

0.06

298

Exposure to sunlight

0.00

0.20

0.0

1.1

—

0.70

—

Fetus and newborn affected by maternal complications of pregnancy

193

1.15

0.20

1.1

1.3

0.42

0.79

u/ml

0.45

143

Polyglandular dysfunction

0.00

0.20

0.0

1.0

—

0.13

—

Eccrine sweat disorders

0.00

0.20

0.0

1.1

—

1.06

—

Injuries to the thorax

266

2573

1.03

0.20

1.1

1.38

1.19

u/ml

0.13

107

1094

Fluid overload

0.00

0.20

0.0

1.1

—

1.08

—

Benign neoplasm of meninges

364

1.10

0.20

1.1

0.92

0.80

u/ml

0.08

148

Benign neoplasm: Endocrine gland, other/unspecified

0.00

0.20

0.0

1.0

—

1.15

—

Other infiltrative disorders of skin and subcutaneous tissue

0.00

0.20

0.0

1.1

—

0.95

—

Collapsed vertebra, not elsewhere classified

0.00

0.20

0.0

1.1

—

1.75

—

Used for control exclusion in common control thyroid runs

1175

6050

0.98

0.20

1.1

1.00

1.18

u/ml

0.54

522

2729

Cholesteatoma of middle ear

187

0.85

0.20

1.0

1.1

0.56

2.38

u/ml

—

Other disorders of ear

714

4662

1.02

0.20

1.1

0.78

1.15

u/ml

1.81

307

2002

Chronic periapical parodontitis

110

1159

0.95

0.20

1.0

1.1

0.53

1.46

u/ml

1.92

475

Psoriatic arthropathies, ICD10

604

0.93

0.20

1.1

1.37

1.28

u/ml

0.03

241

Melanocytic naevi of trunk

810

0.94

0.20

1.1

0.74

1.28

u/ml

0.65

341

Other benign neoplasms of uterus

136

1.18

0.20

1.1

1.0

0.40

1.06

u/ml

—

Anxious personality disorder

176

0.85

0.20

1.0

1.1

1.16

1.53

u/ml

—

Chronic suppurative otitis media, including avohilmo

606

1.07

0.20

1.1

0.42

1.31

u/ml

1.50

304

Hyperfunction of pituitary gland

461

1.09

0.20

1.1

1.94

1.38

u/ml

0.15

210

Convulsions, not elsewhere classified

210

2150

0.96

0.20

1.1

1.14

1.31

u/ml

0.19

102

1078

Pyogenic arthritis

288

1.11

0.20

1.3

1.1

0.77

1.41

u/ml

0.51

125

Presence of other devices

761

1.06

0.20

1.1

0.48

0.94

u/ml

1.04

309

Hirsutism in women

193

1.14

0.19

1.0

1.1

2.30

0.80

u/ml

—

Bacterial pneumonia, not elsewhere classified

232

1983

1.04

0.19

1.0

1.1

1.05

1.06

u/ml

0.01

116

854

Congenital musculoskeletal deformities of head, face, spine and chest

146

1.17

0.19

1.2

1.23

1.36

u/ml

0.05

Duodenal ulcer

250

1.12

0.19

1.1

0.91

0.90

u/ml

0.00

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

811

1.06

0.19

1.1

0.81

1.05

u/ml

0.20

326

Pneumonia derived septicemia

165

0.85

0.19

1.0

1.1

0.91

0.94

u/ml

—

Additional codes for the location of defect, injury or illness

327

1.10

0.19

1.1

1.02

1.47

u/ml

0.29

149

Intestinal stricture

121

1269

0.95

0.19

1.1

0.58

1.24

u/ml

1.38

529

Exclusions for E4_PCOS_BROAD

163

1564

1.04

0.19

1.1

1.30

1.07

u/ml

0.15

795

Other secondary gonarthrosis

184

1.14

0.19

1.0

1.1

0.21

1.15

u/ml

2.39

Open wound of forearm

633

0.93

0.19

1.1

0.31

1.25

u/ml

2.31

264

Reactive arthropathies

569

1.07

0.19

1.0

1.1

0.67

1.13

u/ml

0.75

232

Osteomyelitis

270

1.11

0.19

1.1

1.80

1.72

u/ml

0.02

125

Opening and dilatation of root channel of tooth

488

0.92

0.19

1.2

1.1

0.60

1.19

u/ml

0.76

205

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

194

1.14

0.18

1.1

1.2

0.51

1.65

u/ml

0.82

118

Other metabolic disorders

100

949

1.05

0.18

1.0

1.1

1.03

1.07

u/ml

0.02

409

Ectopic pregnancy

148

1419

1.04

0.18

1.1

1.08

0.97

u/ml

0.10

550

Chronic hepatitis, not elsewhere classified

143

0.84

0.18

1.0

0.01

1.54

u/ml

—

Dislocation, sprain and strain of joints and ligaments of head

405

1.09

0.18

1.1

0.88

1.37

u/ml

0.25

186

Idiopathic gout

196

0.87

0.18

1.1

1.0

0.76

0.94

u/ml

—

Pyothorax

109

1.19

0.18

1.0

1.1

4.48

2.38

u/ml

—

Divergent concomitant strabismus

599

1.07

0.18

1.1

0.33

1.33

u/ml

2.01

264

Deposits [accretions] on teeth

699

0.94

0.18

1.2

1.12

1.09

u/ml

0.02

424

Spontaneous abortion

473

3145

1.02

0.18

1.1

0.61

0.95

u/ml

1.46

178

1254

Congenital malformations of ovaries, fallopian tubes and broad ligaments

551

1.07

0.18

1.1

2.19

0.95

u/ml

0.55

237

Carcinoma in situ of skin of other and unspecified parts of face

100

1.20

0.18

1.0

0.82

0.98

u/ml

—

Neoplasms

1069

5644

1.02

0.18

1.1

1.00

1.23

u/ml

0.63

473

2568

Contact with sharp object, undetermined intent

153

0.85

0.18

1.0

1.1

0.34

1.55

u/ml

—

Filling of root of tooth

166

1.15

0.18

1.1

0.85

2.31

u/ml

—

Leisure time condition

136

1303

1.04

0.18

1.1

0.76

1.18

u/ml

0.97

583

Tuberculosis, wide

166

1.15

0.18

1.1

0.36

1.95

u/ml

—

Purpura and other haemorrhagic conditions

826

0.94

0.18

1.1

0.92

1.21

u/ml

0.19

385

Other osteochondrodysplasias

1.22

0.18

1.1

1.2

0.52

0.58

u/ml

—

Viral warts

824

1.06

0.18

1.1

1.16

1.35

u/ml

0.09

384

Injury of unspecified body region

464

1.08

0.17

1.0

1.1

3.57

1.55

u/ml

0.40

219

Emotionally unstable personality disorder

135

1408

0.96

0.17

1.1

0.46

1.44

u/ml

3.18

598

Angina pectoris

230

1503

1.03

0.17

1.1

1.0

0.90

1.11

u/ml

0.27

589

Iron deficiency anaemia secondary to blood loss (chronic)

651

0.94

0.17

1.1

0.78

1.12

u/ml

0.33

263

Other specified/unspecified arthritis

184

1906

0.96

0.17

1.1

0.77

1.24

u/ml

0.72

788

Diabetic retinopathy

116

767

0.95

0.17

1.0

1.1

2.46

0.78

u/ml

0.50

285

Autism

382

0.91

0.17

1.1

0.72

1.16

u/ml

0.39

213

Exposure to other specified electric current

110

1.19

0.17

1.0

1.1

1.63

1.71

u/ml

—

Nephrotic syndrome

226

0.88

0.17

1.2

0.12

1.18

u/ml

—

140

Disorders of mineral metabolism

368

1.09

0.17

1.1

0.67

1.50

u/ml

0.69

175

UC patients in KELA-register (code 208), prior to 1994

184

0.87

0.17

1.0

1.1

0.41

1.73

u/ml

—

Other ulcerative colitis

444

0.92

0.17

1.1

0.23

1.61

u/ml

2.17

189

Carcinoma in situ of other and unspecified genital organs

0.74

0.17

1.0

—

0.75

—

Other and unspecified disease of Bartholin gland

129

1.17

0.17

1.3

1.1

0.73

1.30

u/ml

—

Agoraphobia

340

0.91

0.17

1.1

0.08

1.33

u/ml

2.18

142

Chronic suppurative otitis media

485

1.07

0.16

1.1

0.47

1.71

u/ml

1.62

233

Coxarthrosis, primary, with hip surgery

126

1245

0.96

0.16

1.1

1.0

0.69

1.03

u/ml

0.70

475

Paroxysmal tachycardia

179

1566

0.97

0.16

1.1

0.95

1.27

u/ml

0.46

706

Other diseases of blood and blood-forming organs, wide

121

1262

0.96

0.16

1.1

0.36

1.05

u/ml

2.43

553

Visual field defects

350

0.91

0.16

1.0

1.1

0.22

1.73

u/ml

2.27

154

ILD medications: azathioprine

116

1211

0.96

0.16

1.1

0.86

1.20

u/ml

0.38

534

Other eating disorders

710

0.94

0.16

1.2

1.1

1.12

1.46

u/ml

0.24

340

204

0.88

0.16

1.0

1.1

0.24

1.03

u/ml

—

Superficial injuries involving multiple body regions

162

0.86

0.16

1.1

0.25

1.59

u/ml

—

Bacterial meningitis

183

0.87

0.16

1.1

2.77

0.83

u/ml

—

Other condition

1027

0.95

0.16

1.1

1.66

1.21

u/ml

0.28

446

Benign neoplasm of breast

720

1.06

0.16

1.1

0.77

0.93

u/ml

0.14

289

Inguinal or femoral hernia, bilateral

331

1.09

0.16

1.1

0.10

1.11

u/ml

2.03

143

Injuries to the hip and thigh

262

2333

1.03

0.16

1.1

1.06

1.31

u/ml

0.23

124

1002

Foreign body or object entering through skin

438

1.07

0.15

1.1

0.68

1.41

u/ml

0.81

190

Hydrocele

442

0.93

0.15

1.1

0.50

1.42

u/ml

1.26

201

Dental pulpitis 4, only avohilmo

1147

6064

0.99

0.15

1.1

1.02

1.16

u/ml

0.30

501

2622

Superficial injury of head

176

1702

1.03

0.15

1.1

1.36

1.34

u/ml

0.01

796

Social phobias

105

1005

1.05

0.15

1.0

1.1

0.45

1.43

u/ml

3.27

458

Constitutional tall stature

121

1.17

0.15

1.1

1.2

0.42

1.07

u/ml

—

Special screening examination for other diseases and disorders

606

0.94

0.15

1.1

0.21

1.33

u/ml

3.67

274

Autism spe, excluding more controls

369

0.92

0.15

1.1

0.72

1.11

u/ml

0.35

205

Gender identity disorders

161

0.87

0.15

1.0

1.1

0.18

1.86

u/ml

—

Other symptoms and signs involving cognitive functions and awareness

195

1886

0.97

0.15

1.1

0.77

1.16

u/ml

0.74

778

Benign neoplasm: Rectum, anus and anal canal

643

1.06

0.15

1.0

1.1

0.36

1.10

u/ml

1.66

257

Event of undetermined intent

497

1.07

0.15

1.1

1.03

1.15

u/ml

0.10

210

Intestinal adhesions without obstruction

274

1.10

0.15

1.0

1.1

9.97

1.08

u/ml

—

125

Benign neoplasm of brain and other parts of central nervous system

338

0.92

0.15

1.1

0.43

1.39

u/ml

1.05

159

Hypotension

361

1.08

0.15

1.1

1.40

1.19

u/ml

0.11

146

All dysplastic lesions of the cervix uteri

292

2844

1.03

0.15

1.1

1.28

0.93

u/ml

0.33

108

1149

Benign neoplasm of other and unspecified endocrine glands

644

1.06

0.15

1.0

1.1

2.01

0.94

u/ml

0.43

267

Sensorineural hearing loss

411

2818

1.02

0.14

1.1

0.74

1.12

u/ml

1.18

162

1129

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

584

0.94

0.14

1.2

1.1

1.22

1.57

u/ml

0.24

260

Ulcerative enterocolitis

198

1.11

0.14

1.1

0.61

1.55

u/ml

0.55

Hyperkalaemia

112

1.16

0.14

1.0

1.1

1.00

0.87

u/ml

—

ILD medications: immunosuppressive drugs

501

4720

1.02

0.14

1.1

1.98

1.01

u/ml

1.00

219

1962

Arterial embolism and thrombosis

131

1.15

0.14

1.0

0.13

1.07

u/ml

—

Cyst of Bartholin Gland

285

1.09

0.14

1.1

0.44

0.80

u/ml

0.60

118

Foreign body on external eye

110

1057

1.04

0.14

1.0

1.1

1.23

1.44

u/ml

0.14

474

Missing teeth due to accident, extraction or parodontitis

489

1.06

0.14

1.1

0.97

1.00

u/ml

0.02

184

Gestational diabetes (for exclusion)

501

3483

1.02

0.14

1.1

0.93

1.14

u/ml

0.30

204

1405

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

394

1.08

0.14

1.1

1.2

0.36

1.11

u/ml

1.61

291

Abnormalities of gait and mobility

501

0.94

0.14

1.1

1.51

1.64

u/ml

0.07

246

Fracture of forearm

426

4064

0.98

0.14

1.1

1.67

1.22

u/ml

0.60

199

1783

Other and unspecified disorders of skin and subcutaneous tissue

295

1.09

0.14

1.1

0.27

1.47

u/ml

1.32

126

Hydatidiform mole

103

1.17

0.14

1.0

2.39

1.46

u/ml

—

Cardiovascular diseases (excluding rheumatic etc)

949

5412

1.01

0.13

1.1

1.32

1.12

u/ml

0.37

409

2470

Dental pulpitis 1, only avohilmo

1150

6072

0.99

0.13

1.1

1.02

1.16

u/ml

0.30

501

2623

Personality disorders

283

2766

1.02

0.13

1.1

0.85

1.25

u/ml

0.86

129

1172

Pustular psoriasis

222

0.90

0.13

1.1

0.31

1.69

u/ml

1.45

Transient global amnesia

222

0.90

0.13

1.1

1.0

0.86

1.32

u/ml

—

Other obstetric trauma

578

1.06

0.13

1.0

1.1

1.46

0.73

u/ml

0.27

238

Other sexually transmitted chlamydial diseases

882

1.04

0.13

1.1

0.57

1.37

u/ml

2.21

397

Lactose intolerance, other/unspecified

199

1.11

0.13

1.0

1.1

0.77

1.82

u/ml

0.74

108

Intentional self-harm by sharp object

263

0.91

0.13

1.0

1.1

0.21

1.88

u/ml

1.79

121

Unspecified misadventure during surgical and medical care

228

1.10

0.13

1.0

1.1

0.50

2.18

u/ml

1.34

102

Impacted maxillary molar

765

0.95

0.13

1.1

0.75

1.62

u/ml

0.94

347

Lupus erythematosus

1.17

0.13

1.4

1.1

1.85

2.31

u/ml

—

Complications of surgical and medical care, not elsewhere classified

833

5898

1.01

0.13

1.1

0.97

1.08

u/ml

0.20

354

2443

Hypokalaemia

462

1.06

0.12

1.1

3.06

0.79

u/ml

0.40

217

Short stature, not elsewhere classified

589

1.05

0.12

1.1

1.2

2.36

1.09

u/ml

0.34

410

Congenital malformations of the circulatory system

151

1507

0.97

0.12

1.0

1.1

1.13

1.09

u/ml

0.04

829

Wet age-related macular degeneration

215

1.10

0.12

1.0

0.76

1.30

u/ml

0.35

Other and unspecified iron deficiency

195

1899

1.03

0.12

1.1

1.05

1.08

u/ml

0.03

830

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

158

0.88

0.12

1.2

1.1

0.42

1.59

u/ml

—

Hypothyroidism, drug reimbursement

153

1127

0.97

0.12

1.1

1.09

0.90

u/ml

0.14

490

Psychotic depression

404

1.07

0.12

1.0

0.35

1.32

u/ml

1.72

189

Other disorders of kidney and ureter

498

0.94

0.12

1.1

0.74

1.17

u/ml

0.41

216

Other and unspecified injuries of shoulder and upper arm

152

1.12

0.12

1.2

1.1

0.14

2.02

u/ml

1.27

Sequelae of infectious and parasitic diseases

416

0.94

0.12

1.1

0.22

1.26

u/ml

2.17

160

Diverticular disease of intestine

380

2478

1.02

0.12

1.1

0.47

1.00

u/ml

3.08

132

954

Abnormal serum enzyme levels

113

1077

1.04

0.12

1.1

0.59

1.07

u/ml

0.76

471

Burn and corrosion of hip and lower limb, except ankle and foot

137

0.87

0.12

1.0

1.1

1.67

1.65

u/ml

—

Disorder of external ear, unspecified

137

0.87

0.12

1.1

1.0

1.16

0.92

u/ml

—

Symptoms and signs involving the urinary system

516

3928

1.02

0.12

1.1

1.01

1.15

u/ml

0.30

234

1674

Retinal vascular occlusion

249

1.08

0.11

1.0

1.1

1.18

1.53

u/ml

0.12

Dislocation, sprain and strain of joints and ligaments of elbow

591

1.05

0.11

1.2

1.1

1.43

1.45

u/ml

0.01

287

Injury of muscle and tendon at forearm level

1.16

0.11

1.0

1.1

2.61

2.42

u/ml

—

Adjustment and management of implanted device

497

0.95

0.11

1.1

1.05

1.23

u/ml

0.09

218

Hernia

767

5264

0.99

0.11

1.1

1.22

1.04

u/ml

0.28

343

2203

Myeloproliferative diseases

271

0.92

0.11

1.0

1.1

0.12

1.33

u/ml

—

105

102

1056

0.97

0.11

1.1

0.72

1.34

u/ml

0.89

412

Liveborn infants according to place of birth

195

1.10

0.11

1.1

1.2

0.45

0.65

u/ml

0.30

129

Anorexia

105

1.15

0.11

1.2

1.1

0.18

0.72

u/ml

—

Follow-up care involving plastic surgery

182

1.10

0.11

1.2

1.1

0.37

1.32

u/ml

—

Systemic sclerosis, icd10

105

1.14

0.11

1.0

1.35

0.77

u/ml

—

Injury of eye and orbit

121

1173

1.03

0.11

1.1

0.96

1.42

u/ml

0.40

537

Systemic sclerosis

105

1.14

0.11

1.0

1.35

0.76

u/ml

—

Papillary adenocarcinoma of thyroid gland

250

0.92

0.11

1.0

1.1

0.95

1.46

u/ml

0.24

104

Lesion of lateral popliteal nerve

219

0.91

0.11

1.1

0.84

1.56

u/ml

—

Evidence of alcohol involvement determined by blood alcohol level

1.17

0.11

1.1

1.0

5.56

1.15

u/ml

—

Preterm labour and delivery

211

2157

0.98

0.11

1.1

2.90

0.81

u/ml

0.73

837

Hypoplasia of dental enamel , including avohilmo

630

0.95

0.11

1.1

1.2

0.68

1.29

u/ml

0.81

417

Hyperkinetic disorders (excl. ADHD)

335

1.07

0.11

1.2

1.51

1.39

u/ml

0.05

215

Bacterial, viral and other infectious agents

681

1.04

0.11

1.0

1.1

0.53

1.57

u/ml

1.73

299

Other strabismus

229

2236

1.02

0.10

1.1

1.17

1.33

u/ml

0.14

109

1084

Motor disorders

432

0.94

0.10

1.1

1.2

1.69

1.31

u/ml

0.15

316

Intracranial trauma

607

4479

1.01

0.10

1.1

0.88

1.34

u/ml

1.99

289

2042

Postprocedural endocrine and metabolic disorders, not elsewhere classified

859

1.04

0.10

1.0

1.1

1.18

1.11

u/ml

0.03

357

AV-block

440

0.95

0.10

1.1

2.51

0.99

u/ml

0.63

204

Cutaneous abscess, furuncle and carbuncle

201

2054

0.98

0.10

1.0

1.1

1.48

1.20

u/ml

0.15

112

905

Intrahepatic Cholestasis of Pregnancy (ICP)

771

1.04

0.10

1.1

0.87

1.08

u/ml

0.16

310

Other CVD (FINNGEN)

317

0.94

0.10

1.1

1.47

0.66

u/ml

0.61

129

Lung diseases due to external agents

427

1.05

0.10

1.1

0.47

1.33

u/ml

0.94

186

Bicuspidal aortic valve syndrome

228

0.92

0.10

1.0

1.1

1.23

1.11

u/ml

—

123

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

349

1.06

0.10

1.0

1.1

0.76

0.95

u/ml

0.15

147

Malignant neoplasm of small intestine

1.11

0.10

1.0

1.1

—

0.82

—

Other congenital malformations of male genital organs

176

0.90

0.09

1.3

1.2

3.80

1.86

u/ml

—

135

Coagulation defects, purpura and other haemorrhagic conditions

129

1325

0.97

0.09

1.2

1.1

0.93

1.07

u/ml

0.13

601

Other psoriatic arthropathies

585

0.96

0.09

1.1

1.37

1.31

u/ml

0.02

233

Foreign body in respiratory tract

379

1.06

0.09

1.1

0.59

1.45

u/ml

0.98

188

Other diseases of pericardium

145

0.90

0.09

1.0

1.1

0.24

0.75

u/ml

—

Bacterial sepsis of newborn

184

1.09

0.09

1.2

0.39

0.96

u/ml

0.81

142

Frostbite

1.04

0.09

1.2

1.1

0.40

3.63

u/ml

—

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

145

1.10

0.09

1.1

0.23

1.01

u/ml

—

Outcome of delivery

246

1552

0.98

0.09

1.1

1.33

0.94

u/ml

0.50

130

639

Retinal vascular disorders

252

1.07

0.09

1.0

1.1

1.18

1.52

u/ml

0.12

Other assisted single delivery

186

0.91

0.09

1.0

1.1

0.50

0.45

u/ml

—

Malignant neoplasm of colon

350

0.94

0.09

1.0

1.1

1.72

1.13

u/ml

0.17

142

Postpartum haemorrhage due to retained placenta

132

1287

1.03

0.09

1.0

1.1

0.55

1.17

u/ml

1.61

508

Other disorders originating in the perinatal period

282

1.07

0.09

1.2

1.3

1.19

0.87

u/ml

0.12

214

Other specified and unspecified personality disorders

793

1.03

0.09

1.1

1.37

1.17

u/ml

0.10

339

Hypertrophic scar

468

1.05

0.09

1.1

0.36

1.30

u/ml

1.62

204

Glaucoma suspect

142

1386

1.02

0.09

1.0

1.1

1.06

1.13

u/ml

0.06

551

Pleural effusion

370

0.95

0.09

1.0

1.1

0.55

1.68

u/ml

1.36

158

Other secondary coxarthrosis

126

1.11

0.09

1.0

1.1

0.18

2.02

u/ml

—

Somnolence, stupor and coma

196

0.92

0.09

1.1

0.74

0.86

u/ml

—

Injury of other and unspecified intrathoracic organs

278

0.93

0.09

1.2

1.1

2.15

1.27

u/ml

0.26

118

Unspecified lump in breast

912

1.03

0.09

1.1

0.71

0.96

u/ml

0.26

359

DVT of lower extremities

766

0.97

0.09

1.0

1.1

0.60

0.93

u/ml

0.55

302

Personal history of certain other diseases

206

0.92

0.08

1.1

2.54

0.62

u/ml

—

Other disorders of the genitourinary system

451

0.95

0.08

1.1

1.0

0.87

1.07

u/ml

0.15

184

Retention of urine

113

981

0.97

0.08

1.1

0.84

0.94

u/ml

0.11

405

Zoster [herpes zoster]

725

0.97

0.08

1.1

4.68

1.10

u/ml

0.85

303

Specific developmental disorder of motor function

422

0.95

0.08

1.1

1.2

1.69

1.25

u/ml

0.18

307

Melanocytic naevi of lower limb, including hip

302

1.06

0.08

1.0

1.1

0.54

1.02

u/ml

0.77

137

Epilepsy

227

2303

0.98

0.08

1.1

0.55

1.27

u/ml

3.43

1108

Procreative management

385

3205

1.01

0.08

1.1

0.77

1.16

u/ml

1.15

196

1508

Motorcycle rider injured in noncollision transport accidents

267

0.93

0.08

1.0

1.1

0.56

1.30

u/ml

0.72

119

Polyhydramnios

489

1.04

0.08

1.0

1.1

0.42

0.91

u/ml

0.95

215

Fracture of lower leg, including ankle

398

4013

0.99

0.08

1.1

1.14

1.05

u/ml

0.10

190

1700

Hypertensive Heart Disease

464

1.04

0.08

1.0

0.61

1.14

u/ml

0.71

197

Cellulitis of external ear

0.78

0.08

1.0

1.1

0.29

0.78

u/ml

—

Cirrhosis of liver, NAS

146

1.10

0.08

1.1

1.0

0.53

1.89

u/ml

—

HSIL lesion of the cervix uteri

200

1964

1.02

0.08

1.0

1.1

1.46

0.90

u/ml

0.39

802

Spondylopathies (FG)

120

1171

1.03

0.08

1.0

1.1

0.60

1.31

u/ml

1.90

482

Other disorders of skin and subcutaneous tissue

438

3965

1.01

0.08

1.1

0.98

1.11

u/ml

0.24

196

1624

Injuries to unspecified part of trunk, limb or body region

647

1.04

0.08

1.0

1.1

2.94

1.40

u/ml

0.40

288

Monoarthritis, not elsewhere classified

234

1.07

0.08

1.1

0.87

1.23

u/ml

0.27

Conduct disorder

297

0.94

0.08

1.0

1.1

5.04

1.05

u/ml

0.40

150

Problems related to social environment

156

1.09

0.08

1.1

1.14

1.61

u/ml

—

Contact with nonpowered hand tool

244

1.07

0.08

1.0

1.1

1.98

1.82

u/ml

0.04

101

Other diseases of the digestive system

134

1370

0.98

0.08

1.1

0.77

0.99

u/ml

0.27

603

Motorcycle rider injured in other and unspecified transport accidents

549

1.04

0.08

1.2

1.1

0.50

1.41

u/ml

1.71

240

Recurrent dislocation and subluxation of joint

642

0.96

0.08

1.0

1.1

0.44

1.50

u/ml

1.89

261

Other specified/unspecified inflammatory spondylopathies

362

1.05

0.07

1.1

0.48

1.66

u/ml

1.32

148

Benign neoplasm: Brain, supratentorial

1.12

0.07

1.0

1.1

0.10

0.81

u/ml

—

Burns and corrosions

122

1192

1.02

0.07

1.1

0.99

1.42

u/ml

0.70

564

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

0.84

0.07

1.0

—

1.03

—

Arthrosis

572

3113

1.01

0.07

1.1

0.74

1.08

u/ml

0.77

240

1204

Parodontitis, under 40 years

136

1331

1.02

0.07

1.1

1.87

1.30

u/ml

0.20

610

Certain zoonotic bacterial diseases

0.81

0.07

1.0

—

1.02

—

Scar conditions and fibrosis of skin

266

0.94

0.07

1.1

0.74

2.03

u/ml

0.88

112

Other noninfective disorders of lymphatic vessels and lymph nodes

174

0.92

0.07

1.2

1.1

0.73

1.43

u/ml

—

Erosion of teeth

176

1.08

0.07

1.3

1.2

0.09

1.81

u/ml

1.73

108

Torsion of testis

225

0.93

0.07

1.1

0.49

1.51

u/ml

0.98

112

Birth asphyxia

147

1.10

0.07

1.2

0.35

0.90

u/ml

—

104

Psoriatic arthropathies

601

0.96

0.07

1.1

1.31

1.28

u/ml

0.01

236

Mental disorders, not otherwise specified

773

0.97

0.07

1.1

0.73

1.13

u/ml

0.48

336

Contact with sharp glass

337

0.95

0.07

1.0

1.1

0.19

1.04

u/ml

—

147

Bell's palsy

688

1.03

0.07

1.0

1.1

2.21

1.34

u/ml

0.48

283

Contusion of ankle

347

0.95

0.07

1.2

1.1

0.47

1.01

u/ml

0.73

155

Deep endometriosis

708

1.03

0.07

1.1

0.71

1.03

u/ml

0.36

302

Degeneration of macula and posterior pole

114

918

1.02

0.07

1.0

1.1

0.69

1.03

u/ml

0.50

366

Maternal care for known or suspected malpresentation of fetus

259

1903

1.01

0.07

1.1

1.70

0.96

u/ml

0.39

100

786

Other renal tubulo-interstitial diseases

153

0.91

0.07

1.1

1.0

0.59

2.36

u/ml

—

Scoliosis

742

0.97

0.07

1.0

1.1

0.48

1.47

u/ml

2.36

358

Congenital malformations of genital organs

120

1219

0.98

0.07

1.1

1.80

1.07

u/ml

0.49

627

Ulcerative rectosigmoiditis

590

0.97

0.07

1.1

0.60

1.34

u/ml

0.93

239

Eating disorder

128

1252

1.02

0.07

1.1

0.98

1.21

u/ml

0.27

597

Assault by sharp object

122

0.90

0.07

1.0

1.1

0.30

2.11

u/ml

—

Inflammatory bowel disease

269

2726

0.99

0.07

1.1

1.59

1.26

u/ml

0.16

108

1207

Osteonecrosis

214

0.93

0.07

1.0

1.1

0.04

1.60

u/ml

—

Parodontitis, under 40 years and operation codes

129

1264

1.02

0.07

1.1

1.86

1.30

u/ml

0.18

582

Parodontitis, operation under 40 years and operation codes

129

1264

1.02

0.07

1.1

1.86

1.30

u/ml

0.18

582

Maltreatment syndromes

549

0.96

0.07

1.1

0.37

1.39

u/ml

2.11

233

Golimumab

275

0.94

0.06

1.0

1.1

0.27

1.70

u/ml

1.50

119

Tooth eruption problems

220

2146

1.02

0.06

1.1

0.87

1.53

u/ml

1.74

122

1090

Embedded teeth, including avohilmo

116

1185

0.98

0.06

1.0

1.1

0.82

1.36

u/ml

1.02

543

Unspecified jaundice

173

0.92

0.06

1.0

1.1

0.74

1.53

u/ml

—

Distal bite

636

1.03

0.06

1.1

2.78

1.46

u/ml

0.31

373

Other disorders of male genital organs

226

1.06

0.06

1.0

1.1

0.33

2.08

u/ml

1.57

105

Cardiomyopathy, other and unspecified

285

0.95

0.06

1.0

1.1

2.13

1.99

u/ml

0.05

127

Torticollis

138

1.09

0.06

1.2

1.1

0.56

2.07

u/ml

—

Weight loss

522

1.03

0.06

1.1

0.76

1.34

u/ml

0.47

255

Cardiodefibrillation

100

1021

0.98

0.06

1.0

1.1

0.45

1.15

u/ml

1.63

422

Slow fetal growth and fetal malnutrition

176

1.08

0.06

1.1

1.2

0.38

0.87

u/ml

0.56

134

Parodontitis, under 40 years, or operation codes

136

1335

1.02

0.06

1.1

1.87

1.30

u/ml

0.20

613

Dipeptidyl peptidase 4 (DPP-4) inhibitors

315

1.05

0.06

1.0

1.1

1.85

1.29

u/ml

0.30

132

Benign neoplasm of thyroid gland

152

0.92

0.06

1.1

0.41

0.80

u/ml

—

Antepartum haemorrhage, not elsewhere classified

102

998

1.02

0.06

1.1

0.52

0.80

u/ml

0.65

410

Polycystic ovarian syndrome, broad definition

145

1425

1.02

0.06

1.1

0.58

1.07

u/ml

1.23

599

Superficial injury of neck

158

1.08

0.06

1.2

1.1

1.19

0.91

u/ml

—

Convalescence

276

1.05

0.06

1.1

0.36

1.45

u/ml

1.42

117

Other coagulation defects

513

1.03

0.06

1.2

1.1

0.79

0.96

u/ml

0.14

223

Focal brain injury

276

1.05

0.06

1.1

1.0

1.11

1.96

u/ml

0.50

112

Infections of genitourinary tract in pregnancy

830

1.02

0.06

1.1

1.74

1.26

u/ml

0.25

354

Follow-up examination after treatment for malignant neoplasms

284

0.95

0.06

1.1

1.0

0.38

1.14

u/ml

—

100

Benign neoplasm of breast

741

1.03

0.06

1.1

0.77

1.06

u/ml

0.26

293

Amiodarone users

233

0.94

0.05

1.0

1.1

0.48

1.53

u/ml

0.99

Hidradenitis suppurativa

304

0.95

0.05

1.0

3.53

1.56

u/ml

0.44

117

Diabetes mellitus in pregnancy

467

3003

1.01

0.05

1.1

0.99

1.21

u/ml

0.30

185

1241

Constipation

657

4672

1.01

0.05

1.1

0.78

1.08

u/ml

0.75

274

2055

Feeding problems of newborn

149

1.08

0.05

1.2

0.14

0.96

u/ml

1.25

122

Other disorders of optic [2nd] nerve and visual pathways

415

1.04

0.05

1.1

2.73

1.41

u/ml

0.26

217

Complications of other internal prosthetic devices, implants and grafts

141

0.92

0.05

1.1

0.04

2.42

u/ml

—

Autoimmune hyperthyroidism

435

1.04

0.05

1.0

1.1

0.45

1.31

u/ml

1.35

164

Gonarthrosis

422

2441

0.99

0.05

1.1

0.92

1.08

u/ml

0.20

172

902

Dental caries

212

2074

1.01

0.05

1.2

1.1

0.70

1.38

u/ml

2.22

118

1007

Spontaneous rupture of synovium and tendon

287

1.05

0.05

1.0

1.1

0.20

1.14

u/ml

—

115

LSIL lesion of the cervix uteri, vagina or vulva

137

1349

1.02

0.05

1.1

0.45

1.01

u/ml

1.33

534

Burns and corrosions of external body surface, specified by site

928

0.98

0.05

1.1

1.05

1.43

u/ml

0.49

435

Abnormal weight loss

426

1.03

0.05

1.1

0.86

1.56

u/ml

0.48

201

Crohn's disease NAS

545

1.03

0.05

1.1

1.61

1.23

u/ml

0.17

245

Medical treatment for female infertility

256

2579

0.99

0.04

1.0

1.1

1.12

0.89

u/ml

0.22

1034

Cerebral aneurysm, nonruptured

367

1.04

0.04

1.1

0.70

1.26

u/ml

—

144

Ankylosing spondylitis, ICD10

615

1.02

0.04

1.0

1.1

0.61

1.26

u/ml

1.06

255

Hypertrophic disorders of skin

496

1.03

0.04

1.1

0.36

1.22

u/ml

1.59

220

Other blood glucose lowering drugs, excl. Insulins

494

0.97

0.04

1.0

1.1

0.25

1.10

u/ml

2.20

215

Diseases of liver

188

1858

1.01

0.04

1.1

0.76

1.24

u/ml

0.98

773

Glaucoma secondary to other eye disorders

140

1.07

0.04

1.0

1.1

0.30

1.79

u/ml

—

Injury of nerves at wrist and hand level

221

0.95

0.04

1.0

1.1

0.20

1.44

u/ml

1.23

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

814

1.02

0.04

1.1

0.29

1.07

u/ml

2.39

318

Carcinoma in situ of skin

150

0.93

0.04

1.1

1.40

0.95

u/ml

—

Pregnancy with abortive outcome

680

3575

0.99

0.04

1.1

1.18

0.94

u/ml

0.34

274

1440

In situ neoplasms

181

1789

1.01

0.04

1.0

1.1

1.65

0.90

u/ml

0.50

711

Hereditary corneal dystrophies

1.10

0.04

1.1

0.38

0.77

u/ml

—

Senile cataract

266

1634

1.01

0.04

1.1

1.0

0.91

1.04

u/ml

0.17

116

603

Open bite

735

1.02

0.04

1.1

0.62

1.15

u/ml

0.98

395

Behavioural disorders, excluding more controls

291

0.96

0.04

1.0

1.1

5.04

1.47

u/ml

0.35

158

Primary coxarthrosis, bilateral

735

0.98

0.04

1.1

1.0

0.56

0.98

u/ml

0.84

296

Dissociative [conversion] disorders

362

0.97

0.04

1.1

1.51

1.57

u/ml

0.01

153

Twin gestation

946

0.98

0.04

1.1

0.71

0.96

u/ml

0.28

386

Arthropod-borne viral fevers and viral haemorrhagic fevers

503

0.97

0.04

1.1

0.48

1.47

u/ml

1.35

200

Gestational [pregnancy-induced] hypertension

283

2801

1.01

0.04

1.1

0.66

1.04

u/ml

1.07

104

1143

Other abnormal findings of blood chemistry

200

1.05

0.03

1.0

1.1

0.26

0.96

u/ml

—

Other and unspecified psoriasis

299

1.04

0.03

1.2

1.1

0.60

1.93

u/ml

0.95

128

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

461

4056

0.99

0.03

1.1

1.06

1.02

u/ml

0.03

169

1593

Psoriasis vulgaris

114

1156

0.99

0.03

1.1

0.71

1.15

u/ml

0.42

478

Hypermetropia

716

1.02

0.03

1.2

1.1

0.47

1.30

u/ml

2.14

402

Hepatic failure, not elsewhere classified

129

0.93

0.03

1.2

1.0

1.98

1.99

u/ml

—

Labour and delivery complicated by umbilical cord complications

448

1.03

0.03

1.0

1.1

0.86

1.01

u/ml

0.10

184

Conductive and sensorineural hearing loss

467

3252

0.99

0.03

1.1

0.68

1.20

u/ml

2.13

185

1310

Elevated blood glucose level

468

1.03

0.03

1.2

1.1

0.63

1.56

u/ml

1.10

217

Chronic periodontitis

633

0.98

0.03

1.0

1.1

3.50

0.89

u/ml

0.50

250

Sequelae of injuries of neck and trunk

139

0.93

0.03

1.1

0.85

2.02

u/ml

—

Inflammatory bowel disease, strict (require KELA)

211

2129

0.99

0.03

1.1

1.74

1.37

u/ml

0.14

947

Neovascular glaucoma

141

1.06

0.03

1.0

1.1

0.30

1.78

u/ml

—

Melanocytic naevi, other sites/unspecified

508

1.02

0.03

1.1

0.62

1.31

u/ml

0.71

210

Injuries involving multiple body regions

250

0.96

0.03

1.0

1.1

0.37

1.56

u/ml

1.25

106

Labour and delivery complicated by fetal stress [distress]

352

2333

1.01

0.03

1.1

0.63

0.98

u/ml

1.14

156

957

All dysplastic lesions of the cervix uteri, vagina or vulva

309

3091

0.99

0.03

1.1

1.23

0.94

u/ml

0.29

114

1234

Benign neoplasm: Adrenal gland

260

0.96

0.03

1.0

1.1

1.78

0.77

u/ml

—

104

Aortic valve malfunction, age under 60 years

562

0.98

0.03

1.0

1.1

0.48

1.32

u/ml

1.56

267

IBD patients in KELA-register

211

2128

0.99

0.03

1.1

1.74

1.30

u/ml

0.17

947

Primary ovarian failure

169

0.95

0.03

1.0

1.1

0.33

0.64

u/ml

—

Squamous cell neoplasms and carcinomas of the skin

161

1.06

0.03

1.1

1.0

2.83

1.57

u/ml

—

Obstructed labour due to malposition and malpresentation of fetus

257

2439

0.99

0.03

1.1

1.74

0.95

u/ml

0.46

106

956

Specific development disorders of speech and language

882

1.02

0.03

1.1

1.2

1.48

1.15

u/ml

0.14

531

Other and unspecified disorders of white blood cells

171

1.05

0.03

1.1

0.07

0.86

u/ml

—

Noise effects on inner ear

171

1.05

0.03

1.1

0.56

1.01

u/ml

—

GI-bleeding

135

1365

0.99

0.03

1.1

1.25

0.99

u/ml

0.19

604

265

1.04

0.03

1.0

0.49

1.22

u/ml

—

108

Non-invasive ventilation

156

1480

0.99

0.03

1.0

1.1

0.26

1.07

u/ml

4.70

642

Other disorders of skin and subcutaneous tissue, not elsewhere classified

672

0.98

0.03

1.0

1.1

0.83

1.13

u/ml

0.26

281

Carcinoma in situ of cervix uteri

907

1.01

0.03

1.0

1.1

2.54

0.89

u/ml

0.51

375

Benign neoplasm: Brain, supratentorial

102

1.08

0.03

1.0

1.1

0.10

0.77

u/ml

—

Strabismus

247

2483

0.99

0.03

1.1

1.11

1.29

u/ml

0.15

115

1199

Abscess of Bartholin gland

211

1.04

0.03

1.1

1.0

0.44

0.88

u/ml

—

Other pleural conditions

221

1.04

0.03

1.1

0.39

2.08

u/ml

—

Other necrotizing vasculopathies

231

1.04

0.02

1.0

1.1

0.28

1.89

u/ml

—

Calcific tendinitis of shoulder

289

0.97

0.02

1.0

1.1

0.27

1.08

u/ml

—

106

Other CVD

520

0.98

0.02

1.1

1.21

0.95

u/ml

0.17

233

Otosclerosis

309

0.97

0.02

1.0

1.1

0.27

1.41

u/ml

—

119

Artificial joint operation, meniscal resection

583

3864

1.00

0.02

1.1

1.13

1.03

u/ml

0.11

222

1513

Bacterial pneumoniae

247

2173

1.01

0.02

1.0

1.1

1.03

1.13

u/ml

0.12

121

935

Tubulo-interstitial nephritis, not specified as acute or chronic

349

0.97

0.02

1.1

0.49

1.32

u/ml

1.22

149

Foreign body entering into or through eye or natural orifice

610

1.02

0.02

1.1

0.54

1.46

u/ml

1.69

279

Neuromuscular dysfunction of bladder

391

1.02

0.02

1.1

0.75

0.90

u/ml

0.15

165

Disorders of adult personality and behaviour

298

2995

0.99

0.02

1.1

0.79

1.23

u/ml

1.10

136

1270

Specific personality disorders

242

2434

0.99

0.02

1.1

0.85

1.29

u/ml

0.84

112

1025

Premature separation of placenta [abruptio placentae]

212

1.04

0.02

1.1

0.33

1.48

u/ml

—

Eating disorders

137

1357

1.01

0.02

1.1

0.93

1.24

u/ml

0.42

642

Exclusion endpoint for clefts

298

0.97

0.02

1.1

1.2

1.34

1.06

u/ml

0.09

196

Open wound of head

373

3688

1.00

0.02

1.1

0.91

1.20

u/ml

0.71

186

1696

Endovascular or surgical operations to intracerebral aneurysms

258

0.97

0.02

1.1

0.73

1.52

u/ml

—

105

Diabetic neuropathy

310

1.03

0.02

1.1

1.48

1.35

u/ml

0.04

113

Behavioural disorders

288

0.97

0.02

1.0

1.1

5.04

1.49

u/ml

0.35

145

Hernia of abdominal wall, postoperative

940

1.01

0.02

1.0

1.1

1.39

1.00

u/ml

0.21

368

Pneumonia, organism unspecified

810

5843

1.00

0.02

1.1

1.11

u/ml

0.00

400

2538

Other congenital malformations of limb(s)

117

0.94

0.02

1.1

0.07

1.37

u/ml

—

Infections specific to the perinatal period

322

1.03

0.01

1.2

0.45

1.06

u/ml

1.28

230

400

1.02

0.01

1.0

0.66

0.96

u/ml

0.33

168

Pneumonias (Asthma/COPD co-morbidities)

964

6689

1.00

0.01

1.1

1.13

1.12

u/ml

0.02

482

2883

Brachial plexus disorders

771

1.01

0.01

1.1

1.04

1.35

u/ml

0.19

307

Entropion and trichiasis of eyelid

143

1.05

0.01

1.0

0.07

1.63

u/ml

—

Perioral dermatitis

153

1.05

0.01

1.1

1.0

1.16

1.29

u/ml

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

548

0.98

0.01

1.2

1.1

0.81

1.39

u/ml

0.42

303

Pedal cyclist injured in transport accident

185

1840

1.01

0.01

1.1

0.99

1.39

u/ml

0.74

828

Fracture of foot, except ankle

207

2080

1.00

0.01

1.1

0.91

1.27

u/ml

0.33

919

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

135

1341

1.01

0.01

1.1

0.77

1.19

u/ml

0.70

536

Fibrosis and cirrhosis of liver

263

1.03

0.01

1.0

0.42

1.26

u/ml

—

119

Bipolar affective disorders

180

1791

1.01

0.01

1.0

1.1

0.48

1.42

u/ml

4.17

732

All pneumoniae

976

6724

1.00

0.01

1.1

1.12

u/ml

0.01

489

2901

Psoriasis

180

1809

0.99

0.01

1.1

0.65

1.13

u/ml

0.75

742

HSIL lesion of the cervix uteri, vagina or vulva

207

2061

1.00

0.01

1.0

1.1

1.43

0.89

u/ml

0.40

831

Injuries to the head

1091

7113

1.00

0.01

1.1

1.03

1.13

u/ml

0.19

511

3090

Family history of certain disabilities and chronic diseases leading to disablement

463

1.02

0.01

1.1

0.89

1.48

u/ml

0.31

192

Ulcerative proctitis

467

0.98

0.01

1.1

0.89

1.53

u/ml

0.43

187

Paranoid personality disorder

104

1.06

0.01

1.0

1.1

0.24

2.44

u/ml

—

Erosion and ectropion of cervix uteri

114

1.05

0.00

1.0

1.1

0.83

1.67

u/ml

—

Pustulosis palmaris et plantaris

206

0.97

0.00

1.1

0.31

1.67

u/ml

1.29

Other obstructive and reflux uropathy

306

0.98

0.00

1.0

1.1

0.97

1.36

u/ml

0.17

126

Autism spe

346

0.98

0.00

1.1

0.72

1.55

u/ml

0.75

188

Ankylosing spondylitis, strict definition

344

1.02

0.00

1.0

1.1

0.47

1.39

u/ml

1.14

135

Iron deficiency anaemia

239

2373

1.00

0.00

1.1

1.03

1.12

u/ml

0.10

104

1027

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

706

0.99

0.00

1.0

1.1

0.72

1.40

u/ml

0.91

283

Dermatophytosis

616

0.99

0.00

1.1

1.09

1.19

u/ml

0.06

282

Injuries to the elbow and forearm

619

5596

1.00

0.00

1.1

1.45

1.13

u/ml

0.56

288

2475

Other and unspecified glaucoma

139

1.01

0.00

1.0

2.49

1.77

u/ml

—

Paralytic ileus and intestinal obstruction

102

1018

1.00

0.00

1.1

2.67

1.09

u/ml

0.35

423

Dentinal caries

177

1763

1.00

0.00

1.1

0.74

1.42

u/ml

1.89

100

858

Hypertensive heart and/or renal disease

532

1.01

0.00

1.0

0.53

1.08

u/ml

0.90

226

Spondyloarthritis

129

1288

1.00

0.00

1.0

1.1

0.85

1.32

u/ml

0.64

539

Primary gonarthrosis, bilateral

186

1624

1.00

0.00

1.0

1.04

0.88

u/ml

0.08

588

Postprocedural musculoskeletal disorders, not elsewhere classified

225

0.98

0.00

1.0

0.96

1.77

u/ml

—

Abscess of anal and rectal regions

562

1.00

0.00

1.0

1.1

1.34

1.24

u/ml

0.05

249

Unspecified abortion

345

1.01

0.00

1.0

1.1

0.84

1.13

u/ml

0.35

137

Carcinoma in situ of cervix uteri

922

1.00

0.00

1.0

1.1

2.54

0.87

u/ml

0.52

379

Melanocytic naevi, other sites/unspecified

525

0.99

0.00

1.1

0.62

1.08

u/ml

0.48

219

Viral haemorrhagic fevers, not elsewhere classified/unspecified

411

1.00

0.00

1.1

0.57

1.62

u/ml

1.10

163

Multiple gestation

985

1.01

0.00

1.1

0.91

0.94

u/ml

0.03

401

Other obstructed labour

601

1.00

0.00

1.1

0.34

0.98

u/ml

1.46

245

Assault by unspecified means

175

0.97

0.00

1.1

1.19

1.68

u/ml

—

Post-traumatic wound infection, not elsewhere classified

124

0.97

0.00

1.1

0.56

1.72

u/ml

—

Benign neoplasm of thyroid gland

136

1.03

0.00

1.1

0.41

1.76

u/ml

—

Congenital malformations of uterus and cervix

225

1.02

0.00

1.0

1.1

0.28

0.73

u/ml

—

Other encephalitis

144

0.97

0.00

1.1

1.54

1.41

u/ml

—

Granulomatous disorders of skin and subcutaneous tissue

154

0.97

0.00

1.1

1.0

0.28

0.71

u/ml

—

Psoriasis (vulgaris), strict definition

174

0.98

0.00

1.1

0.16

1.83

u/ml

—

Other congenital malformations of peripheral vascular system

117

1.03

0.00

1.0

1.1

0.09

1.30

u/ml

—

Myeloproliferative diseases (CML excluded)

226

1.02

0.00

1.0

0.12

1.29

u/ml

—

Subarachnoid haemorrhage

347

1.01

0.00

1.1

0.43

1.15

u/ml

—

142

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

244

0.98

0.00

1.0

1.1

0.18

0.92

u/ml

—

108

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

419

0.99

0.00

1.1

1.2

0.73

0.89

u/ml

0.14

310

Pregnancy hypertension

433

3904

1.00

0.00

1.1

1.08

1.02

u/ml

0.04

161

1533

Anankastic personality disorder

306

1.01

0.00

1.2

1.1

0.09

1.25

u/ml

—

122

Aneurysms, operations, SAH

662

1.00

0.00

1.1

0.52

0.95

u/ml

0.79

266

Carcinoma in situ of cervix uteri, endocervix

102

0.98

0.00

1.0

1.1

0.02

1.32

u/ml

—

Family history of other conditions

122

0.98

0.00

1.1

0.22

0.69

u/ml

—

Seronegative rheumatoid arthritis

544

0.99

0.00

1.1

0.29

1.28

u/ml

2.07

214

Hypertrophic cardiomyopathy

132

0.98

0.00

1.0

1.1

1.34

0.98

u/ml

—

Haemorrhagic and haematological disorders of fetus and newborn

554

1.00

0.00

1.2

1.00

1.15

u/ml

0.10

396

Diabetic retinopathy, strict definition

601

1.01

0.00

1.0

1.1

1.40

0.78

u/ml

0.36

233

Other and unspecified intracranial injuries

148

1.01

0.00

1.1

1.02

1.58

u/ml

—

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

224

1.02

0.00

1.1

0.96

0.78

u/ml

—

Benign neoplasm: Skin of trunk

222

0.99

0.00

1.2

1.1

0.17

1.55

u/ml

1.66

101

Other surgical follow-up care

228

1.01

0.00

1.0

1.1

1.01

1.66

u/ml

0.31

105

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

402

0.99

0.00

1.0

1.1

0.76

0.91

u/ml

0.12

171

Carcinoma in situ of cervix uteri, endocervix

101

0.99

0.00

1.0

0.02

1.30

u/ml

—

Mental and behavioural disorders due to tobacco

458

1.00

0.00

1.0

1.1

2.48

1.30

u/ml

0.21

189

Smoking dependency

458

1.00

0.00

1.0

1.1

2.48

1.30

u/ml

0.21

188

Other osteochondropathies

502

1.00

0.00

1.1

1.19

1.30

u/ml

0.07

218

Burn and corrosion of shoulder and upper limb, except wrist and hand

139

1.01

0.00

1.0

1.1

1.39

2.10

u/ml

—

Urethral stricture

149

1.01

0.00

1.3

1.0

0.28

0.90

u/ml

—

Other inflammatory liver diseases

321

1.00

0.00

1.1

0.29

1.67

u/ml

—

136

Neonatal jaundice from other and unspecified causes

446

1.00

0.00

1.2

1.13

1.18

u/ml

0.03

330

Diseases of the myoneural junction and muscle

541

1.00

0.00

1.1

0.98

1.46

u/ml

0.24

242

Hemiplegia

239

1.00

0.00

1.0

1.1

0.42

1.96

u/ml

1.39

109

Meningitis

304

0.99

0.00

1.1

1.79

1.67

u/ml

0.04

132

Hypo-osmolality and hyponatraemia

508

1.00

0.00

1.1

0.50

1.06

u/ml

1.04

235

Traumatic subdural haemorrhage

296

1.00

0.00

1.1

1.0

0.76

2.00

u/ml

0.81

123

Juvenile rheumatoid arthirtis

217

1.01

0.00

1.1

0.13

1.65

u/ml

—

Calculus of lower urinary tract

127

1.02

0.00

1.0

1.01

2.21

u/ml

—

Oral lichen ruber planus wide, hypothyreosis or thyroxin

183

0.98

0.00

1.1

0.09

1.38

u/ml

—

Other noninflammatory disorders of cervix uteri

207

1.01

0.00

1.1

0.14

1.23

u/ml

—

Failed induction of labour

703

1.00

0.00

1.1

0.27

0.96

u/ml

1.97

290

Motor disorders, excluding more controls

391

1.00

0.00

1.1

1.2

1.69

1.18

u/ml

0.22

289

Conductive hearing loss, unspecified

507

1.01

0.00

1.1

0.20

1.50

u/ml

2.60

230

Artificial joint re-operation

147

1.02

0.00

1.0

1.1

0.35

2.01

u/ml

—

Molar incisor enamel hypoplasia, with caries

256

1.01

0.00

1.2

1.3

0.09

1.38

u/ml

2.60

196

Benign neoplasm: Adrenal gland

253

0.99

0.00

1.0

1.1

1.78

1.28

u/ml

—

104

Carcinoma in situ of skin

143

0.98

0.00

1.1

1.40

1.97

u/ml

—

Other diseases of pancreas

253

0.99

0.00

1.1

0.25

1.36

u/ml

—

106

Pneumothorax

253

0.99

0.00

1.0

1.1

0.34

1.81

u/ml

—

111

Carrier of infectious disease

155

1.03

0.00

1.1

3.83

1.60

u/ml

—

Respiratory distress of newborn

453

1.00

0.00

1.2

1.28

0.80

u/ml

0.36

337

Pedal cyclist injured in collision with motor vehicle

225

1.02

0.00

1.1

1.05

1.83

u/ml

—

Molar incisor enamel hypoplasia

671

0.99

0.00

1.1

1.2

0.68

1.30

u/ml

0.95

449

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Mugwort IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS